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CHAPTER I 
 
BIOGENESIS AND HETEROGENEITY OF CYS-LOOP RECEPTORS 
 
 
Introduction 
 
The human brain is a complex network of approximate 1011 neurons, each 
forming about 1,000 synapses (Greengard, 2001).  The resulting communication between 
neurons gives rise to consciousness and controls voluntary behavior.  More than 99% of 
synapses relay signals using chemical neurotransmitters, which include amino acids (γ-
aminobutyric acid, glutamate and glycine), monoamines (acetylcholine, 5-
hydroxytryptamine, dopamine, epinephrine, norepinephrine, melatonin and histamine), 
and neuropeptides (vasopressin, somatostatin and etc.) (Iversen, 1984;Greengard, 2001).  
The release of neurotransmitters from presynaptic vesicles into the synaptic cleft is 
induced by an action potential, which propagates down the axon to the nerve terminal.  
Neurotransmitter receptors on the cell surface of the postsynaptic neuron then convert the 
chemical signals into electrical and/or secondary chemical signals. 
Depending on how fast the receptors in postsynaptic neurons transduce signals, 
communication across synapses is classified as either fast or slow neurotransmission.  
Fast neurotransmission is mediated mainly by ligand-gated ion channels (LGICs).  Once 
activated by neurotransmitters, LGICs go through a series of conformational changes that 
lead to their opening and initiation of action potential propagation within one millisecond.  
Half of the receptors mediating fast neurotransmission are excitatory and mainly 
activated by glutatmate; the other half of receptors in fast synapses are inhibitory and are 
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responsive to γ-aminobutyric acid (GABA) (Greengard, 2001).  In contrast, slow 
neurotransmission takes hundreds of milliseconds to minutes to achieve its effects, 
because it is primarily mediated by guanine nucleotide binding protein (G protein)-
coupled receptors (GPCRs), which accomplish signal transmission by activating coupled 
G-proteins and then downstream effectors.  It is worth noting that some neurotransmitters 
such as GABA, acetylcholine (ACh) and 5-hydroxytryptamine (5-HT) activate both 
LGICs and GPCRs.  For instance, GABA can activate GABA type A and C (GABAA and 
GABAC) LGICs as well as GABA type B (GABAB) GPCRs. 
Cys-loop superfamily receptors, which include GABAA and GABAC, glycine, 
nicotinic ACh (nACh) and 5-HT type 3 (5-HT3) receptors, are members of LGICs 
(Macdonald and Olsen, 1994;Lynch, 2004;Kalamida et al., 2007;Reeves and Lummis, 
2002).  Thus, functional surface expression of Cys-loop receptors regulates neuronal 
excitability and shapes neuronal plasticity (Biggio et al., 2001).  Expression of Cys-loop 
receptors with diverse electrophysiological and pharmacological properties, and with 
distinct temporal and spatial distributions is primarily regulated by receptor biogenesis.  
Indeed, mutations in Cys-loop receptors, which affect receptor biogenesis and thus alter 
receptor surface density, have been associated with idiopathic generalized epilepsies 
(IGEs) (Macdonald et al., 2006;Frugier et al., 2007;Gallagher et al., 2005;Harkin et al., 
2002;Kang and Macdonald, 2004), startle syndromes (Bakker et al., 2006), congenital 
myasthenic syndromes (CMSs) (Shen et al., 2005), and psychiatric disorders (Niesler et 
al., 2001a).  To develop effective treatment strategies, the biogenesis of Cys-loop 
receptors was investigated in the present studies.  In particular, the studies focused on 
structural determinants of GABAA receptor biogenesis. 
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Archetypal Cys-loop receptor structure and biogenesis 
 
 
 
Cys-loop receptor topology has been deduced by studying the muscle-type nACh 
receptor and the ACh binding protein (AChBP) 
 
Taking advantage of the enrichment of muscle-type nACh receptors in the post-
synaptic membrane preparation from the marine ray (Torpedo marmorata) electric organ 
(which is anatomically similar to skeletal muscle), the receptor structure and subunit 
topology have been determined at a 4 Å resolution using cryoelectron microscopy 
(Unwin, 2005) (Figure 1A).  The Torpedo nACh receptor is composed of five 
homologous subunits that are arranged pseudo-symmetrically around a central axis in an 
order of β-α-γ-α-δ, counterclockwise as viewed from the synaptic cleft.  The tertiary 
structure of each subunit consists of an extracellular N-terminal domain that contains 
binding sites for ligands and drugs  (Blount and Merlie, 1988) (Figure 1B).  This domain 
also has the signature Cys-loop, an absolutely conserved 15 amino acid-long region with 
the two terminal residues forming a disulfide bond (Ortells and Lunt, 1995).  Consistent 
with previous predictions, which were based on hydrophobicity analysis (Noda et al., 
1982), four transmembrane domains (named M1, M2, M3 and M4) were resolved with 
the M2 domain lining the ion channel (Figure 1E).  The cytoplasmic loop linking the M3 
and M4 domains, which is named the M3-M4 loop here after, is the longest of the three 
loops connecting the four transmembrane domains and is the major site for cellular 
regulation (Figure 1B).  Based on the similarity of their primary sequences and secondary 
structures (such as the conserved Cys loop and the predicted 4 transmembrane domains), 
all Cys-loop receptor subunits are believed to share a similar topology.  
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Figure 1.  Structures of Cys-loop receptors 
 
A, The three-dimensional structure of a Torpedo muscle-type nACh receptor was adopted 
from the RCSB protein data bank (http://www.pdb.org/pdb/explore.do?structureId=2BG9) 
(lateral view).  The conserved aspartate residues (D407, D436, and D454 in α, β, and δ 
subunits, respectively) are labeled in white.  Note that large portions of the major 
cytoplasmic loops were omitted here.  B, A schematic presentation of a Cys-loop receptor 
subunit is presented (lateral view).  C and D, Schematic presentations of the N-terminal 
domain arrangements of the Torpedo nACh receptor and an inferred GABAA receptor, 
respectively, are presented (top view from synaptic cleft).  The triangles represent the 
ligands binding to the interfaces of subunits.  E, A schematic presentation of the 
arrangement of transmembrane domains of the GABAA receptor is shown (top view after 
removing the N-terminal domains).  
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The crystal structure of the soluble AChBP from the Lymnaea stagnalis, the fresh 
water snail, has been resolved at 2.7 Å (Brejc et al., 2001).  The AChBP homo-pentamer 
resembles the extracellular portions of homomeric α7 and α9 nACh receptors, and 
advances our understanding of Cys-loop receptor functions in ligand binding and 
interactions between subunit N-terminal domains.  Based on the homology to the AChBP, 
the interacting surface of the N-terminal domain of a GABAA receptor subunit is divided 
into plus (+) and minus (-) sides.  Portions of the loops (named L1, 2, 4, 5, 7, 8 and 10), 
which link α-helixes and/or β-sheets, constitute the (+) side, while portions of α-helix 1, 
β-sheet 1, 2, 3, 5, 6, and L9 constitute the (-) side (Brejc et al., 2001).  The GABA 
binding pocket is located at the α-β subunit interface, which is constituted by portions of 
the β subunit (+) side and the α subunit (-) side (Akabas, 2004) (Figure 1D).  
 
Cys-loop receptor biogenesis has been deduced from study of the muscle-type nACh 
receptor 
 
It is also believed that the essential biogenic steps of all Cys-loop receptors are 
similar since Cys-loop receptor subunits are similar, and all receptors are assembled from 
multiple homologous subunits (Keller and Taylor, 1999).  Given that the muscle-type 
nACh receptor is by far the best characterized Cys-loop receptor, it is considered the 
prototype for biogenesis of other Cys-loop receptors.   
Nascent polypeptides of transmembrane proteins have been demonstrated to be 
translated simultaneously by endoplasmic reticulum (ER)-associated ribosomes and 
inserted through translocons into the membrane of the ER (Alder and Johnson, 
2004;White and von Heijne, 2005).  Nascent nACh receptor subunit polypeptides have 
been shown to undergo several co- and post-translational modifications including 
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cleavage of signal peptides, glycosylation and formation of the signature disulfide bond 
in the Cys-loop (Blount and Merlie, 1990).  Subunit folding is facilitated by glycosylation 
of certain asparagine residues in a consensus sequence in the subunit N-terminal domain 
(Blount and Merlie, 1990) and by association with ER-resident chaperones such as 
immunoglobulin heavy-chain binding protein (BiP) (Paulson et al., 1991), calreticulin, 
and calnexin (Gelman et al., 1995).  The assembly of pentamers leads to dissociation of 
ER-associated chaperones (Wanamaker et al., 2003;Wanamaker and Green, 2007) 
(Figure 2).  Consequently, only fully assembled pentamers are allowed to be trafficked to 
the cell surface. 
Two ER-associated protein machineries act complimentarily to perform ER 
quality control.  First, coat protein complex II (COPII) specifically sorts only fully 
assembled pentameric receptors into forward trafficking vesicles (Aridor and Traub, 
2002).  Second, COPI retrieves incompletely assembled intermediates with exposed ER 
retention signals (Keller et al., 2001;Wang et al., 2002).  Assembled intermediates and 
misfolded proteins that are retained or retrieved then go through refolding, 
oligomerization, and assembly cycles (Wanamaker and Green, 2007).  Subunits that 
undergo several cycles in the ER but fail to incorporate into a fully assembled pentamer 
are than transferred to the cytoplasm via translocons for ER associated degradation 
(ERAD), which is executed by the ubiquitin-proteasome system (UPS) (Christianson and 
Green, 2004;Wanamaker and Green, 2007) (Figure 2). 
Fully assembled Cys-loop receptors, which are released from the ER, pass the 
Golgi compartment and finally reach the cell surface.  Receptors then either  
 
7 
 
 
Figure 2.  Biogenesis of the muscle-type nACh receptor  
 
The identities of some interacting proteins and protein complexes are shown in the box.  
The biogenesis processes includes (1) insertion of a nascent-receptor-subunit polypeptide 
via the translocon to the ER, (2) folding of a polypeptide with the help of chaperones, (3) 
oligomerization of subunits, (4) degradation of a subunit polypeptide by the proteasomal 
system, (5) assembly of a receptor pentamer, (6) releasing of a receptor from the ER, (7) 
retrieval of a receptor from the Golgi apparatus, (8) forward trafficking from Golgi 
apparatus to the cell surface, (9) recycling of receptors, and (10) degradation of a receptor 
by the lysosomal system. 
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continuously recycle between the surface and intracellular pools (Bruneau et al., 2005), 
or are directed to the lysosomal degradation pathway (Fumagalli et al., 1982) (Figure 2). 
These trafficking processes are under regulation by cellular proteins, which mainly 
interact with the receptor subunit M3-M4 loops.  Since the M3-M4 loops are the most 
diverse portions of Cys-loop receptor subunits, these interactions between subunits and 
cellular proteins are predicted to be specific to individual subunits and receptor isoforms.  
Given the focus of this dissertation, the proteins involved in nACh receptor forward 
trafficking and surface stability will not be discussed further, and those involved in 
GABAA receptor trafficking will be discussed later. 
 
Cys-loop receptor biogenesis and functions 
 
 
 
Receptor assembly being the basis for receptor heterogeneity 
 
An early step of Cys-loop receptor biogenesis, multiple-subunit assembly, confers 
receptors with great diversity.  A Cys-loop receptor can be composed of five identical 
subunits (i.e. homo-pentamer) or different subunits (i.e. hetero-pentamer).  While the 
homologous subunits are believed to share a similar topology, they have different 
primary sequences with about 70-80%, 30-40%, and 20-30% of amino acid residues are 
identical among the same type of subunits, among different types of subunits within the 
same family, and among different families, respectively (Macdonald and Olsen, 1994).  
Consequently, specific combinations of subunit subtypes produce different receptor 
isoforms with diverse electrophysiological and pharmacological properties, and with 
distinct temporal and spatial distributions.   
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Table 1. Subunits of Cys-loop receptors 
 
Anionic receptors 
 
Subtypes Cationic receptors Subtypes 
GABAA receptors α1-6, β1-3, γ1-3, δ, ε, 
θ and π 
 
nACh receptors α1-10*, β1-4, γ, δ and 
ε 
 
GABAC receptors 
 
ρ1-3 
 
5-HT3 receptors 5-HT3A, 3B, 3C, 3D and 3E 
Glycine receptors α1-4 and β 
 
  
* α8 subunit of nACh receptor family is absent from human (Millar and Harkness, 2008). 
 
 
 
To date, 16, 3, 5, 16 and 5 subunit subtypes of GABAA, GABAC, glycine, nACh 
and 5-HT3 receptor subunits, respectively, have been identified in humans (Table 1) 
(Darlison et al., 2005;Chebib, 2004;Kirsch, 2006;Millar, 2003;Niesler et al., 2008).  
Furthermore, some subunit subtypes have alternative spicing variants, which further 
increase subunit diversity.  Mathematically, the number of possible receptor isoforms for 
a given Cys-loop receptor family is 5N-1 (where N equals number of subunit subtypes 
including splicing variants that have been identified for a given family of Cys-loop 
receptors).  However, because of additional-assembly constraints, actual pentameric 
isoforms are fewer.  In past decades, investigations using heterologous expression 
systems, in which a specific combination of a recombinant Cys-loop receptor can be 
expressed, have revealed several possible-subunit combinations of functional-surface 
Cys-loop receptors.  However, not all these possible receptor isoforms are present in the 
nervous system, suggesting that some factors limit the diversity of endogenous Cys-loop 
receptors.   
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Constraints on receptor heterogeneity 
 
Several lines of evidence suggest that an early step in receptor biogenesis, inter-
subunit interactions, could favor some assembly intermediates, and thus, play a role in 
determining receptor stoichiometry.  First, although GABAA receptor α1 and β1 subunits 
are sufficient for functional binary receptor surface expression, the presence of γ2 
subunits results in preferential surface expression of ternary receptors, which show higher 
conductance and have benzodiazepine sensitivity (Angelotti and Macdonald, 1993).  
Second, while 5-HT3A single subunit expression results in functional surface receptors, 5-
HT3A and 5-HT3B subunit coexpression leads to favored assembly of binary receptors 
(Boyd et al., 2002).  Third, glycine receptor α1 and β subunit coexpression generates 
receptors with fixed stoichiometry (α13β2), whereas α1 and α2 subunit coexpression 
produces several isoform combinations that are randomly assembled (Kuhse et al., 1993).   
The temporal and spatial availability of subunits, which is regulated by 
regionally-specific-transcriptional regulation of receptor subunit genes, is another 
important factor determining which receptor isoforms are present in the nervous system.  
For instance, only five subtypes of nACh receptor subunits, α1, β1, γ, δ and ε, are 
expressed at the neuromuscular junction, where γ and ε subunit expression is 
developmentally regulated.  Consequently, the embryonic muscle only expresses the 
α12β1γδ nACh receptor isoform, while the adult muscle exclusively expresses the 
α12β1εδ isoform (Mishina et al., 1986).  Similarly, the cessation of glycine receptor α2 
subunit expression and the initiation of glycine receptor α1 and β subunit expression after 
birth leads to the replacement of α2 homomeric receptors by α1β receptors (Lynch, 
2004;Malosio et al., 1991). 
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Receptor biogenesis resulting in functional and distributional heterogeneity 
  
Receptor assembly confers Cys-loop channels with distinct properties, such as 
gating behaviors, pharmacological profiles, and ion selectivity.  These unique properties 
have been use for their classification.  As revealed in their names, although both glycine 
and GABA can activate glycine receptors, potencies of the two ligands are very different 
(Lu et al., 2008).  Likewise, although taurine activates both GABAA and glycine 
receptors, a higher concentration of taurine is required to activate GABAA receptors than 
to activate glycine receptors (Wu et al., 2008).  The distinct pharmacological profiles 
could then differentiate receptors activated by the same ligands.  For instance, the 
bicuculline insensitivity of GABAC receptors distinguishes them from GABAA receptors 
(Rabow et al., 1995).  Finally, based on their ion selectivity, Cys-loop receptors can be 
classified as anionic or cationic channels (Table 1).  The former includes GABAA, 
GABAC and glycine receptors, which are permeable to Cl¯ and HCO3¯ ions, and the 
latter contains nACh and 5-HT3 receptors, which are permeable to Na+, K+ and Ca2+ ions. 
Activation of a Cys-loop receptor by ligand binding leads to opening of the 
receptor channel pore and passive diffusion of permeable ions between the intracellular 
cytoplasm and the extracellular environment.  The net flux of permeable ions is 
determined by the difference between the intracellular and extracellular concentration of 
the specific permeable ions.  Due to their passive ion permeability, Cys-loop receptor 
functions are affected by environmental conditions.  In adult nervous system, the cationic 
nACh and 5-HT3 receptors mediate excitatory neuronal transmission by allowing the net 
influx of cations to depolarize postsynaptic membranes or to induce release of 
neurotransmitters.  In contrast, the GABAA and glycine receptors mediate inhibitory 
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neuronal transmission since the net influx of permeable Cl¯ hyper-polarizes the cells.  
However, the anionic receptors are excitatory right after birth, when the openings of 
channels lead to the net efflux of Cl¯ ions and depolarization of neurons due to the higher 
intracellular Cl¯ concentration.  The decline of inward Na+/K+/2Cl¯ cotransporter 
expression and the increase of K+/Cl¯ co-transporter expression during the first two 
weeks after birth is responsible for the transition of intracellular chloride concentration 
from higher to lower (Delpire and Mount, 2002;Stein and Nicoll, 2003). 
The expression patterns of Cys-loop receptors are also temporally and spatially 
regulated.  Since Cys-loop receptors are mediators of neuronal transmission, 
environments of Cys-loop receptors, where upstream messengers and downstream 
effectors of receptors vary, can profoundly affect Cys-loop receptor functions.  The 
combination of this distribution diversity with different environmental contexts thus 
confers even greater functional heterogeneity.  Consequently, GABAC receptors are 
involved in vision transmission due to their high expression levels in the retina (Boue-
Grabot et al., 1998).  Similarly, glycine receptors regulate motor function and pain 
transmission because they are mainly distributed in spinal cord (Kirsch, 2006).  Finally, 
5-HT3 receptors, which are highly expressed in the areas of the brain stem such as the 
area postrema and the nucleus tractus solitarius, play a role in emesis (Miquel et al., 
2002).  It is worth noting that some Cys-loop receptor families are widely distributed and 
have broad spectrum of functions.  For example, GABAA receptors, the principal 
mediators of the most abundant neurotransmitter in the brain (Somogyi et al., 1998), are 
involved in neural excitability, circadian rhythm, and neural plasticity (Collinson et al., 
2002).  Thus, they are associated with epilepsy (Sperk et al., 2004), sleeping disorders 
13 
(Ning et al., 2004), anxiety, and alcoholism (Follesa et al., 2006;Mohler, 2007).  
Likewise, neuronal nACh receptors are involved in cognition, learning and memory, 
arousal, nicotine abuse, Alzheimer’s disease, Parkinson’s disease and schizophrenia 
(Paterson and Nordberg, 2000).  
 
Disturbances of receptor biogenesis cause congenital diseases  
 
Several congenital human diseases have been associated with mutations of Cys-
loop-receptor subunits, which cause disturbances of receptor biogenesis.  First, bipolar 
affective disorders and schizophrenia have been, respectively, associated with a mutation 
that increases the 5-HT3A subunit mRNA level (Niesler et al., 2001a), and a 
polymorphism in the 5-HT3A subunit that decreases 5-HT3A/B receptor surface levels 
(Niesler et al., 2001b;Krzywkowski et al., 2007).  Second, CMSs, a group of genetic 
disorders showing weak ocular, cranial, and/or limb muscles, are commonly caused by 
insufficient levels of surface-muscle-type nACh receptors.  Several mutations have been 
identified in receptors and shown to affect different biogenic steps.  Some of these 
mutations result in premature termination of translation by introducing a stop codon or 
inducing a frame-shift (Ohno et al., 1997), thus reducing available subunits for receptor 
assembly.  The other mutations hinder subunit assembly by removing the biogenic 
structural determinants for receptor oligomerization, such as N-glycosylation site 
consensus sequences (Ohno et al., 1996), or Cys-loop cysteines (Milone et al., 1998).  
Third, hyperekplexia or startle syndrome, which is characterized by sudden involuntary-
bilateral movements of the body induced by surprise, alarm and acute pain, has been 
linked to mutations of glycine receptor α1 subunits.  A set of these mutations disturb 
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glycine receptor biogenesis by affecting the availability of subunits, transmembrane 
insertion of a subunit, oligomerization of subunits, assembly of a pentameric receptor, 
and/or trafficking of receptors (Bakker et al., 2006;Castaldo et al., 2004;Humeny et al., 
2002).  Finally, IGEs, including childhood absence, juvenile myoclonic, or generalized 
tonic-clonic epilepsy, have been associated with several GABAA receptor subunit 
mutations that decrease surface receptor levels (Macdonald et al., 2004).  These 
mutations are discussed together with other experimental mutations in following sections 
as they reveal some of the structural determinants of GABAA receptor biogenesis.  
 
Structural determinants of GABAA receptor biogenesis 
 
As the prototype-nACh receptor and the AChBP provide structural and biogenic 
information about Cys-loop receptors, it is clear that cellular proteins regulate Cys-loop 
biogenesis by interacting with specific portions/residues of receptor subunits.  Several of 
these regions, which are described here after as structural determinants of GABAA 
receptor biogenesis, have been identified and are discussed based on their position in 
following sections. 
 
In the N-terminal domains 
 
Studies of natural and artificial mutations, combined with homology modeling 
have significantly advanced our understanding of GABAA receptor biogenesis.  To date, 
several motifs or residues that are located in the N-terminal domain of GABAA receptor 
subunits have been shown to regulate subunit oligomerization.  For instance, a γ2 subunit 
mutation, which is a conserved residue across all Cys-loop receptor subunits (S171), has 
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been shown to decrease co-immunoprecipitated partnering α2 and β1 subunits by γ2 
subunits.  Interestingly, although the mutations abolished the benzodiazepine antagonist 
binding sites, they had no significant effects on GABA agonist binding sites.  This 
finding suggests that α2β1 binary receptors are assembled and expressed on the cell 
surface.  Based on homology modeling, this residue is predicted to stabilize an exposed 
loop structure, on the subunit (+) side (Jin et al., 2004). 
Similarly, a naturally occurring mutation in the GABAA receptor γ2 subunit, 
which changes a superfamily conserved arginine to glutamine at position 43 (R43Q), has 
been associated with IGEs (Baulac et al., 2001) and causes the ER retention of mutant 
subunits (Kang and Macdonald, 2004).  Homology modeling predicts that the mutation 
disrupts the inter-subunit contact between the β2 subunit minus side and the γ2 subunit 
plus side (Sancar and Czajkowski, 2004).  Supporting the hypothesis, a γ2 subunit 15 
amino-acid-long peptide with the conserved (R43) residue and its surrounding sequences 
was able to pull-down partnering α1 and β2 subunits.  Furthermore, the equivalent 
regions from α1 and β2 subunits were also capable of pulling-down partnering subunits, 
suggesting that the region is sufficient for mediating subunit oligomerization (Hales et al., 
2005).  Controversially, despite significantly decreased surface expression of mutant 
γ2(R43Q) subunits, oligomerization of γ2(R43Q) subunits with α3 and β2 subunits was 
not impaired as shown by an immunoprecipitation assay (Frugier et al., 2007).  This 
inconsistency may originate from heterogeneity of subunits and/or from the involvement 
of other regions of the full-length subunits. 
Another mutation in γ2 subunits substituting the arginine at position 139 with 
glycine has also been associated with IGEs (Audenaert et al., 2006).  An in depth study 
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revealed that the mutation caused reduction of surface α1β2γ2 receptor levels due to ER 
retention of γ2(R139G) subunits.  Impaired oligomerization/assembly was predicted as 
surface and α1 and β2 subunit levels were not decreased suggesting surface expression of 
normally disfavored α1β2 receptors (Schwartz et al., unpublished). 
It is worthwhile pointing out that some of these oligomerization motifs in GABAA 
receptors are unique for one type or subtype of subunits and mediate interactions with 
specific partnering subunits.  Oligomerization signals in this category are suggested to 
constrain possible combinations and regulate the stoichiometry of receptors.  For instance, 
the β3 subunit sequence from residue 76 to 89, G-I-P-L-N-L-T-L-D-N-R-V-A-D, on the 
minus side of the N-terminal domain mediates the subunit interaction with the α1 but not 
the γ2 subunit, implying that other oligomerization signals on the minus side of the β3 
subunit are involved in β3 and γ2 subunit interactions (Ehya et al., 2003).  The presence 
of more than one oligomerization signal on the same contacting side of the subunit N-
terminal domain suggests that interactions among different types of partnering subunits 
are distinguishable.  In turn, these interactions regulate assembly order and receptor 
stoichiometry.  Supporting the argument, a residue conserved among all α subunit 
subtypes, α1(R66), is specifically required for oligomerization with β2 but not β1 or β3 
subunits (Bollan et al., 2003).  Different affinities of those signals for members of one 
subunit type are potential mechanisms for preferential incorporation of one subunit over 
other subunits within the same subunit type.   
Post-translational modifications in the N-terminal domain also play a crucial role 
in receptor biogenesis.  Blocking N-linked glycosylation of proteins using tunicamycin 
caused the absence of GABAA receptor surface expression (Connolly et al., 1996).  The 
17 
two functional glycosylation sites, N10 and N110 (N38 and N138 if the signal peptide is 
included), in the α1 subunit have been identified (Buller et al., 1994).  In human 
embryonic kidney (HEK) cells, but not Xenopus oocytes, removal of either one of the two 
glycosylation sites by N to Q mutation caused a significant decrease of ligand binding, 
which suggested reduction of surface receptor density.  Furthermore, the temperature-
dependence of the effect of the mutation indicated that glycosylation was important for 
subunit folding (Buller et al., 1994).  Potential glycosylation sites in other GABAA 
receptor subunits are predicted based on their location in a consensus sequence, N-X-S/T, 
where X can be any amino acid except proline.  Whether these predicted glycosylation 
sites are functional or not remains to be determined. 
Some point-mutations associated with IGEs and located in the subunit N-terminal 
domains also cause decrease of surface-receptor-functional expression (Feng et al., 2006).  
However, how these mutations affect receptor biogenesis is less clear.  Given the 
importance of the N-terminal domain in receptor assembly, these mutations may affect 
early steps of receptor biogenesis.  Particularly, the δ(E177A) mutation is right before the 
absolutely conserved cysteine δ(C178), which forms a disulfide bond with δ(C164).  Cys-
loop disulfide-bond formation has been shown to be essential for receptor assembly 
(Green and Wanamaker, 1997).  Thus, it is possible that the δ(E177A) mutation affects 
this essential post-translational modification. 
 
In the M3 transmembrane domain 
 
Insertion of transmembrane helices is essential for establishing the topology of 
transmembrane proteins.  Therefore, residues that are involved in maintaining the helical 
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structure or in interacting with the lipid bilayer play a role in receptor subunit folding 
(Popot and Engelman, 2000).  Recently, an alanine to aspartate mutation in M3 domain 
of GABAA receptor α1 subunit, α1(A322D) has been associated with autosomal 
dominant juvenile myoclonic epilepsy (Cossette et al., 2002).  This mutation exemplifies 
the importance of transmembrane domain structure in GABAA receptor biogenesis, as it 
impaired the biogenesis of GABAA receptors by causing protein misfolding and reducing 
the availability of subunits for receptor assembly (Gallagher et al., 2004;Gallagher et al., 
2005;Gallagher et al., 2007;Bradley et al., 2008).  Few α1(A322D) subunits manage to 
fold correctly, assemble into pentamer, and be expressed on the cell surface.  In this case,  
the α1(A322D) mutation has an additional effect and results in a faster endocytosis rate 
of receptors containing the mutant subunits (Bradley et al., 2008).  
 
In the M2-M3 extracellular loop 
 
The γ2 subunit mutation, K289M, a residue that is conserved across GABAA and 
glycine receptors, has been associated with IGE (Baulac et al., 2001) and shown to cause 
reduction of mutant and partnering subunits in HEK cells (Kang et al., 2006).  
Interestingly, a systematic investigation of the residue equivalents in α1, β2 and γ2L 
subunits demonstrated that the conserved residues were differentially required for 
receptor surface expression.  Supporting the importance of this residue in receptor 
biogenesis, the equivalent β2(K274M) mutation profoundly reduced α1β2(K274M) and 
α1β2(K274M)γ2L receptor surface levels to 4% and 13%, respectively, of wild type α1β2 
and α1β2γ2L receptor levels, respectively.  Controversially, the α1(K278M) and 
γ2L(K289) mutations caused no effects on receptor surface levels (Hales et al., 2006).  
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The inconsistent effects of γ2S(K289M) and γ2L(K289M) mutations may originate from 
the difference between the γ2S and γ2L splice variants, which have different trafficking 
properties (Hales et al., 2006).   
 
In the M3-M4 cytoplasmic loops 
 
The intracellular loop between the M3 and M4 domains is the major site for 
intracellular regulation.  Several proteins and posttranslational modifications have been 
demonstrated to directly interact with subunit M3-M4 loops and to regulate surface 
density of GABAA receptors.   
 
 
Table 2.  Proteins directly associating with M3-M4 cytoplasmic loops of α, β, and γ 
subunits 
 
 Plic-1 BIG2 GRIF-1 AP2 GODZ GABARAP 
α subunits 1-3, 6 - - - - - 
β subunits 1-3 1-3 2 1-3 - - 
γ subunits - - - 2 1-3 1-3 
↑/↓surface 
expression 
↑ ↑ ↑ ↓ ↑ ↑ 
 
 
 
First, the ubiquitin-like protein, Plic-1 (protein linking IAP to the cytoskeleton) 
directly interacts with α1-3, α6, and β1-3 subunit M3-M4 loops.  It increases receptor 
surface density by increasing the stability of receptor subunits in the ER and plasma-
membrane insertion of receptors in the secretory vesicles (Bedford et al., 2001;Saliba et 
al., 2008).  Second, the brefeldin A-inhibited GDP/GTP exchange factor 2 (BIG2) binds 
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to all β subunits.  It functions as a guanine nucleotide exchange factor which can activate 
small G-protein ADP-ribosylation factor 1 and 3.  Thus, BIG2 promotes anterograde 
trafficking from the trans-Golgi network (Charych et al., 2004).  Third, the adaptor 
protein 2 (AP2) complex directly associates with β1-3, γ2 and δ subunits (Kittler et al., 
2005).  It facilitates clathrin-dependent endocytosis, and therefore, decreases the surface 
level of receptors.  Fourth, gephyrin directly and indirectly interacts with α2 and γ2 
subunits, respectively, and facilitates receptor synaptic clustering (Tretter et al., 
2008;Alldred et al., 2005;Essrich et al., 1998;Jacob et al., 2005;Kneussel et al., 1999).  
Fifth, GABARAP binds to γ1-3 subunits.  Its interactions with gephyrin, the N-
ethylmaleimide-sensitive factor, and tubulin suggest that it regulates the intracellular 
trafficking of γ subunit-containing GABAA receptors (Wang et al., 1999).  Sixth, the 
GABAA receptor interacting factor-1 (GRIF-1) binds to β2 subunits.  It may regulate 
receptor trafficking via its interaction with GABARAP (Beck et al., 2002).  Seventh, 
protein kinase C and the receptor for activated C kinase-1 directly associates with β1-3 
subunits (Brandon et al., 1999;Brandon et al., 2002).  Phosphorylation regulates receptor 
surface levels possibly by affecting receptor turn-over (Connolly et al., 1999a;Kanematsu 
et al., 2006).  Last, the Golgi-specific DHHC zinc finger protein (GODZ) directly 
interacts with γ2 subunit M3-M4 loops (Keller et al., 2004) and plays a role in synaptic 
clustering of GABAA receptors (Fang et al., 2006) (Figure 3). 
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Figure 3.  The M3-M4 loops of α1, β2 and γ2S subunits contain multiple protein binding 
motifs 
 
C- and N-terminal portions of M3 and M4 domains, respectively, of individual subunits 
are highlighted in grey.  Numbers above the sequences indicate the start and finish of the 
M3-M4 loop and its protein binding motifs (underlined).  The numbering is relative to the 
first amino acid of the immature polypeptide.  Thus, the residue Q351 mentioned in text 
was indicated as Q390 here.  Note that slashes (//) indicate omitted regions. 
 
 
 
The γ2S subunit mutation, Q351X, which has also been associated with an IGE, 
causes truncation of a γ2 subunit polypeptide C-terminal to residue Q351.  As a result, 
the mutant subunit, which lacks the GABARAP binding motif, the following M4 domain, 
and the C-terminal tail, is retained in the ER (Harkin et al., 2002).  The underlying 
mechanism for the absence of surface expression of the γ2S(Q351X) subunits could be 
similar to the α1 subunit mutation, A322D, ,which reduced availability of subunits due to 
subunit misfolding and ERAD.  Alternatively, the γ2S(Q351X) subunits could result in 
less incorporation of subunits in GABAA receptor complexes, and/or inefficient delivery 
of α1β2γ2S(Q351X) receptors to the cell surface.  Whether the lack of the GABARAP 
binding motif results in the significantly lower surface expression of γ2S(Q351X) 
subunits remains to be elucidated.  Furthermore, it remains to be determined whether or 
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not the decrease of γ2S(Q351X) subunit surface expression changed the population and 
profiles of receptor isoforms expressed on cell surface. 
 
Specific aims 
 
Since Cys-loop receptor channels operate on the cell surface, fluctuations of 
receptor surface levels are accompanied with changes of channel functionalities.  For this 
reason, biogenesis of Cys-loop receptors is the primary determinant that sets the synaptic 
strength of neuronal transmission.  As mentioned above, several intracellular proteins 
interact directly with motifs in GABAA receptor subunits and regulate receptor assembly 
(e.g. the ER chaperones), anterograde trafficking (e.g. the BIG2, GRIF-1 and 
GABARAP), endocytosis (e.g. the AP2), and degradation (e.g. the Plic-1).  Some of these 
proteins cross talk with one another (e.g. gephyrin, GABARAP and GRIF-1), suggesting 
the possibility that they co-exist in a higher order protein complex.  It is predictable that 
removal of motifs involved in receptor anterograde trafficking and recycling processes 
would result in significant alterations in receptor surface expression.  However, 
considering that at least two subunits, such as α1 and β2, are required for efficient surface 
expression, it remains to be determined if there is a subunit specificity of the M3-M4 loop.  
Furthermore, whether there are novel motifs in subunit M3-M4 loops regulating receptor 
surface expression is an open question.  Additionally, whether these structural motif 
binding proteins cross talk to one another and then impose some effects on structural 
motifs where they are not directly bound remains to be elucidated.  Therefore, the 
specific aims of my dissertation are as follows: 
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1. To determine the requirements of individual α1, β2, and γ2 subunit M3-
M4 loops for GABAA receptor surface expression and to narrow down the 
critical structural motifs in the M3-M4 loops for GABAA receptor 
biogenesis.  
2. To determine the roles of the critical structural motifs in GABAA receptor 
biogenesis. 
3. To determine the functional glycosylation sites of the human GABAA 
receptor β2 subunits and to determine if there is cross-talk between the N-
terminal domain of β2 subunits and the M3-M4 loop of the same subunit. 
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CHAPTER II 
 
STRUCTURAL DETERMINANTS IN α1, β2 AND γ2S SUBUNIT M3-M4 
CYTOPLASMIC LOOPS AND THE α1 SUBUNIT EXTRACELLULAR TAIL 
FOR SURFACE EXPRESSION OF GABAA RECEPTORS 
 
 
Introduction 
 
GABAA receptors, members of the Cys-loop superfamily of ligand-gated ion 
channels, mediate fast inhibitory synaptic transmission in the central nervous system.  
GABAA receptor surface density regulates neuronal excitably and is involved in neuronal 
plasticity (Biggio et al., 2001), epilepsy (Frugier et al., 2007;Gallagher et al., 
2005;Gallagher et al., 2007;Kang and Macdonald, 2004;Kang et al., 2006), and anxiety 
(Malizia et al., 1998).  GABAA receptors are pseudosymmetrical pentamers assembled 
from combinations of sixteen subunit subtypes (α1-6, β1-3, γ1-3, δ, ε, θ and π) 
(Macdonald and Olsen, 1994).  De novo synthesized GABAA receptor subunits should 
undergo proper folding (Gallagher et al., 2007;Green and Claudio, 1993), post-
translational modification such as glycosylation (Connolly et al., 1996), oligomerization, 
and assembly in the ER (Blount and Merlie, 1990;Green and Claudio, 1993;Klausberger 
et al., 2001a).  The ER is the frontline of quality control where improperly assembled 
subunits are retained and degraded by ERAD (Gallagher et al., 2007;Christianson and 
Green, 2004;Meusser et al., 2005).  Successfully assembled pentamers are sorted into 
COPII vesicles for forward trafficking (Aridor and Traub, 2002) and monitored by COPI 
complexes that retrieve receptors that expose ER retention signals in the case of improper 
assembly (Wang et al., 2002;Keller et al., 2001;Michelsen et al., 2005).  Receptors that 
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reach the cell surface are then under the regulation of the endosomal system that 
internalizes receptors, sorts them into lysosomes for degradation, or recycles them back 
to the plasma membrane (Kittler and Moss, 2003).   
All GABAA receptor subunits share a similar topology that includes an 
extracellular N-terminal domain, four transmembrane domains, and loops linking the 
transmembrane domains (Macdonald and Olsen, 1994).  The N-terminal portions of 
subunits that precede the major cytoplasmic loop linking the third and fourth 
transmembrane domains (M3-M4 loop) are conserved among subunit types (Thompson et 
al., 1994) and are thought to mediate inter-subunit oligomerization (Hales et al., 2005;Jin 
et al., 2004;Sancar and Czajkowski, 2004).  In contrast, M3-M4 loops vary in length and 
sequence among different GABAA receptor subunit types and contain several protein 
binding motifs that are involved in receptor forward trafficking, endocytosis and 
degradation that up-regulate (Beck et al., 2002;Bedford et al., 2001;Charych et al., 2004) 
or down-regulate (Kittler et al., 2000a) receptor surface density (Figure 3).  However, 
M3-M4 loops may not be the only variable distal GABAA receptor structural regions that 
regulate receptor surface density.  The extracellular C-terminal “tails” distal to the M4 
domains are present only in α1-6 subunits and are composed of ten to thirteen amino 
acids.  Other subunit types, in contrast, have less than two amino-acid “stumps” distal to 
M4 domains (Figure 12).  It has been suggested that this extracellular C-terminal region 
affects receptor assembly, and thus forward trafficking, since addition of C-terminal 
epitope tags results in failure of receptor surface expression (Kittler et al., 2000b). 
To understand better how GABAA receptor surface density is regulated, the roles 
of the α1, β2 and γ2 subunit M3-M4 loops and the α1 subunit C-terminal tail in regulating 
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receptor surface expression were investigated.  A shared signal at the distal end of the 
M3-M4 loops and the long α1 subunit C-terminal tail were shown to be crucial for 
receptor surface expression, as they may affect GABAA receptor assembly or forward 
trafficking. 
 
Materials and methods 
 
 
 
DNA constructs 
  
Complementary DNAs (cDNAs) encoding human α1, β2 and γ2S subunit 
polypeptides, which include the signal peptides, were inserted into pcDNA3.1(+) 
plasmids as described previously.  The cDNA sequences encoding the FLAG-tag amino 
acid sequence, D-Y-K-D-D-D-D-K, were introduced into the α1 subunit (between the 8th 
and 9th amino acids of the mature polypeptide) and β2 and γ2S subunits (between the 4th 
and 5th amino acids of mature polypeptides).  In addition, the HA-tag sequence, Y-P-Y-
D-V-P-D-Y-A, was introduced into the γ2S subunit at the same position as that of the 
FLAG-tags.  Deletions of portions of GABAA receptor subunits and insertions of 
restriction enzyme sites were conducted using the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene).  The forward sequences of the primer pairs for 
mutagenesis are listed below (Table 3).  The γ2(loop∆), γ2(loop∆)FLAG, 
γ2(GABARAP∆)FLAG, and γ2(GABARAP+)FLAG constructs were kindly provided by Dr. 
Kang (Vanderbilt University). 
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Table 3.  Forward sequences of primer pairs for Site-Directed mutagenesis I 
 
Mutation Forward primer sequence (5’ to 3’) 
Deleting major portions of M3-M4 loop 
α1(loop∆)§ GT TAT GCA TGG GAT GGC CTG† TCA AGA AA GCC T 
β2(loop∆) G AGG GGG CCC CAA CGC CAA TGG TCC CGC ATA TTC T 
 
Loop swaps 
Introducing Age I site to M3 domain and M3-M4 loop junction 
α1(Age I+) G ATT GAG TTT GCC ACA GTA ACCGGT* AAC TAT TTC ACT AAG 
AGA GG 
β2(Age I+) CTG GAA TAT GCT TTG GTC ACCGGT AAC TAC ATC TTC TTT GGG 
γ2(Age I+) GTG GAG TAT GGC ACC TTG ACCGGT CAT TAT TTT GTC AGC AAC 
CGG 
Introducing Asc I site to M4 domain and M3-M4 loop junction 
α1(Asc I+) GTC AGC AAA ATT GAC CGA GGCGCGCC CTG TCA AGA ATA GCC TTC 
β2(Asc I+) GTG AAC GCC ATT GAT CGG GGCGCGCC TGG TCC CGC ATT TTC TTC 
γ2(Asc I+) C ATT GCC AAA ATG GAC TCC GGCGCGCC TAT GCT CGG ATC TTC 
TTC 
Deleting Age I site 
α1β2(Age I∆) CTG ATT GAG TTT GCC ACA GTA AAC TAC ATC TTC TTT GGG AGA 
GG 
β2α1(Age I∆) CTG GAA TAT GCT TTG GTC AAC TAT TTC ACT AAG AGA GGT TAT 
GC 
β2γ2(Age I∆) CTG GAA TAT GCT TTG GTC CAT TAT TTT GTC AGC AAC CGG 
γ2α1(Age I∆) GTG GAG TAT GGC ACC TTG AAC TAT TTC ACT AAG AGA GGT TAT 
GC 
γ2β2(Age I∆) GTG GAG TAT GGC ACC TTG AAC TAC ATC TTC TTT GGG 
 
Deleting Asc I site 
α1β2(Asc I∆) GTG AAC GCC ATT GAT CGG CTG TCA AGA ATA GCC TTC CCG 
β2α1(Asc I∆) C AGT GTC AGC AAA ATT GAC CGA TGG TCC CGC ATT TTC TTC CC 
β2γ2(Asc I∆) CGC ATT GCC AAA ATG GAC TCC TGG TCC CGC ATT TTC TTC CC 
γ2α1(Asc I∆) C AGT GTC AGC AAA ATT GAC CGA TAT GCT CGG ATC TTC TTC 
CCC 
γ2β2(Asc I∆) GTG AAC GCC ATT GAT CGG TAT GCT CGG ATC TTC TTC CCC 
 
Regional deletion 
β2(BIG2∆) GAA TAT GCT TTG GTC GCT GCT AGC GCC 
β2(GRIF-1∆) GAG AAA GCT GCT AGC GAA CGA CAT GTG 
β2(postGRIF-1∆) C GCC CTG GAA TGG TCC CGC ATT TTC 
β2(postGRIF-1+) G GAA TAT GCT TTG GTC  CGA CAT GTG GCA C 
β2(postGRIF-1+; 
preAP2∆) 
G GAA TAT GCT TTG GTC AAA AGT CGC CTG AGG 
β2(postGRIF-1+; 
AP2∆) 
CAT GTG GCA CAA AAG ATC ACC ATC CCC GAC 
β2(postGRIF-1+; 
postAP2∆) 
GCC TCC CAA CTG AAA TGG TCC CGC ATT TTC 
 
β2(postAP2∆) GCC TCC CAA CTG AAA TGG TCC CGC ATT TTC 
β2(postAP2+) CTG GAA TAT GCT TTG GTC ATC ACC ATC CCC GAC  
  
§ primer pairs for making α1(loop∆) and β2(loop∆) constructs were from Dr. Kang (Vanderbilt University). 
† sequences underlined are new junction formed after mutagenesis. 
* sequences marked in red indicate restriction enzyme sites. 
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To swap M3-M4 loops among α1, β2 and γ2S subunits, AgeI and AscI restriction 
enzyme sites were introduced into individual subunit cDNAs before the codons encoding 
the N-terminal beginnings of the M3-M4 loop and of the M4 domain, respectively.  The 
boundaries of the M3-M4 loops were predicted based on the UniProt database 
(http://www.expasy.org/sprot/; GBRA1_HUMAN for the α1 subunit, GBRB2_HUMAN 
for the β2 subunit and GBRG2_HUMAN for the γ2S subunit).  It is worth noting that the 
prediction of the boundaries of the M3-M4 loops was based on the Uniprot 
knowledgebase, which predicts longer lengths of the loop than those predicted by the 
homology alignment to nACh receptors (Unwin, 2005).  Since both predictions are 
equally possible due to lack of experimental data, we chose to investigate larger ranges.  
M3-M4 loops of individual type of subunits were excised by double digestion with AgeI 
and AscI and ligated into the other two types of subunits double digested with the same 
enzymes.  Finally, the restriction enzyme sites were deleted.  The mutant constructs were 
confirmed using polymerase chain reactions (PCR). 
To introduce the α1 subunit C-terminal tail into β2 subunits, an overlapping PCR 
strategy was used.  Briefly, the DNA sequence encoding the α1 subunit tail (sequence 
underlined) was embedded in the primer pairs (forward TL+: GG CTT TAC TAT GTG 
AAC AGA GAG CCT CAG CTA AAA GCC CCC ACA CCA CAT CAA TAA GGA 
ACC ACT AGT CCA GTG TGG; reverse TL+: CCA CAC TGG ACT AGT GGT TCC 
TTA TTG ATG TGG TGT GGG GGC TTT TAG CTG AGG CTC TCT GTT CAC ATA 
GTA AAG CC) that were used to amplify two double-stranded DNA segments from β2 
subunit templates.  By pairing the upstream T7 primer with the reverse TL+ primer and 
by pairing the forward TL+ primer with the downstream reverse BGH primer, two β2 
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subunit segments of double-stranded DNA with overlapping sequence (sequence of the 
primer pair) were generated.  These two segments were then used as templates, and 
double-stranded DNA with the inserted α1 subunit tail sequence was amplified using T7 
and BGH primers.  The PCR products were then sub-cloned into pcDNA3.1(+) vectors.  
The FLAG- and HA-tags were inserted using the same strategy. 
 
Cell culture and transfection 
 
HEK293T cells (ATCC (CRL-11268)) were incubated at 37°C in humidified 5% 
CO2/95% air and grown in Dulbecco’s Modified Eagle Medium (Invitrogen) 
supplemented with 10% fetal bovine serum (Invitrogen) plus 100 IU/mL each of 
penicillin and streptomycin (Invitrogen).  Cells were transfected using the FuGene6 
transfection reagent (Roche) using 9 µL of reagent per 3 µg of cDNA.  For transfection in 
a 60 mm diameter culture dish, a total of 3 µg of cDNA was used.  The cDNA-FuGene6 
mixture volumes were scaled up or down proportionally to the surface areas of cell 
culture dishes.  The cDNA mixtures contained α1 and β2 subunits and either empty 
vector or γ2S subunit in a 1:1:1 ratio.  Cells were used for experiments forty-eight hours 
after transfection. 
 
Flow cytometry 
 
To collect single cells for flow cytometry analysis, monolayer cultures of 
HEK293 cells were dissociated by trypsin (Invitrogen) for 2 minutes.  Trypsinization 
then was stopped in 4°C FACS buffer, phosphate buffered saline (PBS) with 2% fetal 
bovine serum and 0.05% sodium azide.  Given that trypsin may cleave the extracellular 
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N-terminal domain and remove the FLAG epitope, the relative surface expression profile 
of FLAG-tagged subunits from cells dissociated by trypsin was compared with that from 
cells dissociated by protease free cell detaching solution, (2 mM EDTA in PBS).  The 
two methods generated similar profiles (Gurba and Macdonald, unpublished).  Following 
washes with FACS buffer, cells were incubated with anti-FLAG IgG directly conjugated 
with R-Phycoerythrin (PE, 1:50 dilution, Martek) for 1 hour.  Cells were then washed 
with FACS buffer again and fixed with 2% paraformaldehyde.  The surface fluorescence 
intensity of each cell was measured using a FacsCalibur (Becton, Dickinson and 
Company).  Data were acquired using Cell Quest (BD Biosciences) and analyzed offline 
using FlowJo (Treestar, Inc.). 
To exclude non-specific surface staining, viable cells were selected based on 7-
amino-actinomycin D (7-AAD) exclusion (Figure 4A).  On the frequency histogram of 
fluorescence intensity of viable cells with mock transfection, a gate for specific 
fluorescence signals was set such that only the brightest 1-2% of cells were included 
(Figure 4B).  For each experimental condition, the percentage of cells with a sufficiently 
high fluorescence intensity to be included in the gate and the mean fluorescence intensity 
of those included cells were obtained (Figure 4C).  By multiplying these two numbers, a 
fluorescence index was obtained that represented the adjusted surface mean fluorescence 
for the whole cell population.  For comparison among various experimental conditions, 
the fluorescence indexes with experimental subunit coexpression were normalized to 
those of control subunit coexpression.  Unless otherwise specified, a one-way ANOVA 
with Tukey’s post test was used to determine if there were significant differences in 
surface levels among transfection conditions. 
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Figure 4. Selections of viable and positively transfected cells 
 
A, A scatter dot plot distinguished individual cells based on their light diffraction 
properties.  Each dot represented a cell which was annotated by two parameters: Y-axis, 
forward scatter (FSC) is proportional to cell size; the bigger the cell, the higher the 
detected signal.  X-axis, side scatter (SSC) is proportional to cell granularity (e.g. 
particles and organelles); the more complex the cytoplasmic contents, the higher detected 
signals.  The viable cell population was gated within the pink circle based on 7-amino-
actinomycin D (7-AAD) exclusion.  B, A representative fluorescence histogram of cells 
in a mock transfection condition is presented.  The Y-axis indicates the cell counts and 
the X-axis indicates the fluorescence intensity (R-Phycoerythrin, PE, in this case, scale is 
from 1 to 10,000 arbitrary units).  The positive-signal gate was set so that only 1% of 
mock transfected cells were included.  C, A representative fluorescence histogram of 
cells with proteins of interests (α1FLAG subunits coexpressed with β2 subunits in this case) 
positively expressed on the cell surface is presented. 
 
 
 
Western blots 
 
Membrane proteins in transfected cells were extracted in modified radio-immuno-
precipitation assay buffers (RIPA buffers), which contained 10-50 mM Tris-HCl (pH 7.4), 
150 mM NaCl, 1.0 mM EDTA, 1-2% NP-40, 0.25-0.5% sodium deoxycholate and 
protease inhibitor cocktail (complete mini, Roche).  Cell lysates were cleaned by 
centrifugation at 10,000X g for 30 minutes.  The supernatants were subjected to further 
experiments or directly to sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
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(SDS-PAGE).  Proteins in gels were transferred to polyvinylidene fluoride (PVDF) 
membranes (Millipore) or nitrocellulose membrane (Amersham Biosciences). 
Monoclonal anti-GABAA receptor α1 subunit antibodies (final concentration 5 
µg/mL, clone: BD24, Chemicon) and monoclonal anti-GABAA receptor β2/3 antibodies 
(4 µg/mL, clone: 62-3G1, Upstate) were used to detect the epitopes in wild type or 
mutant human α1 and β2 subunit N-terminal domains, respectively.  In addition, 4 µg/mL 
monoclonal anti-FLAG antibodies (clone: M2, Sigma) and 1 µg/mL monoclonal anti-HA 
antibodies (clone: 16B12, Covance) were used to detect FLAG-tagged and HA-tagged γ2 
subunits, respectively. Finally, 0.2 µg/mL anti-sodium/potassium ATPase antibodies 
(clone: ab7671, Abcam) were used to control for loading variations.  Following 
incubation with primary antibodies, secondary goat anti-mouse IgG heavy and light chain 
antibodies conjugated with horseradish peroxidase were used at a 1:10,000X dilution 
(Immunoresearch laboratories) for the visualization of specific bands using the enhanced 
chemiluminescent detection system (Amersham Biosciences).  The signals were collected 
in a digital ChemImager (Alpha Innotech), and the integrated density volumes (IDVs, 
pixel intensity X mm2) were calculated using the FluorChem 5500 software.  To compare 
expression levels between the same types of subunits with different mutations, we 
normalized adjusted IDVs (normalized to loading control Na+/K+ ATPase IDVs) to those 
of control conditions. 
 
Glycosidase digestions 
 
Whole cell lysates extracted using modified RIPA buffer were subjected to 
endoglycosidase H (endo H) and peptide N-glycosidase-F (PNGaseF) digestion (New 
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England BioLab) with the supplement of 1X G5 (50 mM sodium citrate, pH5.5) and 1X 
G7 (50mM sodium phosphate, pH7.5) reaction buffer, respectively.  The digestion 
reactions were carried out at 37°C for 3 hours and were then terminated by addition of 
sample buffer.  
  
Immunoprecipitation 
 
Protein complexes containing FLAG-tagged GABAA receptor subunits were 
immunoprecipitated using EZview Red Anti-FLAG M2 beads (Sigma) at 4°C overnight.  
After three washes with extracting RIPA buffer, protein complexes were eluted with 100 
µg/mL FLAG peptide (Sigma).  The presence of GABAA receptor subunits was 
determined by Western blotting.   
 
Results 
 
 
 
The α1, β2 and γ2S subunit M3-M4 loops were required for maximal surface 
expression of α1β2 and α1β2γ2 receptors 
 
To determine if there were different requirements for α1, β2 and γ2S subunit M3-
M4 loops for GABAA receptor surface expression, constructs with large portions of their 
M3-M4 loops deleted (α1(loop∆), β2(loop∆) and γ2(loop∆)) were made.  Twelve amino 
acids, α1N335-G346 and β2N327-Q338, and nine amino acids, γ2H357-P365, at the N-termini of the 
loops were retained to link the M3 and M4 domains (Figure 3).  To detect surface 
expression of α1β2 and α1β2γ2S receptors, FLAG-tags were inserted in α1, β2, γ2S, 
α1(loop∆), β2(loop∆) and γ2(loop∆) subunits and the FLAG-tagged subunits were 
coexpressed with non-FLAG-tagged partnering subunits such that only one subunit was 
34 
FLAG-tagged at a time (e.g. α1FLAG with β2 or α1 with β2FLAG subunits when studying 
coexpressed α1 and β2 subunits).  The surface levels of each type of FLAG-tagged 
subunit using flow cytometry were then measured.  Because anti-FLAG antibodies had 
different affinities for FLAG-tags in different types of subunits, presumably due to the 
differences of adjacent sequences surrounding the tags located in subunit N-terminal 
domains (data not shown), comparisons among different types of subunits were not 
obtained.  However, since the subunit N-terminal portions intact and made mutations in 
only C-terminal portions were kept, anti-FLAG antibodies had the same affinity for 
FLAG-tags in wild type and mutant subunits were assumed.  
For comparison, subunit surface levels in experimental conditions were 
normalized to those obtained with control α1β2 or α1β2γ2S subunit coexpression (e.g. 
coexpression of wild type α1 and β2 or α1, β2 and γ2S subunits).  Unless otherwise 
specified, we used “binary” subunit coexpression to indicate coexpression of α1 and β2 
subunits and “ternary” subunit coexpression to indicate coexpression of α1, β2 and γ2 
subunits, regardless of the wild type or mutant status of each of the subunits.  To 
distinguish wild type partnering subunits coexpressed with mutant subunits from those 
that were coexpressed with other wild type subunits in control conditions, we used 
“control subunits” to specify wild type subunits under control conditions. 
The α1FLAG or β2FLAG subunit surface levels with binary subunit coexpression 
were first evaluated (Figure 5).  Relative to control surface levels, the α1 subunit M3-M4 
loop deletion caused significant partial reductions of both α1(loop∆) and β2 subunit 
surface levels (p < 0.001, n = 6).  The β2 subunit loop deletion resulted in almost 
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Figure 5.  Deletion of the α1 or β2 subunit M3-M4 loop, α1K347-R421∆ or β2K339-R451∆, 
respectively, substantially reduced α1β2 receptor surface expression 
 
A1, Representative distributions of R-Phycoerythrin (PE) fluorescence intensities for 
cells coexpressing α1FLAGβ2 (left panel) or α1FLAGβ2(loop∆) (right panel) subunits and 
stained with a PE-conjugated monoclonal anti-FLAG antibody (M2 clone) were plotted 
as frequency histograms.  The x-axis indicates the fluorescence intensity in arbitrary units 
(note the log scale) and the y-axis indicates the percentage of the maximum cell count.  
Representative distributions obtained from mock transfected cells (unfilled histograms) 
are overlaid with each experimental distribution (filled histograms).  A2, Surface α1FLAG 
subunit levels were quantified using the fluorescence index (see Methods) and plotted as 
a percentage of control α1FLAGβ2 subunit coexpression.  B1, B2, As in Panels A1, A2, 
except for cells coexpressing α1β2FLAG (left panel) or α1β2(loop∆) FLAG (right panel) 
subunits.  *** corresponds to p < 0.001 compared to the control subunit coexpression. 
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complete loss (>95%) reductions of subunit surface levels of both α1 and β2(loop∆) 
subunits such that surface expression of both α1 and β2(loop∆) subunits were 
significantly lower than those with α1(loop∆)β2 subunit coexpression (p < 0.001, n = 4).  
Specifically, subunit surface levels with α1(loop∆)β2 subunit coexpression were 66% and 
53%, and subunit surface levels with α1β2(loop∆) subunit coexpression were only 4% 
and 2% of control α1 and β2 subunits, respectively. 
The α1 and β2 subunit loop deletions caused similar extents of surface level 
reductions of both themselves and partnering subunits with ternary subunit coexpression 
(p < 0.001 for all types, n = 10-14) (Figure 6).  Subunit surface levels with 
α1(loop∆)β2γ2S subunit coexpression were 79%, 69% and 64%, and subunit surface 
levels with α1β2(loop∆)γ2S subunit coexpression were 10%, 5% and 17% of control α1, 
β2 and γ2S subunit surface levels with α1β2γ2S subunit coexpression, respectively.  
Interestingly, while the γ2(loop∆) subunit coexpressed with α1 and β2 subunits had very 
low surface expression (5% of control γ2S subunits, p < 0.001, n = 10), surface levels of 
partnering α1 subunits were much less affected (69% of control α1 subunits, p < 0.001, n 
= 8), and surface levels of partnering β2 subunits were not altered (n = 11).  These 
observations indicated that γ2S subunit loops were essential for α1β2γ2S receptor surface 
expression, but possibly not for α1β2 receptor surface expression.  An explanation for 
this finding was that while γ2(loop∆) subunits had reduced capacity to oligomerize, α1 
and β2 subunits remained free to assemble.  To determine if the γ2(loop∆) subunits could 
still interact with α1 and β2 subunits and decrease surface levels of α1β2 receptors, 
surface levels of α1 and β2 subunits with α1β2γ2(loop∆) subunit coexpression were  
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Figure 6.  Deletion of the α1, β2 or γ2 subunit M3-M4 loop, α1K347-R421∆, β2K339-R451∆ or 
γ2S366-S443∆, respectively, substantially reduced receptor surface expression 
 
A, Representative fluorescence histograms of cells with control α1β2γ2 (first column), 
α1(loop∆)β2γ2 (second column), α1β2(loop∆)γ2 (third column),  α1β2γ2(loop∆) (fourth 
column), or α1β2 (fifth column) subunit coexpression were generated.  Upper panels 
indicates surface α1FLAG subunit levels; middle panels indicates surface β2FLAG subunit 
levels; lower panels indicates surface γ2FLAG subunit levels.  B, Surface α1FLAG (black 
bars), β2FLAG (grey bars), and γ2FLAG (white bars) subunit levels were quantified in each 
condition as a percentage of control subunit coexpression.  *** corresponds to p < 0.001 
compared to the control subunit coexpression; ††† corresponds to p < 0.001 compared to 
the α1β2 subunit coexpression. 
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compared to those with α1β2 subunit coexpression.  To make a proper comparison 
between these two expression conditions, empty pcDNA3.1(+) vector was added with 
α1β2 subunit coexpression to maintain the same amount of  total DNA.  The surface 
levels of α1 and β2 subunits with α1β2γ2(loop∆) subunit coexpression were significantly 
lower (70% and 84% of those with α1β2 subunit coexpression, respectively (p < 0.001 
for both α1 and β2 subunits, n = 8-15).  Taken together, these data suggested that 
γ2(loop∆) subunits could interact with partnering α1 and β2 subunits, but with reduced 
capacity, and that the resulting oligomers or pentamers could not traffic to the cell surface, 
thus decreasing the surface levels of both α1 and β2 subunits. 
 
Total cellular loop-deleted subunit protein levels were not reduced to the same extent 
as surface loop-deleted subunit protein levels 
 
The substantial reductions of GABAA receptor subunit surface expression 
resulting from α1, β2 and γ2S subunit loop deletions could have been due, at least in part, 
to extensive reductions of total cellular protein levels (which includes surface and 
intracellular subunit protein levels).  To examine this hypothesis, the total cellular subunit 
protein levels of mutant and partnering subunits with α1(loop∆)β2, α1β2(loop∆) and 
α1β2γ2(loop∆)HA subunit coexpression were compared to those of control subunits.  The 
subunit total cellular protein expression profiles with α1(loop∆)β2γ2S and 
α1β2(loop∆)γ2S subunit coexpression were not compared since the surface levels of α1 
and β2 subunits with these experimental conditions were similar to those obtained with 
binary subunit coexpression.  In HEK293T whole cell lysates, non-specific proteins were 
recognized by anti-γ2 subunit and anti-FLAG antibodies, thereby masking the specific 
γ2S or γ2SFLAG subunit signals.  Thus, the HA-tag was inserted into the γ2S subunit at the 
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same position as the FLAG-tag to obtain less ambiguous mobility patterns of γ2S 
subunits in Western blots.  
Relative to control subunits, no significant reductions in total cellular protein 
levels of α1(loop∆) or β2(loop∆) subunits with binary subunit coexpression were 
observed (n = 5) (Figure 7A1,B1).  Since total cellular subunit proteins are generally 
composed of two thirds surface protein and one third intracellular protein (Botzolakis and 
Macdonald, unpublished), this suggested that intracellular subunit protein levels were 
actually increased, not decreased (Figure 5).  Surprisingly, significant reductions in total 
cellular protein levels of the partnering subunits (β2 subunits coexpressed with α1(loop∆) 
subunits (p < 0.001, n = 5); α1 subunits coexpressed with β2(loop∆) subunits (p < 0.001, 
n = 5)) (Figure 7A1,B1) were found, consistent with maintained intracellular but reduced 
surface subunit protein levels. 
We compared the surface and total levels of γ2(loop∆)HA subunits with 
α1β2γ2(loop∆)HA subunit coexpression.  Although the subunit-total-protein level was 
significantly reduced relative to that of the control condition (77 % of control subunits, n 
= 6, p = 0.0045, paired t-test) (Figure 7A2, B2), its extent was not as severe as that of 
subunit-surface-level reduction (Figure 6B), consistent with increased, or a least 
maintained, intracellular subunit protein levels.  Similar to α1(loop∆) and β2(loop∆) 
subunits, which caused reduction of partnering subunits with binary subunit coexpression, 
α1 and β2 partnering subunits were significantly reduced with coexpression of 
γ2(loop∆)HA subunits (55% and 67% of control α1 and β2 subunits, p = 0.001 and 0.0021, 
respectively, n = 6), again consistent with increased, or a least maintained, intracellular 
subunit protein levels. 
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Figure 7.  Effects of α1(loop∆), β2(loop∆) and γ2(loop∆) subunits on total cellular 
protein levels of their own and partnering subunits with α1β2 and/or α1β2γ2 subunit 
coexpression 
 
A1, Representative Western blots of RIPA buffer-extracted total proteins from cells with 
α1β2 (first column), α1(loop∆)β2 (second column) and α1β2(loop∆) (third column) 
subunit coexpression are presented.  Loading duplicates were stained with monoclonal 
anti-Na+/K+ ATPase (as loading control, LC; the upper panels of both sets), with anit-α1 
(upper set) or with anti-β2 (lower set) antibodies.  A2, Representative Western blots of 
extracted total proteins from cells with α1β2γ2SHA (first column) and α1β2γ2(loop∆)HA 
(second column) subunit coexpression are presented.  Loading triplicates were stained 
with anti-α1 (upper set), anti-β2 (middle set) and anti-HA (low set) antibodies.  B1, 
Relative total subunit expression levels were expressed as % of corresponding control α1 
or β2 subunits with α1β2 subunit coexpression (e.g. IDVs of α1(loop∆) subunits with 
α1(loop∆)β2 subunit coexpression were normalized to those of control α1 subunits with 
α1β2 subunit coexpression).  B2, Relative subunit expression levels of α1, β2 and 
γ2(loop∆)HA subunits with α1β2γ2(loop∆)HA subunit coexpression were expressed as % 
of corresponding control subunits with α1β2γ2HA subunit coexpression.  ** and *** 
correspond to p < 0.01 and 0.001, respectively, compared to the control subunit 
coexpression.  
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Mutant loop-deleted and partnering subunits were retained in the ER 
 
The low levels of surface expression of β2(loop∆) and γ2(loop∆) subunits 
suggested a severe alteration in GABAA receptor biogenesis or turnover that could have 
been due to either arrest of forward trafficking or to an increased rate of endocytosis.  For 
multimeric subunit protein complexes such as GABAA receptor pentamers, the ER is the 
frontline of quality control where improperly assembled subunits are retained.  Therefore, 
to better understand the underlying mechanism for the loss of GABAA receptor subunit 
surface expression caused by β2 and γ2 subunit loop deletions, we first determined if the 
loop deletions caused subunit ER retention.  GABAA receptor subunits are glycosylated 
proteins and subunit processing in the Golgi apparatus confers resistance to endo H 
glycosidase digestion.  Therefore, endo H digested GABAA receptor subunits that were 
not ER retained would keep complex oligosaccharides and would show populations with 
higher molecular masses than those with all oligosaccharides removed, which could be 
accomplished by PNGaseF digestion.  In contrast, glycosylated subunits that were 
retained in the ER would keep high-mannose oligosaccharides sensitive to endo H 
digestion and would therefore have mobility after endo H digestion similar to that after 
PNGaseF digestion. 
Endo H resistance of α1, β2 and γ2 subunits with α1β2, α1(loop∆)β2, 
α1β2(loop∆), α1β2γ2SHA and α1β2γ2(loop∆)HA subunit coexpression was measured.  
Approximately 80% of total α1 or β2 subunit proteins with control α1β2 subunit 
coexpression were endo H resistant as indicated by the presence of bands with molecular 
masses higher than 46 kDa (for α1 subunits) and 48 kDa (for β2 subunits) following the  
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Figure 8.  Glycosidase digestions 
 
A, RIPA buffer extracted proteins from cells with α1β2 (first set), α1(loop∆)β2 (second 
set) and α1β2(loop∆) (third set) subunit coexpression were undigested (U), or digested 
with endo H (H) or PNGaseF (F).  Proteins were probed with anti-α1 antibodies.  After 
endo H digestion, these α1 subunits showing molecular mass equal to that of PNGaseF 
digestion (46 kDa) were considered endo H sensitive; while after endo H digestion, these 
α1(loop∆) subunits showing molecular mass equal to that of PNGaseF digestion (38 kDa) 
were considered endo H sensitive.  B, A duplicate of the panel A, which was probed with 
anti-β2 antibodies.  β2 and β2(loop∆) subunits migrating at 47 kDa and 34 kDa, 
respectively, after endo H digestion were considered endo H sensitive.  C, Similarly the 
glycosylation status of γ2HA and γ2(loop∆)HA subunits from cell with α1β2γ2HA and 
α1β2γ2(loop∆)HA were analyzed.  γ2HA and γ2(loop∆)HA subunits migrating at 48 kDa 
and 35 kDa, respectively, after endo H digestion were considered endo H sensitive. Four 
independent experiments were analyzed.  D, Fractions of endo H resistant populations of 
total α1, β2 or γ2-HA subunits were quantified.  *, ** and *** correspond to p < 0.05, 
0.01 and 0.001, respectively, compared to the control subunit coexpression; †† and ††† 
correspond to p < 0.01 and 0.001, respectively, compare to α1(loop∆)β2 subunit 
coexpression.  
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endo H digestion (Figure 8A, B).  This was consistent with the observation that the 
majority of control subunit proteins were mature and present on the cell surface.  In 
support of the hypothesis that β2 subunit loop deletion resulted in ER retention of both 
types of subunits, no more than 10% of α1 or β2(loop∆) subunit total proteins with 
α1β2(loop∆) subunit coexpression were endo H resistant (p < 0.001, n = 3, Figure 8D). 
Loop deletion of α1 subunits led to less severe subunit ER retention, with 30% of 
α1(loop∆) and 56% of β2 subunits being endo H resistant with α1(loop∆)β2 subunit 
coexpression.  The α1(loop∆) subunit endo H resistant fraction was significantly lower 
than that of the wild type α1 subunit (p < 0.001, n = 3), but was significantly higher than 
that of the α1 subunit with α1β2(loop∆) subunit coexpression (p < 0.01, n = 3).  Similarly, 
the endo H resistant fraction of the β2 subunit with α1(loop∆)β2 subunit coexpression 
was significantly different from that with control α1β2 (p < 0.05, n = 3) or α1β2(loop∆) 
(p < 0.001, n = 3) subunit coexpression.  Likewise, 70% of γ2SHA subunits with 
α1β2γ2SHA subunit coexpression were endo H resistant, while γ2(loop∆)HA subunits with 
α1β2γ2(loop∆)HA subunit coexpression were significantly different from those with wild 
type coexpression (p = 0.0037, paired t-test) and only 20% of γ2(loop∆)HA subunits were 
endo H resistant (Figure 8 C, D). 
 
Mutant loop-deleted subunits oligomerized with partnering subunits 
 
The retention of mutant and partnering subunits could have been due to lack of 
the prerequisite assembly of pentameric receptors for GABAA receptor surface 
expression.  Although previous findings have demonstrated that the N-terminal domains  
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Figure 9.  Immunoprecipitation of FLAG-tagged and partnering GABAA receptor 
subunits 
 
A, RIPA buffer-extracted proteins from cells with α1β2 (first column), α1FLAGβ2 (second 
column), α1(loop∆)FLAGβ2 (third column) and α1FLAGβ2(loop∆) (fourth column) subunit 
coexpression, respectively, were immunoprecipitated using M2 beads against FLAG-
tagged α1 subunit variants (e.g. α1FLAG).  Proteins immunoprecipitated were detected 
using monoclonal anti-α1 (upper panel) or anti-β2 antibodies (lower panel).  B, Similarly, 
immunoprecipitated proteins from cells with α1β2γ2FLAG (first column), and 
α1β2γ2(loop∆)FLAG (second column) coexpression were detected using monoclonal anti-
α1 (upper panel), anti-β2 (middle panel) and anti-FLAG (lower panel) antibodies.  
 
 
 
are sufficient to mediate GABAA receptor oligomerization, these conclusions were 
derived only from segmental or whole extracellular N-terminal domains (Klausberger et 
al., 2001b).  To exclude the possibility that the absence of subunit M3-M4 loops caused 
global protein misfolding and thus impaired inter-subunit oligomerization, 
immunoprecipitation experiments were conducted to determine if partnering subunits still 
associated with loop-deleted subunits.   
With coexpression of partnering and loop-deleted subunits, anti-FLAG M2 beads 
specifically immunoprecipitated FLAG-tagged α1 subunits whether or not they contained 
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the loop deletion but did not precipitate non-FLAG-tagged α1 subunits (upper panel of 
Figure 9A).  Furthermore, the immunoprecipitated protein complexes contained 
associated partnering subunits whether or not they contained the loop deletion (lower 
panel, Figure 9A).  Likewise, with ternary subunit coexpression, M2 beads specifically 
immunoprecipitated FLAG-tagged control γ2S or mutant γ2(loop∆) subunits.  In addition, 
partnering α1 and β2 subunits were oligomerized with both control γ2S and mutant 
γ2(loop∆) subunits (Figure 9B).  Thus, impaired subunit oligomerization was not the 
main cause of the surface level reductions with α1β2(loop∆) and α1β2γ2(loop∆) subunit 
coexpression.  
 
Replacement of the α1 subunit M3-M4 loop by the β2 subunit M3-M4 loop did not 
restore α1β2(loop∆) and α1β2(loop∆)γ2S “ receptor” surface expression 
 
Since inter-subunit oligomerization was retained with loop-deletion, we assumed 
that pentameric assembly was not abolished.  However, it appeared that β2 subunit loop 
deletion had more profound effects on surface expression than α1 subunit loop deletion.  
Thus, we further hypothesized that the basis for the absence of surface expression of 
α1β2(loop∆) and α1β2(loop∆)γ2S “receptors” was that the β2, but not the α1, subunit 
M3-M4 loop was required for GABAA receptor surface expression.  To test this 
hypothesis, the M3-M4 loops were swapped from β2 to α1 subunits to make α1β2 
subunits (α1 subunits containing the β2 M3-M4 loops, β2N327-R451) (Figure 10A).  Both 
types of subunits with α1β2β2(loop∆) subunit coexpression showed no significant 
difference in surface levels from those with α1β2(loop∆) surface levels (2% of control 
surface levels for both types, n = 5, Figure 10C).  Similarly, surface levels of all three  
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Figure 10.  Surface expression of binary GABAA receptors containing loop-swap subunits 
 
A, Schematic representations of the loop-swap constructs are presented.  B, 
Representative fluorescence histograms of cells with control α1β2 (first column), 
α1β2(loop∆) (second column), α1β2β2(loop∆) (third column), or  α1β2α1 (fourth column) 
subunit coexpression were generated.  Upper panels indicates surface α1FLAG subunit 
levels; lower panels indicates surface β2FLAG subunit levels.  C, Surface α1FLAG (black 
bars), and β2FLAG (grey bars) subunit levels were quantified in each condition as a 
percentage of control subunit coexpression.  *** corresponds to p < 0.001 compared to 
the control subunit coexpression; ††† corresponds to p < 0.001 compared to the 
α1β2(loop∆) subunit coexpression. 
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types of subunits with α1β2β2(loop∆)γ2S subunit coexpression were not significantly 
different from those with α1β2(loop∆)γ2S coexpression (for α1β2, β2(loop∆) and γ2S 
subunits, 5%, 5% and 14% of those in control ternary subunit coexpression remained, n = 
4, Figure 11B).  Therefore, our hypothesis was not supported, as introduction of β2 
subunit M3-M4 loops into α1 subunits was not sufficient to restore the loss of receptor 
surface expression caused by the β2(loop∆) subunit. 
 
Replacement of β2 or γ2S subunit M3-M4 loops with other subunit M3-M4 loops 
partially restored surface GABAA receptor expression 
   
To determine if the presence of M3-M4 loops from other types of subunits could 
reverse the loss of receptor surface expression caused by β2 or γ2S subunit loop deletion, 
four constructs (β2α1, β2γ2, γ2α1 and γ2β2) from the six possible chimeric loop-swapped 
subunits were used (Figure 10A).  Coexpression of α1 subunits with β2α1 subunits (β2 
subunits containing α1 subunit M3-M4 loops, α1N335-R421) led to chimeric subunit and 
partnering subunit surface levels that were significantly lower than those with control 
α1β2 subunit coexpression (p < 0.001), but significantly higher than those with 
α1β2(loop∆) subunit coexpression (p < 0.001, n = 5-8, Figure 10C).  Subunit surface 
levels with α1β2α1 subunit coexpression were 62% and 64% of control α1 and β2 
subunits.  These results thus suggested that the presence of the α1 subunit M3-M4 loops 
alone contained enough information to support receptor surface expression.  
Similarly, with ternary subunit coexpression, replacement of the β2 subunit M3-
M4 loop with α1 or γ2S subunit M3-M4 loops (β2α1 or β2γ2S subunits; Figure 10A) 
significantly restored the receptor surface expression lost by deleting the β2 subunit M3- 
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Figure 11.  Surface expression of ternary GABAA receptors containing loop-swap 
subunits 
 
A, Representative fluorescence histograms of cells with control α1β2γ2 (first column), 
α1β2(loop∆)γ2 (second column), α1β2β2(loop∆)γ2 (third column), α1β2α1γ2 (fourth 
column), α1β2γ2γ2 (fifth column), α1β2γ2(loop∆) (sixth column), α1β2γ2α1 (seventh 
column), α1β2γ2β2 (eighth column) subunit coexpression were generated.  Upper panels 
indicates surface α1FLAG subunit levels; middle panels indicates surface β2FLAG subunit 
levels; lower panels indicated surface γ2FLAG subunit.  B, Surface α1FLAG (black bars), 
and β2FLAG (grey bars) subunit levels were quantified in each condition as a percentage of 
control subunit coexpression.  *, ** and *** corresponds to p < 0.05, 0.01 and 0.001, 
respectively, compared to the control subunit coexpression; ††† corresponds to p < 0.001 
compared to the α1β2(loop∆)γ2 subunit coexpression; §, §§ and §§§ corresponds to p < 
0.05, 0.01 and 0.001, respectively, compared to the α1β2γ2(loop∆) subunit coexpression. 
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M4 loop (p < 0.001 for all types of subunits with α1β2α1γ2S and α1β2γ2Sγ2S subunit 
coexpression, n = 3-6; Figure 6B).  Coexpression of α1, β2α1 and γ2S subunits resulted in 
83%, 86% and 75%, and coexpression of α1, β2γ2S and γ2S subunits resulted in 71%, 
86% and 83% of control α1, β2 and γ2S subunit surface levels, respectively. 
We also determined if replacement of the γ2S subunit M3-M4 loop with α1 or β2 
subunit M3-M4 loops (γ2α1 or γ2β2 subunits; Figure 10A) could restore surface 
expression of γ2 subunits lost by deleting the γ2S subunit M3-M4 loop (γ2(loop∆)).  
Although significantly lower than control γ2S subunit surface levels (p < 0.001 for γ2α1 
and γ2β2 subunits, n = 5), γ2α1 and γ2β2 subunit surface levels were 55% and 45% of 
control γ2S subunit surface levels, respectively, and significantly reversed the γ2 subunit 
loop-deleted induced loss of subunit surface expression (p < 0.001 for γ2α1 subunits and 
p < 0.01 for γ2β2 subunits, n = 5).  Furthermore, surface levels of α1 subunits with 
α1β2γ2α1 and α1β2γ2β2 subunit coexpression were significantly higher than those with 
α1β2γ2(loop∆) subunits coexpression, and thus, no longer different from those of control 
α1 subunits.  On the other hand, surface levels of β2 subunits were not significantly 
different with α1β2γ2, α1β2γ2(loop∆), α1β2γ2α1 and α1β2γ2β2 subunit coexpression.  
Taken together, these results suggested that the presence of M3-M4 loops was required 
for appreciable receptor surface expression, regardless of the identity of the loop. 
 
The extracellular “tail” of the α1 subunit distal to the M4 domain was involved in 
regulating receptor surface expression 
 
The exchangeability of M3-M4 loops among α1, β2 and γ2S subunits suggested 
that specific structures/signals were shared among different types of subunits.  However, 
these specific structures/signals appeared less important for α1(loop∆) subunit surface 
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expression with α1(loop∆)β2 and α1(loop∆)β2γ2S subunit coexpression.  As revealed by 
subunit sequence alignments, α subunits possess a long extracellular C-terminal “tail” 
(Figure 12A).  Could the 13 amino acid extracellular α1 subunit tails be responsible for 
the lesser importance of the α1 subunit M3-M4 loop relative to β2 and γ2S subunits for 
receptor surface expression?  To test this hypothesis, the importance of the α1 subunit C-
terminal tail for receptor surface expression was systematically investigated (Figure 12B). 
Coexpression of C-terminal tail-deleted α1 subunits, α1(tail∆), with β2 subunits 
resulted in a small but significant reduction of GABAA receptors on the cell surface 
(Figure 12C1).  With α1(tail∆)β2 subunit coexpression, 87% and 75% of control α1 and 
β2 subunit surface levels were present on the cell surface (p < 0.001, n = 12).  However, 
deletion of both the α1 subunit M3-M4 loop and C-terminal tail, α1(loop∆tail∆) led to an 
additive reduction of α1β2 subunit surface expression.  As a result, surface levels with 
α1(loop∆tail∆)β2 coexpression were 13% of control α1 subunit surface levels (n = 9) and 
5% of control β2 subunit surface levels and were no longer different from the respective 
subunit surface levels with α1β2(loop∆) subunit coexpression (n = 10, Figure 12C1).   
Since the α1 subunit C-terminal tail was important for GABAA receptor surface 
expression, the α1 subunit C-terminal tail were then introduced into β2 subunits, β2(tail+), 
as a first step toward determining if α1 subunit C-terminal tails could restore β2(loop∆)-
induced reduction of receptor surface levels (Figure 12C2).  Surprisingly, introduction of 
the α1 subunit C-terminal tail into the β2 subunit resulted in a significant reduction of 
surface levels of both types of subunits (p < 0.001, n = 8); 55% and 62% of control α1  
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Figure 12.  Effects of deletion of α1 subunit C-terminal tails and insertion of the tail into 
β2 subunits on α1β2 receptor surface levels 
   
A, Comparison of the extracellular C-terminal portions of α1, β2 and γ2 subunits is 
presented.  The preceding M4 domains are highlighted.  Note that only the α1 subunit 
contains a long C-terminal tail.  B, Schematic representation indicates the region deleted 
in the α1(tail∆) and the region inserted in the β2(tail+).  C1-2, Surface α1FLAG (black 
bars), and β2FLAG (grey bars) subunit levels were quantified in each condition (indicated 
on the bottom) as a percentage of control subunit coexpression.  *** corresponds to p < 
0.001 compared to the control subunit coexpression; §§§ corresponds to p < 0.001 
compared to the α1β2(tail+) subunit coexpression. 
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and β2 subunits were obtained.  To determine if only one type of subunit in a GABAA 
receptor could contain the long C-terminal tail, which may have caused the reduction of 
receptor surface levels with coexpression of α1β2(tail+) subunits, α1(tail∆) and β2(tail+) 
subunits were coexpressed.  However, in this condition, α1 and β2 subunit levels were 
synergistically reduced to 22% and 24% of control subunit levels, respectively (n = 5, 
Figure 12C2). 
The data suggested that the α1 subunit C-terminal tail was important for receptor 
surface expression, and that this was potentially the basis for the reduced impact of α1 
subunit loop deletion on surface expression compared to β2 and γ2S subunits.  
Introduction of the α1 subunit C-terminal tails into β2 subunits reduced surface levels of 
both the mutant β2 subunits and the partnering α1 subunits, whether or not the α1 
subunits contained the long C-terminal tails.  This suggested that that the positions of the 
α1 subunit tails in the receptor pentamer were important, allowing interaction with other 
subunit regions, presumably N-terminal and M4 domains, to support receptor surface 
expression.  
 
A fourteen amino acid motif at the C-terminal end of the β2 subunit M3-M4 loop was 
required for receptor surface expression 
 
To determine the molecular mechanism for the β2(loop∆) subunit-induced 
reduction of receptor surface expression, cDNA constructs with smaller portions of the 
β2 M3-M4 loop deleted were made (Figure 13A).  The β2 subunit M3-M4 loop contains 
several protein binding motifs involved in receptor trafficking and endocytosis including 
BIG2, GRIF-1 and AP2 binding motifs (Figure 3).  Based on BIG2 and GRIF-1 binding 
motifs, the M3-M4 loop was divided into three regions and constructs with individual 
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motifs deleted were made: β2(BIG2∆), β2(GRIF-1∆) and β2(postGRIF-1∆) subunits.  
Coexpression of β2(BIG2∆) with α1 subunits led to a small but significant increase of α1 
subunit surface levels (121% of control α1 subunits, p < 0.01, n = 6) but no significant 
change in β2 subunit surface levels relative to the control condition (Figure 13B).  In 
contrast, coexpression of α1 and β2(GRIF-1∆) subunits significantly reduced surface 
levels of both subunit types (both types of subunits were 80% of control α1 and β2 levels; 
p < 0.05 for α1 subunits and p < 0.05 for β2(GRIF-1∆) subunits, n = 6) (Figure 13B).  
Finally, coexpression of α1 with β2(postGRIF-1∆) subunits resulted in a large reduction 
of cell surface levels of both subunits to levels comparable to those with α1β2(loop∆) 
subunit coexpression (3% and 2% of control α1 and β2 subunit levels, respectively) (n = 
7; Figure 13B).   
Based on these results, the region of interest was narrowed to the C-terminal 
portion of the β2 M3-M4 loop (Figure 13A).  A β2 subunit construct containing only the 
region after the GRIF-1 sequence (β2(postGRIF-1+) subunit; a β2327-419 subunit deletion) 
was then made to determine if the post GRIF-1 region was sufficient for appreciable 
receptor surface expression (Figure 13A).  Although significantly lower than control 
subunit surface levels (p < 0.001, n = 8), α1 and β2(postGRIF-1+) subunit surface levels 
were still 64% and 54% of control α1 and β2 subunit levels, respectively (Figure 13B), 
and were significantly higher than those with α1β2(loop∆) and α1β2(postGRIF1∆) 
subunit coexpression (p < 0.001, n = 8; for both subunits and both transfection conditions; 
Figure 13B).  The β2(postGRIF-1+) construct contained the AP2 binding motif, β2426-437, 
that has been shown to down regulate receptor surface expression (Figure 3).   
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Using a similar strategy, the post GRIF-1 motif was further divided into three 
regions based on the AP2 binding motif and three constructs were made with individual 
regions deleted: β2(postGRIF1+preAP2∆), β2(postGRIF1+AP2∆), and 
β2(postGRIF1+postAP2∆) (Figure 13A).  Deletion of the six amino acids before the AP2 
binding motif (β2(postGRIF1+preAP2∆) further decreased surface levels compared with 
α1 and β2(postGRIF1+) subunit surface levels (29% and 24% of control α1 and β2 
subunit levels, respectively, p < 0.001, n = 8) (Figure 8B2).  Conversely, deletion of the 
12 amino acid AP2 binding motif (β2(postGRIF1+AP2∆)) led to similar surface levels as 
those with α1 and β2(postGRIF1+) subunit coexpression (Figure 13B).  Finally, deletion 
of the 14 amino acids distal to the AP2 binding motif (β2(postGRIF1+postAP2∆)) 
yielded surface expression levels that were not different from those observed following 
deletion of the majority of the loop (β2(loop∆)) or deletion of the postGRIF-1 region 
(β2(postGRIF-1∆)).  To confirm that this region was essential for receptor surface 
expression, a construct that only lacked the post-AP2 region (β2(postAP2∆)) was made.  
Coexpression of this construct with the α1 subunit reduced subunit surface levels 
comparably to those obtained by expressing α1 and β2(loop∆) subunits (Figure 13B).  In 
addition, to determine if this region was sufficient for α1 and β2 subunit surface 
expression, a construct that only contained this region to link the M3 and M4 domains 
(β2(postAP2+); Figure 13A) was made.  Supporting the sufficiency of the post AP2 
region, α1β2(postAP2+) and the α1β2(postGRIF1+) receptor surface levels were not 
significantly different (Figure 13B).  Taken together, these results suggested that the 
stretch of 14 amino acids after the AP2 binding motif played a major role in supporting 
surface expression of α1β2 receptors (more than 50% of control receptors; Figure 13B). 
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Figure 13.  Segmental deletions of the β2 subunit M3-M4 loop decreased α1β2 receptor 
surface levels 
 
A, Schematics of the β2 subunit M3-M4 loop segmental deletion constructs are shown.  
Retained regions of the M3-M4 loop are shown in black, while deleted regions are 
bordered by dotted lines.  B, Relative surface expression levels of α1FLAG (black bars) and 
β2FLAG (grey bars) subunits when each of the each of the β2 subunit deletion constructs 
was coexpressed with a wild type α1 subunit.  *, **, and *** indicate p < 0.05, p < 0.01, 
and p < 0.001, respectively, relative to control α1β2 subunit coexpression.  §§§ indicates 
p < 0.001 relative to α1β2(postGRIF-1+) subunit coexpression. 
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A nineteen amino acid motif at the C-terminal end of γ2S subunit M3-M4 loop, which 
overlaps with the GABAA receptor GABARAP binding motif, was important for 
α1β2γ2S receptor surface expression 
 
We hypothesized that a motif in the γ2S subunit equivalent to the post-AP2 distal 
motif in the β2 subunit was responsible for the reduction of γ2 subunit surface expression 
with coexpression of α1, β2 and γ2(loop∆) subunits.  To test this hypothesis, the role of a 
nineteen amino acid motif located in a similar position, which almost completely 
overlapped with the GABARAP binding motif, on ternary receptor surface expression 
was explored. 
Coexpression of α1 and β2 subunits with a γ2S subunit that lacked this nineteen 
amino acid motif (γ2S(GABARAP∆)) resulted in a substantial reduction of γ2 subunit 
surface levels (14% of control; p < 0.001, n = 3; Figure 14).  To further explore the 
importance of this sequence, a γ2 subunit construct containing only these nineteen amino 
acids linking its M3 and M4 domains (γ2(GABARAP+)) was made.  Coexpression of α1 
and β2 subunits with the γ2(GABARAP+) subunit resulted in γ2 subunit surface levels 
that were significantly higher than γ2S(GABARAP∆) subunit surface levels with ternary 
subunit coexpression (p < 0.001, n = 3), and were 33% of control (n = 3).  Although 
γ2S(GABARAP∆) subunit surface levels with α1β2γ2S(GABARAP∆) subunit 
coexpression were significantly higher than those with α1β2γ2(loop∆) subunit 
coexpression (p < 0.01, n = 3), α1β2γ2S(GABARAP∆) and α1β2γ2(GABARAP+) 
subunit coexpression data nonetheless indicated that this 19 amino acid motif was more 
important than the remainder of the M3-M4 loop (68 amino acids) for α1β2γ2S receptor 
surface expression and was consistent with data obtained with β2 subunit segmental 
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deletions, which indicated that distal portions of M3-M4 loops were much more 
important than the rest of the loops. 
 
 
 
 
 
 
 
Figure 14.  Segmental deletions of the γ2 subunit M3-M4 loop decreased α1β2γ2 receptor 
surface levels 
 
A, Schematics of the γ2 subunit M3-M4 loop segmental deletion constructs are shown.  
Retained regions of the M3-M4 loop are shown in black, while deleted regions are 
bordered by dotted lines.  B, Relative surface expression levels of γ2FLAG subunits when 
each of the each of the γ2 subunit deletion constructs was coexpressed with a wild type 
α1 and β2 subunit.   *** indicates p < 0.001 relative to γ2FLAG surface level with α1β2γ2 
subunit coexpression; †† and ††† indicate p < 0.01 and 0.001, respectively, relative to   
γ2FLAG surface level with α1β2γ2(loop∆) subunit coexpression; §§§ indicates p < 0.001 
relative to γ2FLAG surface level with α1β2γ2(GABARAP∆)  subunit coexpression. 
 
 
 
 
 
 
58 
Discussion 
 
 
 
Deletion of the M3-M4 loop altered the cellular distribution of GABAA receptor 
subunits 
 
By definition, total cellular subunit expression levels include subunits localized to 
both surface and intracellular compartments (~2:1 ratio, Botzolakis and Macdonald, 
unpublished).  The significant reductions of surface, but not total, cellular levels of 
α1(loop∆) and β2(loop∆) subunits thus implied a relative increase of intracellular levels.  
Interestingly, immunoprecipitation studies revealed that α1(loop∆) and β2(loop∆) 
subunits oligomerized with partnering subunits, suggesting that subunit folding and 
subunit-subunit interactions were not abolished.  In contrast, partnering wild type α1, β2 
and γ2S subunit total cellular levels were reduced with both binary and ternary subunit 
coexpression, consistent with a decrease in surface, but not intracellular, subunit levels.  
Thus, the reduced surface levels and immature glycosylation of partnering wild type and 
loop-deleted α1 and β2 subunits suggested impaired forward trafficking and ER retention 
of both wild type and mutant subunits.  In addition, the increased intracellular levels of 
loop-deleted subunits suggested that M3-M4 loops may be involved in subunit 
degradation, possibly via ERAD.  It is possible that motifs in the missing portions of 
subunit M3-M4 loops were required for recognition by the ERAD machinery, thus 
decreasing the degradation efficiency of loop-deleted subunits.   
In contrast to the unchanged α1(loop∆) and β2(loop∆) subunit total cellular 
protein levels with β2 and α1 subunit coexpression, a small but significant reduction of 
γ2(loop∆) subunit total proteins with ternary subunit coexpression was observed.  Similar 
to α1(loop∆) and β2(loop∆) subunits, γ2(loop∆) subunits also significantly reduced total 
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cellular proteins of partnering α1 and β2 subunits despite the ability of α1β2 receptors to 
reach the cell surface with α1β2γ2(loop∆) subunit coexpression.  The reduction of 
partnering α1 and β2 subunit total expression levels may explain why surface levels of 
α1β2 receptors with α1β2γ2(loop∆) subunit coexpression were lower than those with 
α1β2 subunit coexpression.   
 
GABAA receptor subunit M3-M4 loops were involved in process(es) conferring 
permission to forward traffic beyond the ER 
 
Regardless of the mechanism(s) stabilizing loop-deleted subunits, if loop deleted 
and wild type partnering subunits form pentamers, both types of subunits should have 
similar maturation, which could be determined by assessing glycosylation patterns.  
Therefore, if the reduction of total wild type partnering subunits was due to increased 
internalization from the cell surface and subsequent degradation in lysosomes, the 
accumulated mutant subunits should have had mature oligosaccharides that were resistant 
to endo H digestion.  However, the majority of β2 and γ2 loop-deleted subunits were 
endo H sensitive, suggesting that the reduction of partnering subunits was not due to 
endocytosis from the surface, but instead, was due to degradation in the ER, likely ERAD.  
Coexpression of α1β2β2(loop∆) subunits further supported the idea that loop-deletion of 
α1 or β2 subunits caused ER retention of both mutant and partnering subunits.  The 
failure of α1β2 subunits to restore surface expression reduced by the β2(loop∆) subunits 
weakened the hypothesis that GABAA receptor pentamers containing β2(loop∆) subunits 
trafficked to the cell surface, and that reduced surface subunit levels were due to the 
requirement for the β2 subunit M3-M4 loop to stabilize “α1β2(loop∆) receptors” on the 
cell surface. 
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In contrast to loop-deleted β2 and γ2 subunits, loop-deleted α1 subunits attained 
higher surface levels and endo H resistant fractions, suggesting less ER retention.  
Therefore, we cannot rule out the possibility that the reduction of partnering subunit total 
protein with α1(loop∆)β2 subunit coexpression could have been due to destabilization of 
surface α1(loop∆)β2 receptors that underwent fast endocytosis and sorting into lysosome 
for degradation and/or ER retention.   
 
Potential underlying mechanisms for loop-deletion-induced GABAA receptor subunit 
ER retention 
 
Based on the interchangeability of M3-M4 loops among different types of 
subunits and the presence of the extracellular long C-terminal tail that could be the 
cryptic signal used by α1(loop∆) subunits for appreciable receptor surface expression, we 
propose that a shared signal is present at the distal ends of GABAA receptor subunit M3-
M4 loops that is involved in trafficking of receptors beyond the ER.  Long α subunit tails 
are also present in glycine receptors, which are also anionic Cys-loop receptors and are 
evolutionally derived from GABAA receptors (Ortells and Lunt, 1995).  The long 
extracellular tails of glycine receptor α subunits may also regulate glycine receptor 
surface expression, but this remains to be elucidated. 
Failure of oligomerization was excluded as the major cause of impaired β2(loop∆) 
and γ2(loop∆) subunit surface expression, since partnering subunits coexisted with loop-
deleted subunits in coimmunoprecipitated complexes.  Paradoxically, the surface 
expression profiles of GABAA receptors containing the loop-deleted mutant subunits 
were compatible with loop-deleted subunits causing impaired receptor assembly.  
Although the wild type and loop-deleted subunits appeared to be capable of 
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oligomerization, this does not ensure full assembly of receptor pentamers.  In support of 
this argument, nACh receptor M3-M4 loops have been implicated in regulating nACh 
receptor assembly (Quiram et al., 1999;Roccamo and Barrantes, 2007). 
Impaired γ2(loop∆) subunit surface expression with appreciable α1β2 receptor 
surface expression with α1β2γ2(loop∆) subunit coexpression may have a similar 
explanation.  Prior to assembly, it is likely that subunit dimers, trimers, and tetramers are 
formed (Klausberger et al., 2001a).  Our results imply failure of α1γ2(loop∆) and 
β2γ2(loop∆) subunit-containing oligomers to assemble with other oligomers or 
monomers and success of α1β2 subunit-containing oligomers to assemble into pentamers.  
Although γ2 subunits have been shown to be preferentially incorporated into GABAA 
receptor pentamers with α1 and β1 subunits (Angelotti and Macdonald, 1993), the failure 
of incorporation of γ2(loop∆) subunit-containing oligomers during pentameric assembly 
could explain the observed surface expression of α1β2 receptors but not α1β2γ2(loop∆) 
receptors with α1β2γ2(loop∆) subunit coexpression.   
We can not exclude, however, other possible explanations for the appearance 
α1β2 receptors on the cell surface despite γ2 subunit loop deletion.  For example, distal 
motifs in the M3-M4 loops may be essential for sorting receptors into COPII complexes 
or masking ER retention signals in adjacent subunits.  In either case, pentameric 
assembly might not be impaired, but forward trafficking of pentamers containing the 
mutant loop-deleted subunits might be impaired due to failed sorting into forward 
trafficking cargo or retrieval of fully assembled pentamers.  The surface expression of 
α1β2 receptors with α1β2γ2(loop∆) subunit coexpression might thus reflect α1β2 
receptor simply being permitted to forward traffic while α1β2γ2(loop∆) receptors are not.  
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Nevertheless, since assembly of pentamers is a prerequisite step for forward trafficking, 
we propose that the distal motifs in subunits M3-M4 loops are essential for permission to 
forward traffic beyond ER. 
Jansen and colleagues have demonstrated that large portions of the M3-M4 loops 
of the 5-HT3A subunits and ρ1 subunits, which can form homopentamers of 5-HT3 and 
GABAC receptors, respectively, are not absolutely required for receptor assembly, 
surface expression and function.  Thus, the biogenesis of Cys-loop receptors seems not to 
require any of the five M3-M4 loops in a receptor pentamer.  However, their M3-M4 
loop-deletion constructs keep a few amino acids at each ends of the M3-M4 loops (four 
amino acids, A-I-D-K, for the ρ1 subunit distal end; six amino acids, V-L-D-R-L-L, for 
the 5-HT3A subunit distal end) and introduce a heptapeptide (S-Q-P-A-R-A-A), which is 
a prokaryotic equivalent of the eukaryotic M3-M4 loops (Jansen et al., 2008).  Thus, the 
constructs may contain all essential elements of subunit M3-M4 loops for functional 
receptor surface expression.  It is worth pointing out that their finding and the 
observations shown in this chapter are not in conflict.  Furthermore, based on their 
finding, a smaller and more distal region of interest in the M3-M4 loops of GABAA 
receptor subunits is inferred and will be discussed in next chapter.   
 
Interactions of C-terminal motifs with intracellular proteins for forward trafficking 
from the ER 
 
In agreement with previous reports, our study revealed that deletion of GRIF-1 or 
GABARAP binding motifs reduced receptor surface levels, and deletion of AP2 binding 
motifs increased receptor surface levels (data not shown).  In contrast to a previous report 
demonstrating that interactions between BIG2 and GABAA receptors facilitated receptor 
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export beyond the ER (Charych et al., 2004), deletion of BIG2 binding motifs increased 
receptor surface levels.  It is possible that the BIG2 binding motif also interacted with 
other proteins that negatively regulated receptor surface expression. 
Because of the location of the distal M3-M4 motifs, it is unlikely that these motifs 
are involved in inter-subunit interactions.  Instead, the motifs are likely involved in 
recruiting intracellular proteins that regulate GABAA receptor assembly, forward 
trafficking, or masking of ER retention signals.  Proteins interacting with distal motifs of 
subunit M3-M4 loops to regulate GABAA receptor forward trafficking remain to be 
identified.  Since the distal motif responsible for appreciable surface expression of γ2 
subunits almost completely overlaps the motif that binds the microtubule-associated 
protein, GABARAP (Wang et al., 1999;Wang and Olsen, 2000), it is possible that 
interactions between GABAA receptors and microtubules are involved in assembly of 
receptor pentamers and/or their forward trafficking.  In support of this argument, ER 
exports are functionally coupled with microtubules (Watson et al., 2005).  Although 
GABARAP only binds to γ1/2 subunits and not to α1-6, β1-3, δ, ε and ρ1 subunits 
(Nymann-Andersen et al., 2002), this does not exclude the possibility that the distal 
motifs in β2 subunit M3-M4 loops associate with other microtubule-associated proteins 
(MAPs).  These predictions and the identities of MAPs associated with α1 and β2 
subunits will need to be explored in future studies. 
Alternatively, the distal motifs in the M3-M4 loops are involved in interactions 
with cellular chaperones, and deletions of these distal motifs cause misfolding of GABAA 
receptor subunits.  If this is the case, decreasing temperature would facilitate subunit 
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folding and increase assembly efficiency and receptor surface levels.  This postulate 
remains to be investigated. 
 
 
 
 
Figure 15.  Proposed roles of the distal motifs in the M3-M4 loops of the GABAA receptor 
subunits 
 
A schematic of an α1β2γ2 GABAA receptor is presented with the α1 subunits in blue, the 
β2 subunits in red, the γ2 subunit in purple and the lipid bilayer in yellow.  The distal 
motifs of the subunit M3-M4 loops are involved in interacting with cellular proteins (X 
and Y) and are required for receptor assembly and/or forward trafficking.  A 
transmembrane protein (Y) is predicted to interact with the unique extracellular tails of 
the α1 subunits as well and facilitate receptor assembly and/or forward trafficking.  
Microtubule associated proteins (X, which regulate receptor assembly and/or forward 
trafficking) and chaperones (X and/or Y, which regulate receptor subunit folding) are 
candidates for the interacting proteins. 
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CHAPTER III 
 
A CONSERVED CYS-LOOP RECEPTOR ASPARTATE RESIDUE IN THE M3-
M4 CYTOPLASMIC LOOP IS REQUIRED FOR GABAA RECEPTOR 
ASSEMBLY 
 
 
Introduction 
 
The Cys-loop superfamily of ligand-gated ion channels, which includes GABAA 
and GABAC, nACh, glycine, and 5-HT3 receptors, mediates fast synaptic transmission in 
the nervous system.  Mutations that alter Cys-loop receptor surface density by affecting 
receptor biogenesis have been associated with IGEs (Frugier et al., 2007;Gallagher et al., 
2004;Harkin et al., 2002;Kang and Macdonald, 2004), startle syndromes (Bakker et al., 
2006), CMSs (Shen et al., 2005), and psychiatric disorders (Niesler et al., 2001a).  
Unfortunately, because the structural and cellular determinants of receptor biogenesis are 
poorly understood, development of effective treatment strategies remains a significant 
challenge. 
A wealth of evidence suggests that Cys-loop receptors are assembled as 
heteropentamers from a large repertoire of neuronal subunits (Macdonald and Olsen, 
1994;Le Novere and Changeux, 1999;Millar, 2003;Lynch, 2004).  Subunits share a 
similar topology that includes an extracellular N-terminal domain, four transmembrane 
domains, three loops including a large cytoplasmic loop, and a variable length 
extracellular C-terminal tail (Macdonald and Olsen, 1994;Unwin, 2005).  Receptor 
assembly is thought to occur in the ER following glycosylation and folding of de novo 
synthesized subunits (Smith et al., 1987;Green and Claudio, 1993;Connolly et al., 
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1996;Gallagher et al., 2007).  Assembly is closely monitored by ER quality control 
machinery, and consequently, subunits that fail to assemble properly are retained and 
degraded (Wang et al., 2002;Gallagher et al., 2005;Gallagher et al., 2007).  While N-
terminal motifs are known to be important for subunit assembly (Klausberger et al., 
2001b;Hales et al., 2005), recent studies in nACh receptors suggest that C-terminal 
motifs may also play a role (Roccamo and Barrantes, 2007). 
GABAA receptors are the most abundant Cys-loop receptor in the mammalian 
brain, and are responsible for the majority of fast inhibitory neurotransmission.  Like 
other Cys-loop superfamily receptors, they are assembled from 16 subtypes of subunits 
(α1-6, β1-3, γ1-3, δ, ε, θ, and π) (Macdonald and Olsen, 1994).  The β2 subunit, in 
particular, is an essential component of several widely distributed GABAA receptor 
isoforms (McKernan and Whiting, 1996) and is known to interact directly with several 
cellular regulatory proteins via its intracellular M3-M4 loop.  For instance, it interacts 
with BIG2 and GRIF-1, which promote forward trafficking of GABAA receptors (Beck et 
al., 2002;Charych et al., 2004), and with AP2, which participates in clathrin-mediated 
receptor endocytosis (Kittler et al., 2000a). 
To better understand how C-terminal motifs regulate Cys-loop receptor 
biogenesis, the role of the GABAA receptor cytoplasmic M3-M4 loop in receptor surface 
expression was evaluated in the previous chapter.  Segmental deletions of the M3-M4 
loops revealed that the C-terminal portions of the M3-M4 loops were important for 
receptors exiting from the ER.  A multiple sequence alignment of Cys-loop receptor 
subunits reveals a highly conserved aspartate residue at the boundary of the M3-M4 loop 
and M4 domain.  The study presented here demonstrates that the conserved residue in the 
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GABAA receptor α1, β2, or γ2 subunit is required for binary and/or ternary receptor 
surface expression.  Results from endo H digestion, brefeldin A treatment, and analytic 
centrifugation revealed that mutation of this aspartate residue caused mutant and 
partnering subunits to be retained in the ER, the result of impaired higher-order 
oligomerization.  The data thus provide evidence that C-terminal motifs are also 
important for receptor assembly. 
 
Materials and methods 
 
 
 
Preparation of cDNA constructs 
 
The cDNAs encoding human α1, β2, and γ2S subunit polypeptides including their 
signal peptides were inserted into the pcDNA3.1(+) vector as described previously 
(Gallagher et al., 2005).  The cDNA encoding the FLAG peptide, D-Y-K-D-D-D-D-K, 
was introduced between the 8th and 9th amino acid of the mature α1 subunit and the 4th 
and 5th amino acid of the mature β2 and γ2S subunits.  Of note, murine β2 and γ2 
subunits (which have identical sequences to their human counterparts) containing FLAG 
tags at the same position have previously been demonstrated to form receptors that are 
functionally indistinguishable from wild-type receptors (Connolly et al., 1996).  
Consistent with this finding, we demonstrated that insertion of the FLAG tag between the 
8th and 9th amino acid of the human α1 subunit did not alter GABAA receptor current 
amplitude, GABA EC50, or surface expression (Lo et al., 2008).  Point mutations were 
performed with the QuikChange Site-Directed Mutagenesis Kit (Stratagene). 
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Table 4.  Forward sequences of primer pairs for Site-Directed mutagenesis II 
 
Mutation Forward primer sequence (5’ to 3’) 
Mutating the conserved aspartate residues in the α1, β2 and γ2 subunits 
α1(D420A) GTC AGC AAA ATT GCC* CGA CTG TCA AG 
β2(D450A) GTG AAC GCC ATT GCT CGG TGG TCC CGC  
β2(D450E) GTG AAC GCC ATT GAG CGG TGG TCC CGC 
γ2(D442A) CGC ATT GCC AAA ATG GCC TCC TAT GCT CGG 
 
* codons in bold were responsible for the designed point mutation. 
  
 
 
Cell culture and transfection  
  
HEK293T cells were purchased from ATCC (CRL-11268).  Cells were incubated 
at 37°C in humidified 5% CO2/95% air and grown in Dulbecco’s Modified Eagle 
Medium (Invitrogen) supplemented with 10% fetal bovine serum, 100 i.u./mL penicillin, 
and 100 µg/mL streptomycin (Invitrogen).  For binary subunit coexpression, cells were 
cotransfected with equal amounts (by mass) of α1 and β2 subunit cDNAs using the 
FuGene6 transfection reagent (Roche) (6 µL of reagent per 2 µg of cDNA per 60-mm 
diameter culture dish), and for ternary subunit coexpression, cells were transfected with 
equal amounts of α1, β2, and γ2S subunit cDNAs (9 µL of reagent per 3 µg of cDNA at a 
1:1:1 cDNA ratio per 60-mm culture dish).  The cDNA-FuGene6 mixture volumes were 
scaled up or down proportionally to the surface areas of different sized cell culture dishes.  
Forty-eight hours later, transfected cells were subjected to the following experiments. 
 
Flow cytometry 
 
To collect cells for flow cytometry analysis, monolayer cultures of HEK293T 
cells were dissociated by 37°C trypsin (Invitrogen) for 2 minutes.  Trypsinization then 
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was stopped in 4°C PBS containing 2% fetal bovine serum and 0.05% sodium azide 
(FACS buffer).  Although trypsin could cleave the extracellular N-terminal domain, 
thereby removing the FLAG epitope, the relative surface expression profile of FLAG-
tagged subunits from cells dissociated by trypsin was similar to that of cells dissociated 
by protease-free cell detaching solution, (2 mM EDTA in PBS) (Gurba and Macdonald, 
unpublished). 
Following washes with FACS buffer, cells were incubated with anti-FLAG IgG 
directly conjugated with R-Phycoerythrin (PE, 1:50 dilution, Martek) for 1 hour.  Cells 
were then washed with FACS buffer again and fixed with 2% paraformaldehyde.  
Samples were run on a BectonDickson FACS Calibur equipped with 488 nm argon-ion 
and 635 nm red-diode lasers.  For each staining condition, 50,000 cells were analyzed.  
Non-viable cells were excluded from analysis based on forward- and side-scatter profiles 
(chapter II), as determined by staining with 7-AAD (Invitrogen), which was excited using 
the 488 nm laser and detected with a 670 nm longpass filter (FL3).  The PE fluorophore 
was excited using the 488 nm laser and detected with a 585/42 bandpass filter (FL2).  
Data were acquired using CellQuest (BD Biosciences) and analyzed offline using FlowJo 
7.1 (Treestar, Inc.).  For each sample, the fluorescence index (FI) was calculated by 
determining the percentage of positively-transfected cells (i.e., cells with a fluorescence 
intensity greater than 99% of mock-transfected cells) and multiplying this value by the 
mean fluorescence intensity of those cells.  The FI of each experimental condition was 
then normalized to that of the control condition (i.e., α1FLAGβ2 or α1β2FLAG) for 
comparison.  Unless otherwise specified, a one-way ANOVA with Tukey’s post test was 
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used to determine if there were significant differences in surface levels among 
transfection conditions.  Data were expressed as mean ± SD. 
 
Multiple sequence alignment 
 
45 polypeptide sequences of human Cys-loop superfamily receptor subunits were 
aligned using Multalin software (bioinfo.genopole-toulouse.prd.fr/multalin/multalin.html) 
(Corpet, 1988).  Penalties (subtractions of alignment scores) were applied to insertion and 
extension of internal gaps, and also to terminal gaps.  This was required for proper 
alignment of C-terminal domains. 
 
Immunoblotting 
 
Membrane proteins in transfected cells were extracted in modified RIPA 
containing 10-50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1.0 mM EDTA, 1-2% NP-40, 
0.25-0.5% sodium deoxycholate, and protease inhibitor cocktail (complete mini, Roche).  
Cell lysates were cleaned by centrifugation at 10,000X g for 30 minutes.  The 
supernatants were subjected to further experiments or directly to SDS-PAGE.  Proteins in 
gels were transferred to PVDF membranes (Millipore). 
Monoclonal anti-GABAA receptor α1 subunit antibodies (final concentration 5 
µg/mL, clone: BD24, Chemicon) and monoclonal anti-GABAA receptor β2/3 antibodies 
(4 µg/mL, clone: 62-3G1, Upstate) were used to detect wild type or modified human α1 
and β2 subunits, respectively.  Anti-sodium potassium ATPase antibodies (0.2 µg/mL, 
clone: ab7671, Abcam) were used to check loading variability.  Following incubation 
with primary antibodies, secondary goat anti-mouse IgG heavy and light chain antibodies 
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conjugated with horseradish peroxidase were used in 1:10,000X dilution 
(Immunoresearch laboratories) for the visualization of specific bands in enhanced 
chemiluminescent detection system (Amersham Biosciences). 
The signals were collected in a digital ChemImager (Alpha Innotech).  The IDV, 
pixel intensity X mm2, were then calculated using the FluorChem 5500 software.  To 
compare the expression levels between the same subtype subunits with different 
mutations, we normalized adjusted IDVs (normalized to loading control Na+/K+ ATPase 
IDVs) to those of control conditions (coexpression of wild type α1 and β2 subunits).  
 
Biotinylation of cell surface proteins 
 
Cell surface proteins were biotinylated with membrane impermeable reagent 
sulfo-NHS-SS-biotin (1 mg/mL, Pierce) in phosphate buffered saline containing 1.0 mM 
MgCl2 and 0.1 mM CaCl2 (PBS+MC) at 4°C for 30 minutes.  After incubation, biotin 
was quenched with 0.1 M glycine in PBS+MC.  Following washes with PBS+MC, cells 
were lysed in RIPA buffer with protease inhibitors.  After centrifugation to pellet cellular 
debris, the biotin-labeled plasma membrane proteins were pulled down by streptavidin 
beads (Pierce) from the supernatant.  Pulled down proteins were eluted with sample 
buffer (Pierce) and were subjected to SDS-PAGE and western blots.   
 
Glycosidase digestion 
 
Whole cell lysates obtained from 10 mM-Tris RIPA buffer (10 mM Tris-HCl, 150 
mM NaCl, 1.0 mM EDTA, 1% NP-40, 0.25% sodium deoxycholate) extraction were 
subjected to endo H and PNGaseF digestion (New England BioLab) following the 
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manufacturer’s recommended protocol.  The digestion reactions were carried out at 37°C 
for 3 hours and terminated by addition of sample buffer. 
 
Brefeldin A treatment 
 
The forward trafficking of fully assembled GABAA receptors is a slow process.  
Although pentamer formation peaks six hours after de novo synthesis, appreciable surface 
expression is not detected until eight hours after subunit synthesis (Gorrie et al., 1997).  
Thus, to block fully assembled receptor pentamers from trafficking beyond the ER and 
being expressed on the cell surface, HEK293T cells were treated with 0.5 µg/mL 
brefeldin A (Sigma) six hours after transfection, and 24 hours after transfection, cells 
were harvested.  The surface and total cellular protein levels were then measured using 
flow cytometry and immunoblots, respectively. 
 
Analytic centrifugation 
 
The use of sucrose density gradient fractionation to analyze the size of GABAA 
receptor subunit protein-complexes has been described (Taylor et al., 1999;Taylor et al., 
2000).  Membrane proteins were extracted using high-detergent RIPA buffer, which 
consisted of 25 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 2% NP-40, and 
0.5% sodium deoxycholate.  Supernatants were loaded on a 5-20% sucrose density 
gradient in high-detergent RIPA buffer with protease inhibitors.  To calibrate each 
gradient, BSA was added as a control marker (sedimentation coefficient of 4.3 S).  
Endogenous aldolase was used as a second marker (sedimentation coefficient of 7.4 S).  
To separate protein complexes of different sizes, gradients were centrifuged in a 
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Beckman SW41 rotor at 33,500 rpm for 20 hours at 4°C.  Each gradient was then 
manually fractionated at 500 µL intervals.  The distributions of GABAA receptor subunits 
and protein markers within the sucrose density gradients were analyzed by Western blot. 
 
Immunoprecipitation 
 
Protein complexes containing FLAG-tagged GABAA receptor subunits were 
immunoprecipitated using EZview Red Anti-FLAG M2 beads (Sigma) at 4°C overnight.  
After three washes with extracting RIPA buffer, protein complexes were eluted with 100 
µg/mL FLAG peptide (Sigma).  The presence of GABAA receptor subunits was 
determined by Western blot. 
 
Results 
 
 
 
A conserved aspartate residue was required for α1β2 receptor surface expression 
 
By comparing the α1 and β2 subunit M3-M4 loop sequences, only three amino 
acids, I-D-R, were found to be shared between α1 and β2 subunits in the β2 subunit 
postAP2 region (Figure 16).  Furthermore, multiple sequence alignments showed that the 
aspartate in the I-D-R motif was conserved in the entire Cys-loop receptor superfamily 
(Figure 16).  We thus hypothesized that the loss of this residue was responsible for the 
β2(loop∆) induced loss of receptor surface expression.  To test this hypothesis, the 
conserved aspartate was mutated to alanine in the α1 and β2 subunits, and the surface 
levels of α1(D420A)β2 and α1β2(D450A) receptors were measured using flow cytometry.  
Relative to the control condition, the α1(D420A) mutation caused more than a 90% 
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reduction in surface levels of both α1(D420A) and β2 subunits, while the β2(D450A) 
mutation resulted in more than a 95% surface reduction of both subunits (n = 4) (Figure 
17A, B), demonstrating that the conserved aspartate residue was required for receptor 
surface expression. 
 
 
 
Figure 16.  Alignment of human Cys-loop receptor subunits revealed a conserved 
aspartate residue at the junction of the M3-M4 loop and the M4 domain 
 
Partial sequences surrounding the junction of the M3-M4 cytoplasmic loop and the M4 
transmembrane domain are shown for a subset of Cys-loop receptor subunits.  The I-D-R 
and comparable motifs were highlighted in grey, and the conserved aspartate residues 
were bolded.  Note that all forty-five known human Cys-loop receptor subunits contain 
this residue. 
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Figure 17.  Mutation of the conserved M3-M4 aspartate residue in either α1 or β2 
subunits markedly reduced α1β2 receptor surface levels 
 
A, Representative fluorescence histograms of cells with control α1β2 (first column), 
α1(D420A)β2 (second column), α1β2(D450A) (third column),  or α1β2(D450E) (fourth 
column) subunit coexpression were generated.  Upper panels indicated surface α1FLAG 
subunit levels while lower panels indicated surface β2FLAG subunit levels.  B, Surface 
α1FLAG (black bars) and β2FLAG (grey bars) subunit levels were quantified in each 
condition as a percentage of control subunit coexpression.  C, Biotinylation was used to 
measure surface expression levels of α1 or β2 subunits.  HEK 293T cells surface proteins 
were labeled with sulfo-NHS-SS-biotin, and then were pulled down using streptavidin 
beads.  α1 and β2 subunits and loading control (LC, Na+/K+ ATPase) were detected using 
monoclonal antibodies, clones BD24, 62-3G1 and ab7671, respectively.  D, To control 
the variations from the streptavidin pull-down, integrated density volumes (IDV, pixel 
intensity X mm2) of various α1 and β2 subunits were normalized to those of Na+/K+ 
ATPase (LC).  To compare surface expression levels of various α1 and β2 subunits with 
expression of α1β2, α1(D420A)β2 and α1β2(D450A) subunits, adjusted IDVs for various 
α1 and β2 subunits were further normalized to those of wild type α1 or β2 subunits. *** 
indicates p < 0.001 relative to control α1β2 subunit coexpression.  † and †† indicate p < 
0.05 and p < 0.01, respectively, relative to α1(D420A)β2 subunit coexpression.  §§ 
indicates p < 0.01 relative to α1β2(D450A) subunit coexpression. 
76 
To determine if the loss of negative charge conferred by the aspartate residue was 
an important factor in the loss of surface expression, the conserved β2 subunit aspartate 
(D450) was mutated to glutamate, which is structurally conserved and has the same 
charge as aspartate.  Expression of the β2(D450E) subunit, however, yielded α1β2 
receptor surface levels that were still less than 10% of control levels.  Although the 
reduction was significantly less than that produced by the D to A mutations (p < 0.05 for 
α1 subunits and p < 0.01 for β2 subunits as compared between α1(D420A)β2 and 
α1β2(D450E) expression; p < 0.01 for comparison between α1β2(D450A) and 
α1β2(D450E) expression for both subtypes of subunits; n = 4) (Figure 17A, B), the 
results nonetheless suggested that the loss of charge of the aspartate residue was not 
responsible for the reduction of receptor surface expression. 
Surface biotinylation assays were also conducted to compare with results from 
flow cytometry analysis (Figure 17C).  The α1(D420A) mutation led to more than a 95% 
reduction in α1(D420A)β2 receptor surface levels, while the β2(D450A) mutation led to 
more than a 98% reduction of surface levels (Figure 17D) as indicated by normalized 
IDVs.  Thus, both techniques were in agreement and revealed that surface expression was 
abolished by the D450A mutant subunits.  The slight difference in the extent of the 
reduction may originate from different affinities of the anti-FLAG, anti-α1 and anti-β2 
antibodies. 
 
The α1(D420A) or β2(D450A) subunit mutations reduced total protein levels and 
promoted ER retention of mutant and partnering subunits 
 
There are several possible explanations for the low surface levels of α1(D420A) 
and β2(D450A) subunits.  These include accelerated degradation, inefficient assembly, 
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impaired forward trafficking, and decreased cell surface stability.  For multimeric subunit 
protein complexes such as the GABAA receptor, the ER is the frontline of quality control 
where misfolded and/or improperly assembled subunits are retained.  Indeed, several 
mutations associated with IGEs have been shown to cause ER retention of GABAA 
receptor subunits (Harkin et al., 2002;Kang and Macdonald, 2004;Gallagher et al., 
2005;Kang et al., 2006).  We thus first determined if the loss of α1(D420A)β2 and 
α1β2(D450A) receptor surface expression was associated with ER retention.  To explore 
this possibility, we took advantage of the fact that GABAA receptor subunits are 
glycosylated proteins and that oligosaccharide processing in the Golgi compartment 
confers resistance to endo H glycosidase digestion (Helenius and Aebi, 2004).  As a 
result, GABAA receptor subunits that are ER retained should display endo H sensitivity, 
and endo H digestion should reduce the ER-retained subunit molecular mass to that 
produced by PNGaseF digestion (which removes all N-linked carbohydrates). 
Endo H resistance was determined for α1 and β2 subunits expressed alone and 
also with α1β2, α1(D420A)β2, and α1β2(D450A) subunit coexpression (Figure 18).  In 
agreement with reports that single subunits were retained in the ER (Connolly et al., 
1996), expression of α1 or β2 subunits alone resulted in no visible bands with molecular 
masses higher than 46 kDa (for α1) or 48 kDa (for β2) after endo H digestion.  
Furthermore, the patterns for single subunit endo H digestions showed no difference from 
those for PNGaseF digestions (Figure 18A, B).  Quantification of the endo H resistant 
fractions indicated that less than 3% of total proteins were endo H resistant (Figure 18C).  
In contrast, approximately 80% of α1 or β2 subunit total proteins were endo H resistant  
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Figure 18.  Mutation of the conserved aspartate residue resulted in reduced subunit total 
protein levels and ER retention of both mutant and partnering subunits 
 
A, 10 mM Tris-RIPA buffer extracted proteins from expression of the α1 subunit alone 
(“single subunit”) or coexpression of α1β2, α1(D420A)β2, and α1β2(D450A) subunits 
were undigested (U) or digested with endo H (H) or PNGaseF (F).  An equal amount of 
total protein was loaded in each well.  The undigested α1 subunits had mobility mainly at 
50 kDa with a less apparent band that migrated at 48 kDa.  After Endo H digestion, α1 
subunits with mobility equal to that of subunits digested with PNGaseF (46 kDa) were 
considered endo H sensitive, while those with a higher molecular masses were considered 
endo H resistant.  B, The criteria used in A were used to distinguish endo H sensitive and 
resistant populations of β2 subunits.  Therefore, subunits that migrated at 54 and 51 kDa 
were considered to be endo H resistant, while those that migrated at 47 kDa were 
considered to be endo H sensitive.  C, The fractions of endo H resistant populations of 
total α1 (black bars) or β2 (grey bars) subunits in the four expression conditions were 
quantified by dividing the IDVs of the Endo H resistant bands by the summed IDVs of 
the Endo H resistant and sensitive bands.  D, Total subunit levels in each of the four 
expression conditions were compared.  IDVs of α1 or β2 subunits were normalized to 
those obtained with control subunit coexpression.  *** indicated p < 0.001 relative to 
control subunit coexpression. 
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with control α1β2 subunit coexpression, as represented by the presence of bands with 
molecular masses higher than 46 kDa (for α1) and 48 kDa (for β2) following endo H 
digestion (Figure 18A, B, C).  The D to A mutations resulted in receptor subunit ER 
retention, and no more than 8% of α1 or β2 subunit total proteins were endo H resistant 
with α1(D420A)β2 and α1β2(D450A) subunit coexpression (Figure 18A, B, C). 
Interestingly, while the α1(D420A) and β2(D450A) subunit endo H resistant 
fractions were significantly different from those of the control condition, they were not 
significantly different from those with single subunit expression.  Similarly, while both 
α1 and β2 subunit total protein levels were reduced with α1(D420A)β2 and α1β2(D450A) 
subunit coexpression, total subunit levels were not significantly different from those with 
single subunit expression (Figure 18D).  Thus, the results revealed that the majority of 
subunits with α1(D420A)β2 and α1β2(D450A) subunit coexpression were not distributed 
in compartments beyond the ER, and moreover, demonstrated that mutant subunits were 
processed similarly to individually transfected wild-type subunits. 
 
The loss of receptor surface expression caused by the D to A mutation was not due to 
impaired forward trafficking or accelerated endocytosis from the cell surface 
 
The observation that mutant subunits were retained in the ER suggested that the 
loss of receptor surface expression was mediated either by impaired receptor assembly or, 
alternatively, by impaired forward trafficking of normally assembled receptors.  However, 
the possibility also remained that receptors were normally assembled and forward 
trafficked, but that surface levels appeared reduced because of markedly accelerated 
endocytosis.  To distinguish between altered trafficking (either due to a decreased rate of 
forward trafficking or an increased rate of endocytosis) and impaired assembly, forward 
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trafficking of receptors was blocked by brefeldin A, a compound that inhibits receptor 
trafficking beyond the ER by collapsing the Golgi apparatus (Fujiwara et al., 1988).  
Indeed, if the loss of surface expression was caused by accelerated endocytosis, then in 
the absence of an appreciable surface pool, total expression levels should be the same for 
those subunits with control and mutant subunit coexpression.  Similarly, if mutant 
subunits had impaired forward trafficking, then there should be no difference in total 
expression levels between wild-type and mutant receptors when neither is capable of 
leaving the ER.  In contrast, if assembly of mutant subunits was compromised, then the 
reduction in total expression would still be expected, even when forward trafficking is 
blocked. 
 
 
 
 
Figure 19.  Application of 0.5 µg/mL brefeldin A could successfully block receptor 
surface expression 
 
Surface α1FLAG (black bars) and β2FLAG (grey bars) subunit levels were quantified in each 
condition as a percentage of control α1β2 subunit coexpression after applying either 
DMSO (left) or 0.5 µg/mL brefeldin A (BFA; right) six hours after transfection. *** 
indicates p < 0.001 relative to control subunit coexpression with DMSO treatment. 
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Figure 20.  Control subunit total protein levels remained higher than those with 
α1(D420A)β2 or α1β2(D450A) subunit coexpression when retained in the ER 
 
A, Immunoblots measuring Na+/K+ ATPase (upper panel, loading control) and α1 subunit 
(lower panel) total protein levels with α1β2, α1(D420A)β2, or α1β2(D450A) subunit 
coexpression after applying either DMSO (left) or 0.5 µg/mL brefeldin A (BFA; right) six 
hours after transfection.  B1, Normalized total α1 protein levels with DMSO treatment.  
B2, Normalized total α1 protein levels with BFA treatment.  *** indicates p < 0.001 
relative to control subunit coexpression with DMSO treatment.  †† indicates p < 0.01 
relative comparison to control subunit coexpression with BFA treatment. 
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Measuring receptor subunit surface levels using flow cytometry revealed that 0.5 
µg/mL brefeldin A successfully blocked cellular forward trafficking, as surface levels of 
control subunits were similar to those observed with α1(D420A)β2 or α1β2(D450A) 
subunit coexpression (n = 4; Figure 19).  While treatment with brefeldin A decreased 
total expression levels for all conditions, presumably due to its cellular toxicity, total 
protein levels were still substantially higher with control α1β2 subunit coexpression than 
with α1(D420A)β2 or α1β2(D450A) subunit coexpression (p < 0.01 for both conditions; 
n = 5) (Figure 20A, B2).  Thus, the accumulation of mutant subunits in the ER and 
reduction in total subunit levels could not be attributed to impaired forward trafficking or 
accelerated endocytosis of mutant receptors.  Instead, the results suggested that mutation 
of the conserved aspartate residue affected early steps in receptor biogenesis. 
 
With single subunit expression, mutant α1(D420A) and β2(D450A) subunits had the 
same total protein levels as wild type subunits but different glycosylation patterns 
 
We demonstrated previously that the GABAA receptor α1(A322D) mutation 
caused subunit misfolding that resulted in rapid ERAD of mutant subunits prior to 
oligomerization (Gallagher et al., 2007).  To determine if the total protein reductions 
observed with α1(D420A)β2 and α1β2(D450A) subunit expression were caused also by 
reductions in individual subunit availability, we compared expression of individual wild 
type α1 and β2 subunits to that of individual α1(D450A) and β2(D450A) subunits.  
Interestingly, we found that total protein levels of α1 or β2 single subunits were not 
significantly reduced by the D to A mutations (Figure 21A, B), suggesting that the 
mutation did not cause gross subunit misfolding (which would have been expected to 
trigger subunit degradation) (Gallagher et al., 2007).  Both mutant subunits, however, had 
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altered glycosylation patterns, indicating that their cellular processing was abnormal.  
The β2(D450A) mutation shifted the molecular masses of the two major bands from 54 
and 51 kDa to 52 and 50 kDa (Figure 21A), and while the α1(D420A) mutation did not 
produce mobility shifts, it increased the population migrating at 48 kDa at the expense of 
the population migrating at 50 kDa (Figure 21A). 
 
 
 
 
Figure 21.  Single subunit total protein levels were determined using Western blot 
analysis 
 
A, Total proteins were extracted from cells expressing single α1, α1(D420A), β2, or 
β2(D450A) subunits using RIPA buffer and immunoblotted with monoclonal anti-α1 
(upper panels) and anti-β2 (lower panels) antibodies.  Na+/K+ ATPase was used as 
loading control (LC).  B, Total protein levels with single subunit expression were 
quantified.  Black bars represented α1 subunit levels, while grey bars represented β2 
subunit levels.  To control for loading variability, the specific IDVs of α1 or β2 subunits 
were normalized to those of Na+/K+ ATPase.  To compare wild type and mutant subunits, 
the adjusted IDVs of mutant subunits were further normalized to those of wild type 
subunits. 
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The α1(D420A) and β2(D450A) mutations impaired α1β2 receptor pentamer formation 
 
The results in the previous sections suggested that mutation of the conserved 
aspartate residue in α1 or β2 subunits likely affected receptor biogenesis prior to 
pentameric forward trafficking and did not likely affect the availability of subunits for 
assembly.  Thus, reduction of mutant and partnering subunit surface and total proteins to 
levels similar to those with single subunit expression could be the result of impaired 
assembly.  To evaluate this possibility, analytic centrifugation was conducted to 
investigate the mass and shape of protein complexes with single subunit expression and 
with α1β2, α1(D420A)β2, and α1β2(D450A) subunit coexpression. 
Analyses using 5-20% sucrose density gradients revealed that the sedimentation 
coefficient of the α1 subunit transfected alone was 7.4S, which was slightly higher than 
the previously reported 5S coefficient (Gorrie et al., 1997;Taylor et al., 1999).  The 
sedimentation coefficient of α1β2 receptor complexes was 10.5S, which was also higher 
than the previously reported 9S coefficient (Gorrie et al., 1997;Taylor et al., 1999).  The 
sub-population of α1β2 receptors that migrated as protein complexes smaller than 10.5 
pentamers were assumed to be incompletely assembled subunit monomers or oligomers 
(Figure 22A, B).  In contrast, the major receptor population formed with α1(D420A)β2 
and α1β2(D450A) subunit had a sedimentation coefficient of 7.4S, with a profile that 
appeared to overlap with that of single subunit expression.  However, a sub-population 
was evident with a sedimentation coefficient higher than 9S, suggesting that some 
pentamer formation could not be excluded entirely (Figure 22A2, B2).  Nonetheless, even 
if this was the case, the results demonstrated that pentameric assembly was  
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Figure 22.  GABAA receptor protein complexes were analyzed using sucrose density 
gradients 
 
Whole cell lysates were extracted using high-detergent RIPA buffer and subjected to 5-
20% linear sucrose density gradients.  Following centrifugation to separate protein 
complexes of different sizes, gradients were fractionated into 23 fractions from the top to 
bottom.  14 fractions were selected to analyze the sedimentation coefficients using 
Western blot and compared to proteins with known sedimentation coefficients (BSA, 
4.3S; aldolase, 7.4S).  The chosen fractions were indicated beneath the Western blots.  
A1, Representative Western blots of α1 subunit staining in single subunit (α1), α1β2, 
α1(D420A)β2, and α1β2(D450A) expression conditions were presented.  A2, The 
distribution of α1 subunits in protein complexes with α1(D420A)β2 (thick blue line) and 
α1β2(D450A) (thick red line) subunit coexpression was plotted.  The distributions of α1 
subunits in protein complexes with single subunit expression (dotted line with ▲) or 
α1β2 subunit coexpression (hair-line with ●) were included for comparison.  B1 and B2, 
As in Panels A1, A2, and A3, except that staining was for β2FLAG subunits using anti-β2 
antibodies following immunoprecipitation with anti-FLAG M2 beads (to eliminate non-
specific staining; see Figure 20). 
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substantially impaired by mutation of the conserved aspartate residue.  It should be noted 
that the observed shifts to sedimentation coefficients higher than those predicted may 
have been caused by the strong association of interacting proteins with receptor 
complexes. 
 
The α1(D420A) and β2(D450A) subunits oligomerized with partnering subunits 
 
The sub-populations migrating with sedimentation coefficients higher than those 
of single subunit expression seen with α1(D420A)β2 and α1β2(D450A) subunit 
coexpression suggested that subunit oligomerization was still possible in the absence of 
the conserved aspartate residue.  To determine if partnering subunits could, in fact, still 
associate with D to A mutated subunits, immunoprecipitation experiments were 
performed.  With coexpression of D to A mutant and wild type partnering subunits, anti-
FLAG M2 beads specifically immunoprecipitated FLAG-tagged β2 subunits whether 
they contained the D to A mutation or not (lower panel of Figure 23), but did not 
precipitate non-FLAG-tagged β2 subunits (data not shown, and Figure 9).  Furthermore, 
the immunoprecipitated protein complexes contained associated partnering subunits 
whether or not they contained the D to A mutation (upper panel, Figure 23).  Thus, the 
subunit surface level and total cellular protein reductions with α1(D420A)β2 and 
α1β2(D450A) subunit coexpression was not due to lack of subunit oligomerization. 
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Figure 23. FLAG-tagged and partnering GABAA receptor subunits were 
coimmunoprecipitated 
 
Representative immunoblots of proteins immunoprecipitated from cells with α1β2FLAG, 
α1(D420A)β2FLAG, and α1β2(D450A)FLAG subunit coexpression using anti-FLAG M2 
beads.  Immunoprecipitated proteins were detected using monoclonal anti-α1 (upper 
panel) or anti-β2 antibodies (lower panel).  Note the 1 kDa shift in molecular mass due to 
insertion of the FLAG epitope in the β2 subunit (compared to immunoblots of untagged 
subunits shown previous figures). 
 
 
 
The conserved aspartate residue was required for α1β2γ2S receptor surface expression 
 
Having established the importance of the conserved aspartate residue for binary 
α1β2 receptor expression, which is the simplest subunit combination supporting 
functional receptor surface expression, we next determined if the conserved residue was 
also required for surface expression of ternary α1β2γ2S receptors.  Relative to control 
subunits, the D to A mutation in the α1 or β2 subunit caused significant surface level 
reductions of mutant and partnering subunits with ternary subunit coexpression (p < 
0.001 for all subtypes of subunits and for both expression categories, n = 4-7) (Figure 
24B).  Subunit surface levels with α1(D420A)β2γ2S subunit coexpression were 27%, 
36%, and 32% of control α1, β2, and γ2S subunit surface levels, respectively.  With 
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α1β2(D450A)γ2S subunit coexpression, subunit surface levels were 11%, 8%, and 26% 
of control α1, β2, and γ2S subunit surface levels, respectively.  Relative to 
α1(D420A)β2γ2S subunit coexpression, surface levels of α1 and β2 subtype subunits 
with α1β2(D450A)γ2S subunit coexpression were significantly lower (p < 0.05 for both 
subtype, n = 4), while γ2S subtype levels were not.  Comparing the effects of the D to A 
mutation on ternary and binary receptor surface expression revealed that the presence of 
γ2S subunits could partially restore surface expression levels of α1 and β2 subunits when 
either of them contained the D to A mutation (to more than double the levels observed 
with binary subunit coexpression) (Figure 17B).  However, the γ2S subunit is known to 
be able to reach the cell surface when expressed alone (Connolly et al., 1999b).  It is 
therefore possible that these partnering subunits in incompletely-assembled intermediates 
associated with γ2S subunits and escaped from the ER. 
Interestingly, while the γ2(D442A) subunit coexpressed with α1 and β2 subunits 
had very low surface expression (2% of control γ2S subunits, p < 0.001, n = 4), surface 
levels of partnering α1 subunits were not significantly affected (87% of control α1 
subunits, n = 3), and surface levels of partnering β2 subunits were even increased (143% 
of control β2 subunits, p < 0.001, n = 4).  These data indicated that the conserved residue 
of the γ2S subunit was essential for α1β2γ2S receptor surface expression, but not for 
α1β2 receptor surface expression.  An explanation for this finding was that while 
γ2(D442A) subunits could not be incorporated into pentameric receptors, α1 and β2 
subunits remained free to assemble and forward traffic. 
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Figure 24.  Mutation of the conserved aspartate residue to alanine in α1, β2, or γ2S 
subunits markedly reduced α1β2γ2S receptor surface levels 
 
A, Representative fluorescence histograms of cells with control α1β2γ2S (first column), 
α1(D420A)β2γ2S (second column), α1β2(D450A)γ2S (third column),  or 
α1β2γ2S(D442A) (fourth column) subunit coexpression were generated.  Upper panels 
indicated surface α1FLAG subunit levels, middle panels indicated surface β2FLAG subunit 
levels, and lower panels indicated surface γ2S FLAG levels.  B, Surface α1FLAG (black bars), 
β2FLAG (grey bars), and γ2S FLAG (white bars) subunit levels were quantified in each 
condition as a percentage of control subunit coexpression.  *** indicates p < 0.001 
relative to control α1β2γ2S subunit coexpression.  † indicates p < 0.05 relative to 
α1β2(D450A)γ2S  subunit coexpression. 
 
 
90 
Discussion 
 
 
 
Mutation of a highly-conserved aspartate residue decreased GABAA receptor surface 
expression by impairing an early step in receptor biogenesis 
 
Using a combination of flow cytometry, M3-M4 loop swaps, segmental deletions, 
and multiple sequence alignments, we identified an aspartate residue that was highly 
conserved among members of the Cys-loop receptor superfamily and required for 
GABAA receptor surface expression.  Analysis of subunit maturation using glycosidase 
digestion and Western blotting revealed that mutation of this conserved residue resulted 
in ER retention of both mutant and partnering subunits, thereby decreasing their surface 
levels.  This decrease in subunit surface levels was not due to impaired forward 
trafficking or accelerated endocytosis, as the relative total subunit levels were similar for 
control, α1(D420A)β2, and α1β2(D450A) subunit coexpression in the presence of 
brefeldin A, which prevented forward trafficking.  Indeed, absolute total subunit levels 
with α1(D420A)β2 and α1β2(D450A) subunit coexpression were still lower than the 
control condition in the presence of brefeldin A, suggesting that subunits were trapped in 
the ER because of impaired receptor assembly. 
 
Mutation of the conserved aspartate residue compromised pentameric receptor 
assembly without causing severe subunit misfolding 
 
In combination, the glycosylation and brefeldin A experiments suggested that 
mutation of the conserved aspartate residue impaired an early step in receptor biogenesis, 
either by decreasing subunit availability for oligomerization, impairing subunit 
oligomerization, or preventing complete pentameric assembly.  Our results, however, 
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argued against decreased subunit availability.  We have previously demonstrated that an 
alanine to aspartate mutation in the GABAA receptor α1 subunit associated with juvenile 
myoclonic epilepsy, α1(A322D), caused protein misfolding and an increased rate of 
ERAD.  Consequently, total cellular expression of α1(A322D) subunits was significantly 
reduced when expressed individually (Gallagher et al., 2005;Gallagher et al., 2007).  
Thus, if the α1(D420A) and β2(D450A) subunits were severely misfolded, we would 
have expected a similar outcome.  However, with single subunit expression, mutating the 
conserved aspartate residues did not alter total subunit levels, suggesting that the rates of 
de novo synthesis and degradation of the α1(D420A) and β2(D450A) subunits were 
unchanged.  This suggested that the observed reduction of partnering subunit total protein 
levels was secondary to reduced pentamer formation, as neither α1 nor β2 subunits are 
trafficking-competent when expressed alone (Connolly et al., 1996). 
Using analytic centrifugation, we provided direct evidence that the conserved 
aspartate residue was required for receptor assembly.  In agreement with previous reports 
that demonstrated that intact N-terminal domains were capable of mediating inter-subunit 
interactions (also demonstrated here using immunoprecipitation), protein complexes 
showing higher sedimentation coefficient than 7.4S with α1(D420A)β2 and α1β2(D450A) 
subunit coexpression were observed, indicating the presence of oligomerized subunit 
assembly intermediates.  While we cannot rule out the possibility that some pentamers 
were formed, the lack of an appreciable 10.5 S sedimentation fraction suggests the 
pentameric population was relatively small.  Thus, we concluded that mutating the 
conserved aspartate residue permitted some degree of subunit oligomerization, but 
prevented complete assembly of pentameric receptors. 
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The role of C-terminal motifs in the assembly of other Cys-loop family members 
 
While this is the first report implicating a region other than the N-terminal domain 
in GABAA receptor assembly, the M3-M4 loop and M4 domain are known to be 
important for assembly of nACh receptors (Quiram et al., 1999).  A three-amino acid 
deletion in the nicotinic acetylcholine receptor β subunit M3-M4 loop, β426∆EQE, 
associated with CMS has been demonstrated to impair the interaction between β and δ 
subunits (Quiram et al., 1999).  Moreover, mutation of histidine 408 in the α subunit, 
which is adjacent to the conserved aspartate residue, impaired receptor assembly and 
reduced the 9S pentamer population (Roccamo and Barrantes, 2007).  The significance of 
the conserved aspartate residue was further emphasized by the finding that the nACh 
receptor εN436∆ subunit mutation associated with CMS, which is adjacent to the 
conserved aspartate residue in the ε subunit, reduced α2βδε receptor surface expression, 
as did deletion of the conserved aspartate residue, εD435∆ (Shen et al., 2005).  While it 
remains unclear if this loss of surface expression also reflected impaired assembly, these 
examples nonetheless support the idea that C-terminal motifs are important determinants 
of Cys-loop receptor biogenesis. 
 
The conserved aspartate residue may be exposed to the intracellular milieu 
 
Increasing experimental evidence suggests that the conserved aspartate residue is 
not buried within subunit interfaces, and may actually be exposed to the intracellular 
milieu.  For example, the H408 residue in nACh receptor α subunits, which is adjacent to 
the conserved D407 residue, was found to be labeled by the photoactivatable compound, 
3-[3H]azioctanol (Pratt et al., 2000).  Thus, the region in nACh receptor α subunits 
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containing the M-D-H motif, which is analogous to the I-D-R motif in GABAA receptor 
α1 and β2 subunits, was not protected by intersubunit interactions.  Support for this 
hypothesis comes from homology alignments to muscle nACh receptors, where the 
conserved aspartate residue appears exposed, even in the context of fully-assembled 
pentamers (Unwin, 2005).  Furthermore, mass spectrometry of a motif containing the 
conserved aspartate residue in glycine receptors has been demonstrated to be exposed to 
the intracellular milieu (Leite et al., 2000).  Although a crystal structure of the GABAA 
receptor has yet to be generated, given the degree of homology between GABAA 
receptors and the remainder of the Cys-loop family, these findings suggest that the 
conserved aspartate residue is exposed on the surface of pentamer complex (regardless of 
its location in the M3-M4 loop or M4 domain). 
 
The conserved aspartate residue may be involved in interactions with other proteins 
 
Based on the resolved structure of the nACh receptor, it has been suggested that 
the conserved aspartate residue is located at the beginning  of a helix comprising the end 
to the M3-M4 loop and the M4 (Unwin, 2005).  Because charged residues are hydrophilic, 
the conserved aspartate reside is favored to be in the cytoplasmic milieu (White and von 
Heijne, 2005).  Substitution of the conserved aspartate with alanine could cause 
transmembrane helix tilt to move the hydrophobic alanine into the lipid.  This allosteric 
change could theoretically affect subunit assembly.  However, the D to E mutations in the 
β2 subunits disfavored this hypothesis as the conservative substitution, which is less 
likely to cause allosteric change, also caused significant reduction of surface receptor 
levels.  
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Mutation of the conserved aspartate not only caused ER retention of α1 and β2 
subunits but also affected their glycosylation patterns.  Although altered glycosylation did 
not preclude receptor surface expression (Buller et al., 1994) (data not shown), the results 
nonetheless demonstrated that C-terminal motifs could affect post-translational 
modification of N-terminal domains.  This suggested the existence of mechanisms that 
coordinate intracellular and extracellular protein processing.  Assuming that the 
conserved aspartate residue is not buried within subunit interfaces, one possibility is that 
it interacts with transmembrane and/or cytoplasmic proteins, which in turn, mediate 
communication between subunit domains located in extracellular, membrane, and/or 
intracellular environments.  The observation that the conservative substitution of the 
aspartate residue with a glutamate residue could only partially restore receptor surface 
expression suggested that the residue could be located in a tightly structured environment 
where both charge and side-chain length play an important role for interaction.  
Furthermore, the aspartate residue could be important for maintaining critical secondary 
structure for protein interaction, although this secondary structure did not impair subunit 
oligomerization or cause protein degradation before oligomerization. 
While the identity of the interacting cellular machinery and its distribution among 
different types of cells remains to be established, ER chaperones such as calnexin (a type 
I-integral membrane protein) (Ou et al., 1995) have been shown to regulate receptor 
subunit folding, assembly, and half-life, and are thus potential components of the yet-to-
be-identified protein complex (Gelman et al., 1995;Wanamaker and Green, 2007).  It is 
worth noting that Cys-loop superfamily receptors are present not only in neurons, but also 
in myocytes, epithelial cells, and lymphocytes (Maus et al., 1998;Skok et al., 2003).  A 
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naturally occurring mutation in nACh receptor subunit M3-M4 loops associated with 
CMS has been shown to affect receptor assembly within muscle cells (Quiram et al., 
1999).  Furthermore, charged residues including the conserved aspartate in subunit M3-
M4 loops have been demonstrated to affect receptor assembly in epithelium-like cells 
(Roccamo and Barrantes, 2007).  Thus, the conserved aspartate residue may interact with 
ubiquitous cellular machinery. 
 
Conclusions 
 
With the simplest binary combination that allowed for functional GABAA 
receptor surface expression, our results demonstrated that the conserved aspartate residue 
at the boundary of the M3-M4 loop and the M4 transmembrane domain was required for 
Cys-loop receptor assembly.  Consistent with this finding, D to A mutation in α1 and β2 
subunits substantially decreased surface levels of ternary α1β2γ2S GABAA receptors, the 
most abundant isoform expressed in the mammalian brain (McKernan and Whiting, 
1996).  Interestingly, while D to A mutation of the γ2S subunit also reduced the ternary 
receptor population, it did not prevent formation of binary α1β2 receptors.  This reflected 
the fact that α1 and β2 subunits could still assemble in the absence of γ2S subunits.  
Notably, α1 and β2 subunit surface levels were not reduced at all by the mutant γ2S 
subunit, supporting the hypothesis that the mutant γ2S subunit was unable to oligomerize 
with α1 and β2 subunits, or if it did oligomerize, the interaction was not sufficient for the 
γ2S subunit to have a dominant negative effect on assembly of α1β2 receptors. 
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CHAPTER IV 
 
GLYCOSYLATION OF GABAA RECEPTOR β2 SUBUNITS 
 
Introduction 
 
N-linked glycosylation is important for biogenesis of glycosylated membrane 
proteins (Helenius and Aebi, 2004).  Specifically, it plays an important role in protein 
folding, stability and trafficking.  Co-translational conjugation of a N-glycan precursor, 
which is composed of two N-acetylglucosamine, nine mannose and three glucose residues, 
to the nascent polypeptide (Figure 25), is directed by the consensus sequence, N-X-S/T 
(where X can be any amino acid except proline).  This post-translational covalent 
modification increases hydrophilicity of nascent polypeptides and prevents aggregation 
of folding intermediates (Ruddock and Molinari, 2006). 
Several ER resident proteins have been demonstrated to facilitate protein folding.  
The removal of the outermost two glucose residues from an N-glycan by glucosidase I 
and II, respectively, leads to direct binding of calnexin and calreticulin to the nascent 
polypeptide (Hammond et al., 1994).  The ER chaperones then introduce the nascent 
polypeptide to other proteins involved in protein folding such as ERp57, a homologue of 
protein disulfide isomerase (PDI), which has been shown to facilitate formation of 
structural disulfide bonds (Frickel et al., 2002).  Conversely, removal of the third 
(innermost) glucose residue by glucosidase II leads to release of the glycoprotein from 
calnexin and calreticulin.  Because the calnexin/calreticulin complex is part of the ER 
quality control machinery, polypeptides that dissociate from the ER chaperone complex 
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are directed to one of two pathways.  If the glycoprotein folds and assembles properly 
(for multimeric proteins), it will exit from the ER and be trafficked to its final destination.  
However, if the glycoprotein is not in its native conformation, a UDP-glucose: 
glycoprotein glucosyltransferase (UGGT) can add back a single glucose to the outermost 
mannose residue on branch A (Parodi, 2000) (Figure 25), which results in re-association 
of the glycoprotein with the calnexin/calreticulin protein complex.  It is worth noting that 
though a glycoprotein may contain multiple folding domains, the UGGT will only re-
glycosylate N-glycans in the misfolded region.   
 
 
 
 
Figure 25.  The schematic presentation of a precursor of all N-glycans added to a protein 
 
Unprocessed oligosaccharides are composed of two N-acetylglucosamine residues (black 
squares), nine mannose residues (green circles), and three glucose residues (red triangles), 
which are numbered based on their extremity.  The three branches in the glycan are 
labeled as A, B, C.  Figure adapted from Ruddock and Molinari, 2006.   
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It has been proposed that cycles of deglucosylation/reglucosylation of N-glycans 
and disassociation/reassociation with calnexin/calreticulin are limited by a “mannose-
timer” (Helenius, 1994).  The model postulates that, once mannose trimming occurs, the 
proteins responsible for translocating glycoproteins from the ER to the cytosol for ERAD 
compete with calnexin for glycoprotein binding.  In support of this model, inhibition of 
demannosylation protects misfolded glycoproteins from ERAD (Liu et al., 1999;Su et al., 
1993), while overexpression of mannosidase accelerates onset of ERAD (Wu et al., 2003). 
Blocking glycosylation of GABAA receptors using tunicamycin has been 
demonstrated to abolish receptor biogenesis at a stage later than receptor subunit 
oligomerization (Connolly et al., 1996).  Furthermore, two glycosylation sites in the rat 
GABAA receptor α1 subunit have been shown to be important for receptor subunit 
folding as mutation of either of the two glycosylation sites decreased surface and total 
receptor expression at 37°C (Buller et al., 1994).  Based on the consensus sequence, N-X-
S/T, the human β2 subunit is predicted to have three glycosylation sites.  Whether or not 
the predicted glycosylation sites are functional remains to be elucidated since predicted 
glycosylation sites are not always glycosylated (Apweiler et al., 1999;Kowarik et al., 
2006).  Furthermore, as demonstrated in chapter III, mutation of the absolutely conserved 
aspartate residue affected glycosylation of the β2 subunit N-terminal domain.  To 
understand better how glycosylation regulates GABAA receptor biogenesis, particularly if 
the receptor surface level reduction caused by the β2 subunit mutation, D450A, is due to 
the disturbed glycosylation, the potential glycosylation sites in the β2 subunit were 
examined. 
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Figure 26.  A schematic presentation of the human β2 subunit 
 
The primary sequences of the N-terminal domain and the four loops were incorporated. 
The three glycosylation sites were marked in orange.  Note that the third putative 
glycosylation site, N173 (including the signal peptide), is adjacent to the second residue 
of the two Cys-loop cysteines (highlighted in blue), which form the disulfide bond of the 
signature Cys-loop.  The conserved aspartate residue at the boundary of the M3-M4 loop 
and the M4 domain was marked in red. 
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Materials and methods  
 
 
 
DNA constructs 
 
The cDNAs for native and FLAG-tagged human α1 and β2 subunits were 
prepared as described in previous chapters.  Briefly, one FLAG epitope was introduced 
between the 8th and 9th position and the 4th and 5th position of the α1 and β2 subunit, 
respectively.  FLAG-tagged subunits were functionally indistinguishable from native 
subunits in their electrophysiological properties and effects on partnering-subunit surface 
levels (Lo et al., 2008).  Three potential glycosylation sites, N32, N104 and N173, were 
individually mutated to glutamine (N to Q mutations) using QuikChange Site-Directed 
Mutagenesis Kit (Stratagene).  Furthermore, double- and triple-point mutations were 
performed on backbones containing single- and double-point mutations, respectively.  
The forward sequences of the primer pairs used to mutate the putative glycosylation sites 
are listed below. 
 
 
  Table 5.  Forward sequences of primer pairs for Site-Directed mutagenesis III 
 
Mutation Forward primer sequence (5’ to 3’) 
Mutating the conserved aspartate residues in the α1, β2 and γ2 subunits 
β2(N32Q) C AAT GAC CCT AGT CAA ATG TCG CTG G 
β2(N104Q) GTA ATC CCT TTA CAA TTG ACT TTG GAC 
β2(N173Q) CCA CTG GAT GAA CAA CAA TGC ACG TTG GAG 
 
* codons in bold were responsible for the designed point mutation. 
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Cell culture and transfection 
 
HEK293T cells were incubated at 37°C in humidified 5% CO2/95% air and 
grown in Dulbecco’s Modified Eagle Medium (Invitrogen) supplemented with 10% fetal 
bovine serum, 100 i.u./mL penicillin, and 100 µg/mL streptomycin (Invitrogen).  For 
single subunit expression, binary subunit and ternary subunit coexpression, cells were 
transfected with 1 µg, 2 µg and 3 µg (containing individual subtypes of subunits in an 
equal amount) of cDNA using 3 µL, 6 µL and 9 µL of FuGene6 transfection reagent per 
60 mm diameter culture dish, respectively.  The cDNA-FuGene6 volumes were scaled up 
or down proportionally to the surface area of cell culture dishes.  Cells were subjected to 
the following experiments 48 hours after transfection.   
 
Western blots 
 
Cell membranes were lysed using RIPA buffer composed of 50 mM Tris-HCl (pH 
7.4), 150 mM NaCl, 1 mM EDTA, 1% NP40, 0.25% sodium deoxycholate and protease 
inhibitor cocktail (Sigma).  Cell lysates were cleaned by centrifugation at 10,000X g for 
30 minutes.  The supernatants were subjected to SDS-PAGE, and proteins in gels were 
transferred to PVDF membranes (Millipore).   
Monoclonal anti-GABAA receptor α1 subunit antibodies (final concentration 5 
µg/mL, clone: BD24, Chemicon) and monoclonal anti-GABAA receptor β2/3 antibodies 
(4 µg/mL, clone: 62-3G1, Upstate) were used to detect wild type or modified human α1 
and β2 subunits, respectively.  Anti-sodium potassium ATPase antibodies (0.2 µg/mL, 
clone: ab7671, Abcam) were used to control for loading variability.  Following 
incubation with primary antibodies, secondary goat anti-mouse IgG heavy and light chain 
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antibodies conjugated with horseradish peroxidase were used in 1:10,000X dilution 
(Immunoresearch laboratories) for the visualization of specific bands in enhanced 
chemiluminescent detection system (Amersham Biosciences). 
The signals were collected in a digital ChemImager (Alpha Innotech).  The IDV 
of each band, pixel intensity X mm2, was then calculated using the FluorChem 5500 
software.  To compare the expression levels between the same subtype subunits with 
different mutations, adjusted IDVs (normalized to loading control Na+/K+ ATPase IDVs) 
were normalized to those of control conditions.   
 
Glycosidase digestion 
 
Whole cell lysates obtained from RIPA buffer extraction were subjected to endo 
H and PNGaseF digestion (New England BioLab) following the manufacturer’s 
recommended protocol.  The digestion reactions were carried out at 37°C for 3 hours and 
terminated by addition of sample buffer. 
 
Flow cytometry 
 
Cells were detached from culture dishes using trypsin, washed with FACS buffer, 
and incubated with anti-FLAG antibodies directly conjugated with PE (50X diluted in 
FACS buffer) for 1 hour on ice.  Stained cells were fixed with 2% paraformaldehyde.   
The surface fluorescence intensity of each cell was measured using a FacsCalibur 
(Becton, Dickinson and Company).  Data were acquired using Cell Quest (BD 
Biosciences) and analyzed offline using FlowJo (Treestar, Inc.).   
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To exclude non-specific staining presented in dead cells, viable cells were 
selected based on 7-AAD exclusion.  The distributions of cellular PE fluorescence were 
plotted as frequency histograms.  Based on the fluorescence histogram of mock 
transfection, a fluorescence gate was set such that only the brightest 1% of cells were 
included.  For each experimental condition, two numbers, the % of viable cells with 
fluorescence higher than the gate and the mean fluorescence of these cells, were 
determined.  Subunit surface levels for whole cell population were than compared using 
fluorescence index, the product of multiplying the two numbers.  Because fluorescence 
unit is arbitrary, the subunit surface level of each experimental condition was expressed 
as % of those of control-wild-type subunit coexpression.  One-way ANOVA with 
Tukey’s post test was used to evaluate the significance of relative level differences. 
 
Results 
 
 
 
All three predicted glycosylation sites of the GABAA receptor β2 subunit contained N-
glycans, which contributed differently to molecular mass shifts 
 
Endo H and PNGaseF glycosidase digestions revealed that there were 
glycosylation modifications on GABAA receptor subunits, since removing the covalently 
conjugated N-glycans decreased subunit molecular masses (Figure 8 and Figure 18).  
Furthermore, as demonstrated in chapter III, the conserved aspartate residue located in 
the cytoplasmic compartment affected glycosylation on the extracellular N-terminal 
domain of the β2 subunit and caused a shift in molecular mass (Figure 21).  To determine 
whether or not the three putative β2 subunit glycosylation sites (N32, N104 and N173) 
are functional and how their glycans interact with the conserved aspartate residue located 
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in the cytoplasmic side and with partnering subunits, three β2 subunit constructs with a N 
to Q mutation on one of the three glycosylation sites were made.  Molecular mass 
analyses using SDS-PAGE revealed that the three glycosylation sites were functional as 
mutations of individual putative glycosylation sites of β2 subunit resulted in a decreased 
molecular mass.  Interestingly, β2(N32Q), β2(N104Q) and β2(N173Q) subunits did not 
migrate at the same molecular mass.  Furthermore, the mutation of the conserved β2 
subunit residue, D450A, caused a molecular mass shift similar to that of mutation of the 
third glycosylation site (Figure 27A, B). 
To understand better how individual N-glycans on each glycosylation site 
contributed to the shifts in β2 subunit molecular masses, double-Q and triple-Q β2 
subunit mutations (mutating two or three asparagines to glutamines) were made such that 
only one or no glycosylation site, respectively, remained.  The triple-Q β2 subunit, 
β2(N32Q/N104Q/N173Q) moved in SDS-PAGE as a single band at a molecular mass of 
47 kDa, while the major bands of the three double-Q mutant subunits, which retained 
only the N32, N104 or N173 site, migrated at higher molecular masses of 49, 50 and 48 
kDa, respectively.  Furthermore, 34% of β2(N104Q/N173Q) subunits migrated at a lower 
molecular mass equal to that of the triple-Q mutants, suggesting that appreciable 
β2(N104Q/N173Q) subunits were de-glycosylated or non-glycosylated (possibly due to 
weak recognition of the consensus sequence).  Consistent with this conclusion, apparent-
additional populations that migrated at smaller molecular masses only occurred with 
those subunits that did not contain a mutation of the first glycosylation site, i.e. wild-type 
β2, β2(D450A), β2(N104Q), β2(N173Q) and β2(N104Q/N173Q) (Figure 27A, B). 
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Figure 27.  The β2 subunits with various combinations of glycosylation-site mutations 
were expressed alone 
 
A, Relative to the wild-type β2 subunit, the shifts of molecular masses and changes of 
subunit total-protein levels of single-, double- and triple-N to Q mutants with single 
subunit expression were evaluated using Western blots.  Upper panel presented the anti-
Na+/K+ ATPase staining for the purpose of loading control (LC); lower panel presented 
the anti-β2 subunit staining.  The third to fifth lanes stained for single-Q mutants, in an 
order such that N32, N104 and N173, respectively, mutated; the sixth to eighth lanes 
stained for double-Q mutants, in an order such that N32, N104 and N173, respectively, 
remained; the last lane stained for triple-Q mutant where no putative glycosylation site 
were remained.  Also note that the D450A mutation of β2 subunits was also presented in 
lane two.  B, A schematic presentation was added to facilitate analysis of the β2 subunit 
staining.  The bottom bands (47kDa) were the forms of the polypeptide with no 
glycosylation and were labeled as dash-line in most of lane since they were less apparent.  
1, 2 and 3 represent the contribution from N-glycans at N32, N104 and N173 
glycosylation sites, respectively.  C, Quantification of single subunit expression of β2 
subunit glycosylation-site mutants is presented. The band intensity of each lane, after 
being corrected for loading variation, was expressed as % of the intensity of the wild-type 
β2 subunit presented in lane one.  Data were presented as mean ± standard deviation.  * 
and *** indicate p < 0.05 and 0.001, respectively, relative to wild-type β2 subunit 
expression; †† and ††† indicate p < 0.01 and 0.001, respectively, relative to β2(N32Q) 
subunit expression;  §§§ indicates p < 0.001 relative to β2(N104Q) subunit expression; 
‡‡ and ‡‡‡ indicate p < 0.01 and 0.001, respectively, relative to β2(N173Q) subunit 
expression. 
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Glycosylation of β2 subunits was important for single subunit expression  
 
The importance of glycosylation on individual sites for β2 subunit folding before 
heteromeric oligomerization was also evaluated by measuring subunit total-protein levels.  
It has been demonstrated that the misfolded GABAA receptor α1(A322D) subunit, is 
rapidly degraded by ERAD before heteromeric oligomerization (Gallagher et al., 2007).  
Thus, subunits with glycosylation-site mutations may also be misfolded or have impaired 
oligomerization and result in decreased total protein levels.  Supporting the importance of 
glycosylation for subunit folding and oligomerization, single-, double-, and triple-Q 
mutations significantly reduced subunit total-protein levels, relative to wild-type β2 
subunits expressed alone.   Furthermore, the glycosylation mutations had additive effects, 
and total-protein levels of β2(N32Q/N104Q), β2(N32Q/N173Q) and 
β2(N32Q/N104Q/N173Q) subunits were significantly decreased relative to those of 
β2(N32Q) subunits (p < 0.01 for double-Q and p < 0.001 for triple-Q mutants) (Figure 
27C). 
 
Mutation of the β2(N104) glycosylation site caused greater reductions in surface 
GABAA receptor expression than mutations in  the two other glycosylation sites 
 
To further evaluate how individual glycosylation sites regulate GABAA receptor 
biogenesis, β2 subunits with glycosylation-sites mutated were coexpressed with wild-
type α1 subunits and surface levels of both subunits were measured using flow cytometry.  
To facilitate measurement, one FLAG epitope was introduced into the α1 and the β2 
subunit (see Methods).  Subunits were coexpressed in a way such that only one subtype 
was tagged.  For instance, to evaluate the effect of the N32Q mutation, two transfection 
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conditions were carried out, i.e. α1FLAGβ2(N32Q) and α1β2(N32Q)FLAG subunit 
coexpression. 
Expression profiles of single-Q mutated subunits revealed that the N104Q 
mutation significantly decreased surface receptor levels (p < 0.001, n = 5), while N32Q 
and N173Q mutations did not alter surface levels.  With α1β2(N104Q) subunit 
coexpression, only 50% and 39% of control α1 and β2 subtype-surface levels, 
respectively, remained (Figure 28).  Interestingly, the double-Q mutant expression profile 
demonstrated that the presence of the single N104 glycosylation site (β2(N32Q/N173Q)) 
only was sufficient to support full levels of subunit surface expression.  On the other hand, 
removing more glycosylation sites from the β2(N104Q) subunit caused further reduction 
of receptor surface levels.  Consequently, there was no significant difference between 
surface receptor levels with α1β2(N32Q/N104Q), α1β2(N104Q/N173Q) and 
α1β2(N32Q/N104Q/N173Q) subunit coexpression (n = 4).  10%, 22% and 3% of control 
α1 and 14%, 14% and 4% of control β2 subunit with α1β2(N32Q/N104Q), 
α1β2(N104Q/N173Q) and α1β2(N32Q/N104Q/N173Q) subunit coexpression, 
respectively, remained. 
Taken together, the data were consistent with the conclusion that glycosylation at 
the β2 subunit N104 site was responsible for attaining maximal level of surface α1β2 
receptors.  Importantly, despite the finding that the glycosylation pattern change caused 
by the β2 subunit mutation, N173Q, was similar to that caused by the β2 subunit mutation, 
D450A, loss of glycosylation at residue N173 was not the cause of the profound decrease 
of surface receptors when the conserved aspartate residue, β2(D450), was mutated to 
alanine (Figure 28). 
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Figure 28. With binary subunit coexpression, subunit surface levels of α1 and β2 subunits 
were changed in response to different combinations of β2 subunit glycosylation site 
mutations 
 
Effects of glycosylation-site mutations on α1 and β2 subunit-surface levels in the context 
of α1 and β2 subunit coexpression were evaluated.  A, The histogram with each binary 
coexpression was overlapped with that of mock expression.  Upper panels showed 
histograms of surface α1FLAG subunit staining with various coexpression conditions, 
while the lower panels showed those of β2FLAG subunits.  B, Fluorescence indexes of 
surface α1FLAG (black bars) and β2FLAG (grey bars) subunit levels were obtained in each 
condition and expressed as a percentage of control α1FLAG or β2FLAG subunits, the wild-
type FLAG-tagged α1 and  β2 subunit coexpressed with non-FLAG-tagged wild-type β2 
and α1 subunits, respectively.  Data were presented as mean ± standard deviation.  *** 
indicates p < 0.001 relative to control α1β2 subunit coexpression; ††† indicates p < 0.001 
relative to α1β2(N32Q/N104Q/N173Q) subunit coexpression. 
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With binary subunit coexpression, subunit surface levels were not the only factors 
determining subunit total protein levels 
 
It is worth pointing out that individual glycosylation sites had different levels of 
significance for single subunit expression and binary receptor surface levels.  The N32Q 
or N173Q mutations reduced total subunit levels with single subunit expression; while 
the N104Q mutation was more crucial for binary receptor surface expression.  Decreasing 
the availability of subunits due to their misfolding could profoundly affect pentameric-
GABAA receptor assembly (Gallagher et al., 2005;Gallagher et al., 2007).  On the other 
hand, relative to single subunit expression, binary subunit coexpression could prolong 
both subunit half-lives and result in a two to three fold increase of subunit total protein 
levels (Figure 18).  It is possible that coexpression of partnering α1 subunits differentially 
increases the total protein levels of individual β2 subunits with distinct combinations of 
glycosylation site mutations.  To examine this possibility, total protein levels of both 
subtypes of subunits with various combinations of wild-type α1 and glycosylation site-
mutated β2 subunits coexpression were evaluated by Western blotting. 
The total protein profile of partnering α1 subunits was similar to the binary 
receptor surface expression profile.  In the single Q mutation subset, mutating the N104 
residue caused significant reduction of total α1 subunit proteins (60% of control α1 
subunits remained, p < 0.05, n = 4).  In the double Q mutation subset, the N32Q/N173Q 
mutation led to no significant change, while the N104Q/N173Q or N32Q/N104Q 
mutation caused more than 50% reductions of α1 subunit total proteins (p < 0.01 and 
0.001 with α1β2(N104Q/N173Q) and α1β2(N32Q/N104Q) subunit coexpression, 
respectively, n = 4). 
110 
Interestingly, coexpression of α1 subunits differentially increased surface protein 
expression of β2 subunits containing various combinations of glycosylation site 
mutations.  With α1β2(N32Q) subunit coexpression, the β2(N32Q) subunit total protein 
level was significantly reduced (60% of control subunits, p < 0.001, n = 3).  This was a 
surprising result because mutation of the N32 glycosylation site did not decrease surface 
receptor and partnering α1 subunit total protein levels.  The inconsistency may originate 
from subunit misfolding caused by the mutation.  Alternatively, this finding also 
suggested that fewer than control subunit total protein levels could support full level of 
surface receptor expression.  Consistent with this, 33% of control subunit level of 
β2(N32Q/N173Q) subunits maintained full receptor surface levels.  It has been 
demonstrated before that the β2 subunit total protein level with α1β2 subunit 
coexpression is 2.6 times of that with single subunit expression (Figure 18).  After 
correcting for this factor, α1 subunit coexpression increased total protein levels of β2 
subunits with or without glycosylation site mutations.  However, only those mutated β2 
subunits showing no significant reductions at surface expression levels were increased 
more by the partnering subunits.   
In summary, changes of subunit total protein levels did not always correlate with 
changes in receptor surface levels. Conversely, total protein expression of glycosylation 
site mutated β2-subunit directly correlated receptor surface levels and may possibly be 
determined by the rate of protein degradation induced by subunit misfolding. 
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Figure 29.  With α1β2 subunit coexpression, α1 and β2 subunit surface levels were not 
the only factors determining subunit total protein levels  
 
Effects of glycosylation-site mutations on α1 and β2 subunit total-protein levels in the 
context of α1β2 subunits coexpression were evaluated.  A, Total proteins were extracted 
from cells with mock, control α1β2, α1β2(N32Q), α1β2(N104Q), α1β2(N173Q), 
α1β2(N104Q/N173Q), α1β2(N32Q/N173Q), α1β2(N32Q/N104Q) and 
α1β2(N32Q/N104Q/N173Q) subunit coexpression and probed with anti-α1 antibodies.  
Na+/K+ ATPase was used as loading control (LC).  B, Duplicate of A but probed with 
anti-β2 antibodies.  C, The band intensity of each lane, after being corrected for loading 
variation, was expressed as % of the intensity of the control subunits. Black bars 
represented α1 subunit levels, while grey bars represented β2 subunit levels.  Data were 
presented as mean ± standard deviation.  *, ** and *** indicate p < 0.05, 0.01 and 0.001, 
respectively, relative to control α1β2 subunit coexpression; †, †† and ††† indicate p < 
0.05, 0.01 and 0.001, respectively, relative to α1β2(N32Q/N104Q/N173Q) subunit 
coexpression.  Note that non-specific bands (arrowheads) were detected in β2 subunit 
staining by this batch of antibodies. 
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Total protein level changes of α1 and β2 subunits with α1β2γ2 subunit coexpression 
were similar to those with α1β2 subunit coexpression but were less dependent on the 
β2(N104) residue 
 
The α1β2γ2 receptor is the most abundant receptor isoform in the central nervous 
system (McKernan and Whiting, 1996;Sieghart and Sperk, 2002).  In addition, it has been 
demonstrated that incorporation of γ2 subunits into GABAA receptor pentamers changes 
receptor single channel conductance and macroscopic current kinetics (Angelotti and 
Macdonald, 1993;Haas and Macdonald, 1999).  To determine if incorporation of γ2 
subunits into receptor pentamers affects the dependence on β2 subunit glycosylation sites 
for subunit total protein levels, relative amount of α1 and β2 subunits with or without 
glycosylation site mutations were measured with ternary subunit coexpression. 
With α1β2γ2 subunit coexpression, changes of α1 subunit total protein levels 
were similar to that found with binary subunit coexpression except that β2(N104Q) did 
not significantly reduce α1 subunit expression (n = 3).  Likewise, the β2 subunit total 
protein profile was comparable to that with binary subunit coexpression except that the 
β2(N104Q) subunit total protein level was not significantly reduced (n = 3) (Figure 30).  
This observation suggested that the total protein levels of α1 and β2 subunits with ternary 
subunit coexpression were less affected by the mutation of the N104 glycosylation site. 
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Figure 30.  With ternary α1β2γ2 subunit coexpression, α1 and β2 subunit total protein 
levels were differentially affected by  mutations of β2 subunit glycosylation sites  
 
A, Total proteins were extracted from cells with mock, control α1β2γ2, α1β2(N32Q)γ2, 
α1β2(N104Q)γ2, α1β2(N173Q)γ2, α1β2(N104Q/N173Q)γ2, α1β2(N32Q/N173Q)γ2, 
α1β2(N32Q/N104Q)γ2 and α1β2(N32Q/N104Q/N173Q)γ2 subunit coexpression and 
probed with anti-α1 antibodies.  Na+/K+ ATPase was used as loading control (LC).  B, 
Duplicate of A but probed with anti-β2 antibodies.  C, The band intensity of each lane 
was expressed as % of the intensity of the control subunits. Black bars represented α1 
subunit levels; grey bars represented β2 subunit levels.  Data were presented as mean ± 
standard deviation.  *, ** and *** indicate p < 0.05, 0.01 and 0.001, respectively, relative 
to control α1β2γ2 subunit coexpression; †† and ††† indicate p < 0.01 and 0.001, 
respectively, relative to α1β2(N32Q/N104Q/N173Q)γ2 subunit coexpression.  Note that 
non-specific bands (arrowheads) were detected in β2 subunit staining. 
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The endo H digestion patterns of β2 subunits with α1β2 subunit coexpression were 
different from those with α1β2γ2 subunit coexpression. 
 
It has been demonstrated that folding, oligomerization and assembly of 
oligomeric proteins can affect N-glycan processing at certain positions by hindering their 
presentation to the Golgi resident enzyme, mannosidase II, which confers N-glycans with 
endo H resistance (Cals et al., 1996;Kornfeld and Kornfeld, 1985).  Thus, N-glycans 
conjugated at those sites were removed by endo H glycosidase even though they were 
conjugated to matured glycoproteins.  To determine if N-glycans conjugated to subunits 
in α1β2 receptors are differentially processed compared to those in α1β2γ2 receptors in 
the Golgi apparatus, endo H digestion patterns of N-glycans of α1 and β2 subunits were 
analyzed.  It was predicted that if N-glycan processing at a specific site is hindered by 
partnering γ2 subunits, the N-glycan at that site will be removed by endo H glycosidase, 
which then will appreciably decrease molecular mass of the subunit having the N-glycan 
removed because N-glycans have appreciable molecular masses (more than 1 kDa 
because the core of all forms of N-glycans, which contains two N-acetylglucosamine and 
three mannose residues, weights about 1 kDa). 
With binary α1β2 or ternary α1β2γ2 subunit coexpression, “mature” α1 subunits, 
possessed both endo H sensitive and insensitive N-glycans even though these “mature” 
peptides had presumably been exposed to the Golgi resident glycosidase.  This is 
consistent with the prediction that N-glycan processing at one of the two glycosylation 
sites was hindered by subunit folding and assembly.  Consequently, endo H digestion 
decreased the molecular mass of the mature α1 subunit by 2 kDa, while PNGase F 
digestion reduced its mass by 4 kDa (Figure 31A).  Likewise, with α1β2γ2 subunit 
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coexpression, mature β2 subunits migrated at 51 kDa and contained both endo H resistant 
and sensitive N-glycans (Figure 31B).   
Interestingly, with α1β2, but not α1β2γ2 subunit coexpression, we observed two 
endo H resistant β2 subunit bands with molecular mass 54 and 51 kDa.  This result is 
consistent with two forms of mature β2 subunits.  One mature form contained both endo 
H resistant and sensitive N-glycans as what with α1β2γ2 subunit coexpression; the other 
contained solely endo H resistant N-glycans, which were accessible by Golgi resident 
mannosidase II (Figure 31B, asterisk). 
 
 
 
 
Figure 31.  A 54 kDa endo H resistant band was detected in lysates from cells with α1β2, 
but not α1β2γ2 subunit coexpression 
 
A, RIPA buffer extracted proteins from cells with single subunits (first set), α1β2 (second 
set) and α1β2γ2 (third set) subunit coexpression were undigested (U), or digested with 
endo H (H) or PNGaseF (F).  Proteins were probed with anti-α1 antibodies.  These α1 
subunits, after endo H digestion, showing similar molecular masses (46 kDa) to those 
after PNGaseF digestion were considered endo H sensitive.  B, Duplicate of A but probed 
with anti-β2 antibodies.  * indicates the β2 subunit population, which had all three 
conjugated N-glycans resistant to endo H digestion. 
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The N-glycans at the β2(N32) and β2(N104), but not the β2(N173), glycosylation sites 
were involved in the presence of endo H resistant β2 subunits migrating at 54 kDa 
 
The molecular mass difference between the 54 kDa endo H resistant band and the 
lower 51 kDa molecular mass endo H resistant bands was similar to those caused by 
N32Q or N104Q mutation.  We hypothesized that N-glycans at the N32 or N104 site of 
mature β2 subunits with 54 kDa masses were endo H resistant while those of mature β2 
subunits with 51 kDa masses were endo H sensitive.  Thus, following the removal of the 
N-glycans, the endo H resistant β2 subunits with α1β2 subunit coexpression would 
migrate as single band migrating at the same molecular mass as those with α1β2γ2 
subunit coexpression.  To determine which N-glycans (at N32 or N104) are involved in 
the presence of the endo H resistant band with 54 kDa, single-Q mutant β2 subunits with 
binary subunit coexpression were compared with those with ternary subunit coexpression. 
With α1β2 subunit coexpression, the β2(N32Q) and β2(N104Q) subunits migrated 
as a single endo H resistant band of the same molecular mass as that of undigested and 
fully glycosylated subunits (51 kDa).  In contrast, the β2(N173Q) subunit migrated as 
two endo H resistant bands with the lower molecular mass endo H resistant band 
containing a endo H sensitive N-glycan at one of the two remaining glycosylation sites.  
Molecular masses of endo H resistant β2(N32Q) subunits with ternary subunit 
coexpression were similar to those with binary subunit coexpression, although 
preliminary data  (n = 2) suggested that the β2(N32Q) subunit population with the 
remaining two N-glycans being endo H resistant in α1β2γ2 pentamers was smaller 
(Figure 32A).  Likewise, the endo H digestion patterns of β2(N104Q) subunits with 
binary or ternary subunit coexpression were similar although the endo H resistant 
population with ternary subunit coexpression was bigger (Figure 32B).  Importantly, the 
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β2 subunit endo H digestion patterns with α1β2(N173Q) or α1β2(N173Q)γ2 subunit 
coexpression were different from each other (Figure 32C). 
 
 
 
 
Figure 32.  Processing of the N-glycans at the β2(N173) site was not involved in the 
presence of two endo H resistant bands of β2 subunits with α1β2 subunit coexpression 
 
RIPA buffer extracted proteins from cells with binary α1β2 subunits (lanes 1-3, first set), 
and ternary α1β2γ2 (lanes 4-6, second set) subunit coexpression were undigested (U), or 
digested with endo H (H) or PNGaseF (F).  The β2 subunits in theses expression 
conditions contained single Q mutation at N32 (A, upper panel), N104 (B, middle panel), 
or N173 (C, bottom panel). Proteins were probed anti-β2 antibodies.  Note that there were 
two non-specific bands migrating at 54 and 51 kDa, which were different from previous 
blots (due to different batches of antibodies, which were used in figure 29). 
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Taken together, the data suggest that processing of N-glycans at the N32 and 
N104, but not the N173, sites were involved in conferring the distinct endo H digestion 
patterns of β2 subunits from α1β2 and α1β2γ2 pentamers. 
 
Discussion 
 
 
 
The N-glycans conjugated to individual β2 subunit glycosylation sites had different 
masses 
 
By analyzing the molecular masses of the β2 subunits containing no, single Q, 
double Q, or triple Q mutation of the three N-linked glycosylation sites, it was revealed 
that the N-glycans conjugated to individual β2 subunit glycosylation site had different 
masses.  The decrease in molecular mass by removing individual glycosylation sites 
(single Q mutation) correlated well with the increase in molecular mass by keeping 
individual glycosylation sites (double Q mutation).  For instance, relative to the wild-type 
β2 subunit, mutation of the N173 site resulted in a smaller decrease in molecular mass 
than mutation of N32 or N104 sites, consistent with a smaller contribution by the N-
glycan at the N173 site (evaluated by subtracting the molecular mass of the triple Q 
subunit from that of the β2(N32Q/N104Q) subunit) than those at other two glycosylation 
sites.  This consistency weakened the possibility that the molecular mass differences were 
caused by modifications at other regions secondary to the N to Q mutations.  Of note, due 
to rounding off error, the observed molecular mass of the fully glycosylated β2 subunit 
(54 kDa) was slightly higher than the calculated molecular mass (53 kDa) (obtained by 
adding the molecular mass contributions from individual N-glycans). 
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It is worth pointing out that the two apparent populations of β2(N104Q/N173Q) 
subunits migrating at 47 and 49 kDa suggested that only a fraction (66%) of the β2 
subunits are glycosylated at N32.  Incomplete N32 glycosylation could have resulted 
from weak recognition of the glycosylation site, i.e., the glycosylation site might not be 
fully glycosylated.  Alternatively, incomplete glycosylation could have resulted from 
removal of the whole N-glycan from this site during the folding and maturation processes, 
i.e. the glycosylation site might be de-glycosylated. 
 
The β2(N104) site is on the minus side of subunit-subunit interface 
 
Based on homology modeling, the β2(N104) site of GABAA receptors is 
comparable to the α(K77) site (numbering from mature peptide) of nACh receptors from 
T. marmorata (Ernst et al., 2005;Akabas, 2004).  Since α(K77) site of the nACh receptor 
is close to the minus side of α subunit interface R79 (Unwin, 2005), it is predicted that 
the N104 site is located on the minus side of GABAA receptor β2 subunit inter-subunit 
interface and that glycosylation at this site is important for α1-β2, β2-β2, and γ2-β2 
subunit interactions (Figure 33). 
Consistent with the predicted role of the N104 glycosylation, with binary subunit 
coexpression, N104 is necessary and sufficient for full level of receptor surface 
expression.  Because about 40% of control α1β2 receptor level remained following the 
β2(N104Q) mutation, the interactions between β2(N104Q) and partnering subunits were 
not likely to be totally abolished.  In agreement with this prediction, α1, β2 and γ2L 
subunits co-immunoprecipitated from extracted of cells treated with tunicamycin 
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suggesting that glycosylation was not absolutely required for subunit oligomerization 
(Connolly et al., 1996). 
Preliminary data examining effects of β2 subunit glycosylation site mutations on 
α1β2γ2 receptor surface levels showed similar trend as those of α1β2 receptors (data not 
shown).  The surface level profile was also similar to the α1 subunit total protein levels.  
By referring to the α1 subunit total protein level profile, it is suggested that the N104 site 
is less necessary for ternary receptor biogenesis because mutations of the site did not 
significantly reduce α1 subunit total protein levels.  The difference may result from the 
postulated replacement of a β2 subunit by a γ2 subunit in an α1β2γ2 pentamer, and thus, 
the impairment on α1β2γ2 receptor biogenesis is less severe (Figure 33). 
 
 
 
 
Figure 33.  The N104 site in the β2 subunit was located on the minus side of inter-subunit 
interface and was predicted to play a role in α1-β2, β2-β2, or γ2-β2 subunit interaction 
 
A, The predicted stoichiometry of the α1β2 receptor is presented.  A GABAA receptor is 
believed to contain at least two α and two β subunits.  The fifth position could be taken 
by a β subunit (as shown here) or α subunit. B, The predicted stoichiometry of the 
α1β2γ2 receptor is presented.  The γ2 subunit is predicted to replace the β2 subunit (or α1 
subunit) in the fifth position. 
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The distinct endo H digestion patterns of β2 subunits in α1β2 and α1β2γ2 receptors 
may result from conformational differences 
 
Following endo H digestion, a population of β2 subunits that migrated at 54 kDa 
and contained all conjugated N-glycans being processed was specifically detected in 
lysates from cells transfected with α1 and β2 subunits but not from cells with α1β2γ2 
subunit coexpression.  The appearance of the special population could be contributed by 
the β2 subunits taking the fifth position, which could be incorporated into the receptor 
pentamer differently from the other two β2 subunits.  Alternatively, the disappearance of 
this specific population could have resulted from the conformational changes induced by 
γ2 subunit incorporation, and steric hindrance preventing β2 subunit N-glycan processing 
by mannosidase II in the Golgi apparatus.  If the population containing all of the three 
conjugated N-glycans being endo H resistant is contributed solely by the β2 subunits 
taking the fifth position, it is predicted that this population is 50% of (for α12β23 
stoichiometry) or smaller than (for mixed receptor isoforms, α12β23 and α13β22) the other 
endo H resistant population with lower molecular mass.  Since the two endo H resistant 
populations were similar in size (Figure 31), it is likely that the exclusive presence of the 
54 kDa endo H resistant β2 subunits in α1β2 receptors but not α1β2γ2 receptors resulted 
from the conformational differences between the two receptor isoforms. 
With ternary subunit coexpression, the molecular masses of endo H resistant β2 
subunits containing single-Q mutation at either N32 or N104 sites were the same as those 
undigested subunit that were fully glycosylated suggesting that the incorporation of γ2 
subunits only decreases molecular masses of endo H resistant β2 subunits when both N32 
and N104 sites were retained.  Consistent with postulation, molecular masses of endo H 
resistant β2 subunits with the N173Q mutation were decreased by the incorporation of γ2 
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subunits.  By comparing the molecular masses of the endo H resistant population of β2 
subunits with α1β2γ2 subunit coexpression to the molecular masses of β2(N32Q/N104Q) 
subunits, it is less likely that the presence of γ2 subunits hindered glycan processing at 
both N32 and N104 sites, since it would result in removal of N-glycans at both sites and 
produce β2 subunits that would migrate at the same molecular mass as the 
β2(N32Q/N104Q) subunits.  Thus, incorporation of γ2 subunits into a pentamer further 
hinders N-glycan processing at the N32 or N104 site but not at both.   
Since pentameric assembly can hinder processing of N-glycans at specific sites, it 
is possible that some “mature” subunits, which have been trafficked beyond Golgi 
apparatus, contain no endo H resistant N-glycans and were not migrated at higher 
molecular mass than those digested with PNGaseF.  With ternary subunit coexpression, a 
large population of β2 subunits containing the N32Q mutations migrated at molecular 
mass equal to those digested with PNGaseF.  Given that the N32Q mutation did not 
reduce receptor surface levels, it is less likely that the β2 subunits with N32Q mutation 
were ER retained.  It is possible that processing of N-glycans conjugated to the N104 and 
N173 sites of β2(N32Q) subunits were hindered by the presence of γ2 subunits and were 
removed by endo H glycosidase even though the β2(N32Q) subunits have been trafficked 
beyond the Golgi apparatus. 
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α1β2(D450A) and α1β2(N173Q) subunit coexpression 
 
The molecular mass shifts caused by the β2 subunit D450A mutation, which 
resulted in profound subunit surface-level reductions to less than 10% of control subunits, 
were mimicked by the β2 subunit mutation, N173Q.  However, α1β2(N173Q) receptor 
surface levels were not decreased significantly, suggesting that lacking glycosylation at 
the N173 site was not the cause of the reduced surface expression but resulted 
secondarily from the β2 subunit mutation, D450A.  As shown in figure 25, the N173 site 
is right before one of the two cysteines that form the signature Cys-loop, and thus a 
change in Cys-loop disulfide bond formation might prevent glycosylation at N173.  The 
integral membrane chaperone calnexin can interact with N-glycans of glycoproteins and 
regulate disulfide bond formation of the protein through its association with the ERp57, a 
homologue of protein disulfide isomerase (PDI) (Frickel et al., 2002). 
It is possible that calnexin also interacts with the D450 residue and coordinates 
communication between the subunit N-terminal domain and the cytoplasmic loop, two 
regions separated by the lipid bilayer.  The D to A mutation then might impair the 
interaction between calnexin and the subunit cytoplasmic loop (David et al., 1993), and 
affect formation of the signature disulfide bond in the N-terminal domain.  Finally, due to 
this misfolding of the N-terminal domain microenvironment, glycosylation at the N173 
site is blocked.  It remains to be established whether or not the D to A mutation impairs 
Cys-loop disulfide bond formation, and whether or not the cytoplasmic loop interacts 
with calnexin (Figure 34). 
The conserved aspartate residue is located at the boundary of the M3-M4 loop and 
M4 domain.  Based on the homology modeling, it is at the N-terminal end of the M4 
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helix.  Although mutations at the helix end are less likely to affect the insertion of helix 
(Gallagher et al., 2007;Hessa et al., 2005), we cannot rule out the possibility that the D to 
A mutations affect secondary structure of the M4 helix and cause the misfolding of the 
microenvironment containing the N173 site. 
 
 
 
 
Figure 34.  The conserved aspartate residue in the M3-M4 cytoplasmic loop might affect 
interaction between the β2 subunit microenvironment and the calnexin 
 
The proposed interaction between the microenvironment of GABAA receptor β2 subunit 
and the calnexin is presented.  It is postulated that the calnexin interacts with the N-
glycan conjugated to N173 (in the consensus sequence N-C-T, where the C is the second 
cysteine involved in forming the signature Cys-loop) as well as a homologue of PDI, 
ERp57.  The mutation of the conserved aspartate residue in the β2 subunit may impair 
interaction between the β2 subunit and calnexin.  Consequently, signature Cys-loop 
formation of β2 subunit is affected, and glycosylation at N173 is blocked due to the mild 
misfolding of the local region. 
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Conclusions and future directions 
 
This is the first demonstration showing that the three putative β2 subunit 
glycosylation sites are functional with their conjugated N-glycans having different 
molecular masses.  The suggested differential N-glycan processing, such as de-
glucosylation and de-mannosylation, requires further analysis of the structures of N-
glycans conjugated the three β2 subunit glycosylation site.  The finding that the β2 
subunit site, N32, is not completely glycosylated further suggests the complex nature of 
glycosylation.  It remains to be elucidated if other GABAA receptor subunits have their 
N-glycans processed differently and have incomplete N-glycan conjugation like N32.   
Based on homology modeling, the N104 site is located on the β2 subunit minus 
side for subunit-subunit interaction.  The significant decreases of α1 and β2(N104Q) 
subunit surface and total protein levels with α1β2(N104Q) subunit coexpression thus 
could have resulted from impairment of subunit oligomerization and receptor assembly.  
Consistently, it has been demonstrated in the muscle-type nACh receptor that some 
glycosylation sites are essential for receptor assembly (Wanamaker and Green, 2005).  
An immunoprecipitation assay could determine if the oligomerization of subunits is 
impaired or not.   
Because the β2 subunit glycosylation site, N173, is in close proximity to one of 
the Cys-loop cysteines, the redox status of the Cys-loop cysteines may regulate 
glycosylation at this site.  It is possible that the β2 subunit mutation, D450A, disturbs 
Cys-loop disulfide bond formation, which then affects glycosylation on residue N173.  
The redox status of Cys-loop cysteines could be evaluated by native gel electrophoresis. 
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Furthermore, the endo H digestion patterns suggest that incorporation of a γ2 
subunit into the fifth position changes receptor conformation.  Endo H resistance is 
conferred by a Golgi apparatus resident enzyme, and occurs only after assembly of 
pentameric receptors.  Therefore, with coexpression of α1 and β2 subunits, existence of a 
β2 subunit population with three endo H resistant N-glycans would be an indication of 
the assembly of α1β2 receptors.  It remains to be established if other subunits, such as δ, ε, 
θ and π, which are predicted to take the fifth position, could induce similar 
conformational changes and result in the disappearance of the 54 kDa endo H resistant β2 
subunits.  If this phenomenon is specific to α1β2 receptors, it may be applicable for the 
identification of α1β2 receptors in vivo. 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
Studies presented in this dissertation provide information on GABAA receptor 
biogenesis 
 
Genetic-linkage studies have associated several Cys-loop receptor mutations or 
polymorphisms with epilepsy syndromes, startle syndromes, congenital myasthenic 
syndromes and affective disorders, and many of these mutations have been shown to 
disturb the delicate balance between receptor biogenesis and turn over.  The resultant 
alterations of receptor surface density are usually accompanied by dysfunction of Cys-
loop receptors.  In these cases, modulation of Cys-loop biogenic steps is a therapeutic 
option, which requires a good understanding of biogenic steps, particularly on how 
receptor subunits interact with one another and with regulatory cellular proteins. 
For the studies reported in this dissertation, mutagenesis, which actively mutates 
regions of interests, was employed to identify structural determinants of receptor 
biogenesis because these sites are where interactions between subunits and regulatory 
cellular machineries occur.  As an initial approach to structural domains involved in 
biogenesis, the relative requirement of individual α1, β2 and γ2 subunit M3-M4 loops 
was evaluated.  Since a disturbance in any step of subunit or receptor biogenesis will alter 
receptor surface expression, subunit surface levels were measured using flow cytometry 
to determine whether or not specific structural domains are necessary for receptor surface 
expression.  Consistent with receptor subunit heterogeneity, the three α1, β2 and γ2 
subtype M3-M4 loops were differentially required for receptor surface expression.  A 
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sequential deletion of subunit M3-M4 loops led to the identification of a structural 
residue located at the boundary of the M3-M4 loop and M4 domain that was 
indispensable for receptor surface expression.  Furthermore, a combination of glycosidase 
digestion, BFA treatment, analytical centrifugation and immunoprecipitation established 
that this residue is required for late stages of receptor assembly. 
The finding that a single C-terminal residue in the M3-M4 loop is required for 
receptor assembly explains the observation that γ2 subunit M3-M4 loop deletion 
drastically reduced γ2 subunit surface expression, but only mildly reduced α1β2 receptor 
surface expression.  It has been demonstrated that the presence of the γ2 subunits resulted 
in preferential assembly of the ternary α1β1γ2 receptors (Angelotti and Macdonald, 
1993).  Therefore, the conserved residue may play a role in preferred α1β1γ2 receptor 
biogenesis.  Given the observation that the residue was not absolutely required for the 
early steps of subunit oligomerization, the mechanism favoring ternary over binary 
receptor biogenesis may occur at later steps of pentameric assembly. 
Furthermore, the requirement of the conserved aspartate residue or C-terminal 
portions of the M3-M4 loop suggest a pathogenic mechanism for the γ2 subunit mutation, 
Q351X, that is associated with associated an IGE.  Since the Q351X mutation results in 
deletion of the conserved residue, the γ2(Q351X) subunit may be poorly incorporated 
into a receptor pentamer, and thus, would be retained in the ER.  Consequently, the 
surface receptor isoform expression profile is changed.  The Q351X mutation might 
mirror the effect of losing functional αβγ2 receptors in γ2 subunit knock-out mice, i.e. 
homozygously, causing neonatal lethal, and heterozygously/haploinsufficiently, causing 
increased anxiety (Chandra et al., 2005;Essrich et al., 1998).  Furthermore, the ER 
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retained mutant γ2(Q351X) subunits could have additional effects and cause apoptosis of 
neuronal cells (Kang et al., unpublished).   
Intriguingly, while α1(D420A) subunits caused a substantial reduction of receptor 
surface levels to an extent not significantly different from that caused by β2(D450A) 
subunits, α1(loop∆) subunits caused significantly less receptor surface level reduction 
than that caused by β2(loop∆) or β2(D450A) subunits.  The relatively long extracellular 
tails of α subunits may account for the difference.  It is possible that after removing large 
portions of the subunit M3-M4 loops, a second α1 subunit structural motif of receptor 
assembly is activated that allows some extent of receptor assembly.  An α subunit motif 
at the boundary of the M4 domain and extracellular tail is either N-R-E-S/P (for α1-3 and 
5) or S-K-D-T (for α4 and 6), which is similar to the I-D-R motif in a reverse way, is a 
potential candidate for the second assembly determinant.  Supporting this postulate, 
deletion of the α1 subunit extracellular tail further reduced the surface level of 
α1(loop∆)β2 receptors to an extent not different from α1β2(loop∆) subunit coexpression.  
Several lines of evidence suggest that the extracellular tails of Cys-loop receptor subunits 
are important for pentamer assembly.  The α subunit charged residues flanking both ends 
of its M4 domain have been demonstrated to be important for nACh receptor assembly 
and surface expression (Roccamo and Barrantes, 2007).  Additionally, mutations of the 
nACh receptor ε subunit that resulted in the removal of a cysteine near the tip of the 
extracellular tail have also been shown to affect receptor surface expression (Ealing et al., 
2002). 
This is the first report showing that GABAA receptor assembly is regulated by a 
structural determinant that is not in the N-terminal domain and is on the opposite side of 
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the lipid bilayer.  While the lipid-bilayer provides a two-dimensional plane for receptor 
folding, oligomerization, assembly, and finally (through membrane fusion) functional 
presentation on the cell surface, it imposes a physical barrier hindering communication of 
proteins binding to GABAA receptor subunit extracellular/ER luminal or cytoplasmic 
portions.  Transmembrane proteins such as calnexin are predicted to coordinate the 
events occurring in the two compartments.  Supporting the postulate that the cytoplasmic 
conserved aspartate residue interacts with some transmembrane protein, the cytoplasmic 
D to A mutation altered the glycosylation patterns of α1(D420A) and β2(D450A) 
subunits in the extracellular/ER luminal compartment. 
The N-linked glycosylation site at the β2(N173) position is conserved in nACh 
and 5-HT3 receptors (with the exceptions of the nACh receptor α9 and α10 subunits) and 
has been demonstrated to be essential for receptor assembly (Green and Wanamaker, 
1997).  Furthermore, mutation of this position in the GABAA receptor δ subunit, E177A, 
has been associated with IGEs and decreased GABAA receptor surface expression (Feng 
et al., 2006;Macdonald et al., 2004).  The charged E177 residue in the δ subunit and the 
N-glycan-attached glycosylation site in the nACh and 5-HT3 receptors may play similar 
roles in pentamer assembly, and the flexibility of glycosylation modification may confer 
another level of assembly regulation.  Although glycosylation of GABAA and glycine 
receptors occurs less frequently at this position, all three GABAA receptor β subunits 
contain a glycosylation site here.  Intriguingly, preventing glycosylation at the N173 site 
by N to Q mutation did not cause reduction of receptor surface level.  Thus, the lack of 
glycosylation at N173 caused by the D to A mutation is more likely a result of the 
disturbed biogenesis step(s) and not a cause of the assembly failure.  Cys-loop motifs 
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have asymmetric contributions to muscle-type nACh receptor subunit oligomerization 
(Fu and Sine, 1996), which may account for the different effects of the β2 subunit, 
N173Q, and δ subunit, E177A, mutations on GABAA receptor surface expression. 
Based on homology modeling, the N104 glycosylation site is located on the β2 
subunit minus side for subunit-subunit interaction.  It is predicted that the N104Q 
mutation impaired, but did not abolish, subunit oligomerization, since glycosylation is not 
absolutely required for subunit oligomerization (Connolly et al., 1996).  Supporting the 
hypothesis, the β2 subunit, N104Q, mutation incompletely decreased subunit surface and 
total protein levels of both mutated and wild-type partnering subunits with binary subunit 
coexpression.  Based on the established stoichiometry of α1β2 and α1β2γ2 receptors and 
assuming that the γ2 subunit replaces a β2 subunit to form an α1β2γ2 receptor pentamer, 
the β2 subunit, N104Q, mutation would caused less severe reduction of subunit surface 
and total protein levels.  Changes of α1 and β2 subunit total protein levels with ternary 
subunit coexpression in response to the N104Q mutation supported this prediction.  
Whether it is also true for receptor surface levels remains to be investigated. 
 
Studies presented in this dissertation provide information on biogenesis of Cys-loop 
receptors 
 
The aspartate residue described in chapter III is conserved across all 45 subunits 
of human Cys-loop receptors, and it may be conserved across all species, given that Cys-
loop receptor subunit orthologs (genes from different species) share higher sequence 
similarity than paralogs (genes of the same species).  While the structural determinant of 
GABAA receptor assembly identified in this study is the first residue that has been 
reported to be outside the N-terminal domain, several mutations in the subunit C-terminal 
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portions have been shown to affect receptor subunit oligomerization (Ealing et al., 
2002;Quiram et al., 1999) or surface function (Rea et al., 2002;Shen et al., 2005). 
Particularly, the nACh receptor ε subunit mutation, N436∆, which is a mutation 
that deletes the asparagine residue in an L-D-N motif (an equivalent of the I-D-R motif of 
GABAA receptor α1 and β2 subunits) has been associated with CMS and shown to 
decrease receptor current amplitudes (Shen et al., 2005).  The glycine receptor α1 subunit 
mutation, R428H, which mutates the arginine residue in the I-D-K-I-S-R motif to a 
histidine (where the I-D-K is the equivalent of the I-D-R motif of GABAA receptor α1 or 
β2 subunit), has been associated with startle disease and demonstrated to reduce receptor 
surface levels (Rea et al., 2002).  While the mutations reveal the importance of the region 
near the M3-M4 loop and M4 domain junction for receptor function, the underlying 
mechanisms are less well understood.  Given the postulate that Cys-loop receptors share 
early biogenic steps due to the similar topology and combinatory nature, the finding of 
this study might be applicable to other Cys-loop receptors.  Therefore, it might be true for 
all Cys-loop receptors that the region at the boundary of the cytoplasmic loop and M4 
domain contains structural determinants for receptor assembly, and mutations occurring 
in this region will disturb early steps of receptor biogenesis. 
 
Future directions 
 
The requirement of the cytoplasmic loop aspartate residue for receptor assembly 
and the necessity for glycosylation of the N-terminal residue (e.g. N173) suggest that 
events associated with the GABAA receptor subunit extracellular domain (e.g. 
glycosylation) and those associated with the intracellular loop manage to communicate 
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across the physical barrier presented by the lipid bilayer.  Therefore, the protein 
machinery interacting with the conserved aspartate residue and regulating receptor 
assembly should contain at least a transmembrane protein coordinating the events 
occurring in the two compartments on opposite sides of the membrane.   
A potential candidate for this task is the ER resident transmembrane protein, 
calnexin, which has been shown to associate with GABAA receptors (Connolly et al., 
1996).  Calnexin contains a large N-terminal domain that is located in the ER lumen, a 
transmembrane domain, and a 90 amino acid long cytoplasmic tail (David et al., 1993).  
The structure of its N-terminal domain has been resolved at 2.9Å and is composed of a 
lectin domain responsible for monovalent glycan binding and an extended arm involved 
in interaction with PDI (Schrag et al., 2001).  Hypothetically, the effect of the β2 subunit 
mutation, D450A, could cause the disorientation of the calnexin and PDI-containing 
protein complex.  Given that calnexin also coordinates disulfide-bond formation through 
its interaction with PDI and that the β2 subunit residue, N173, and the conserved Cys-
loop cysteine are adjacent to each other, the D to A mutations might have direct effects 
on subunit disulfide bond formation, which in turn, cause de-glycosylation/non-
glycosylation of N173.  This putative effect preventing disulfide bond formation might 
not be severe enough to activate ERAD or to prevent subunit oligomerization, but might 
be the actual cause of the assembly failure at later steps. 
Since calnexin is a lectin-like protein that can interact with GABAA receptor 
subunits through multiple glycosylation sites, the lack of glycosylation at the N173 site 
caused by the β2 subunit mutation, D450A, is not likely to abolish interactions between 
calnexin and β2(D450A) subunits.  Thus, to verify the hypothesis postulated above, it is 
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necessary to establish the interactions between the C-terminal portions (downstream of 
the transmembrane domain) of calnexin and the cytoplasmic portions (containing the 
conserved aspartate residue) of GABAA receptor subunits.  The interactions are not 
necessarily direct; therefore, an assay showing that a GST-fusion protein containing the 
cytoplasmic tail of calnexin pulls down a protein complex containing GABAA receptors, 
or vice versa, will establish the interaction.  It is also necessary to determine if the D to A 
mutations prevent disulfide bond formation, and if preventing disulfide bond formation 
causes assembly failure.  The later can be tested using reducing reagents such as 
glutathione on cells; while the former can be determined by separating GABAA receptor 
subunits using SDS-PAGE without reducing reagents.  It is predicted that if the disulfide 
bond formation is affected by the D to A mutation, the mutant subunits will have 
different mobility from wild-type subunits. 
The preliminary regional deletion results of this study suggested a role of α1 
subunit extracellular tail in receptor biogenesis.  The involvement of the reverse 
consensus R-E-P motif located on the opposite side of the lipid bilayer to regulate 
receptor biogenesis remains to be determined.  If it is proven to be true, the associated 
proteins may have the capability to flip between different compartments. 
The conserved aspartate residue is predicted to be important for assembly of all 
Cys-loop receptors based on its absolute conservation.  Given the great heterogeneity of 
Cys-loop receptors, this prediction, particularly, whether the ε(N436∆) mutation of nACh 
receptor and the α1(R428H) mutation of glycine receptor impair pentameric receptor 
assemble remain to be examined.  Likewise, although it is postulated that the early 
biogenic steps of Cys-loop receptors are conserved in different cell types, such as 
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epithelial cells and neurons (based on the wide distribution of Cys-loop receptors), 
whether the conserved aspartate residue is as important as what have been shown in 
present studies in HEK cells remains to be examined. 
By measuring the surface levels of α1 and β2(N104Q) subunits with binary 
subunit coexpression, it suggested that the biogenesis of α1β2(N104Q) receptors was 
disturbed by the glycosylation site mutation.  Since the N104 glycosylation site is on the 
β2 subunit minus side for subunit-subunit interaction, it may decrease the efficiency for 
β2 subunits to oligomerize with partnering subunits.  An immunoprecipitation assay may 
provide evidence of this prediction.  Furthermore, analytic centrifugation analyzing 
oligomerized/assembled protein complexes containing GABAA receptor subunits would 
help to determine if the β2(N104Q) mutation caused receptor assembly impairment. 
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